<SEC-DOCUMENT>0001493152-23-026375.txt : 20230802
<SEC-HEADER>0001493152-23-026375.hdr.sgml : 20230802
<ACCEPTANCE-DATETIME>20230802092024
ACCESSION NUMBER:		0001493152-23-026375
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230801
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230802
DATE AS OF CHANGE:		20230802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		231133945

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:SMTI="http://sanaramedtech.com/20230801">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_SMTI_sanaramedtech.com_20230801 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230801_20230801 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityCentralIndexKey">0000714256</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20230801.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-08-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 18pt">UNITED
STATES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 18pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 40%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 18pt">FORM
<span id="xdx_901_edei--DocumentType_c20230801__20230801_zY8qop3eIfCc"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported): <b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_901_edei--DocumentPeriodEndDate_c20230801__20230801_zEUOFgewJ3Te"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August
1, 2023</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20230801__20230801_zAAoMApIej18"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityRegistrantName">SANARA
MEDTECH INC.</ix:nonNumeric></span></b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20230801__20230801_zkwJOBLlzaEj"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityFileNumber_c20230801__20230801_z33Vgzo2ZKuh"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityFileNumber">001-39678</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20230801__20230801_zUQf2Vhr2VT6"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityTaxIdentificationNumber">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20230801__20230801_zTLQol2UG4Ie"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityAddressAddressLine1">1200 Summit Avenue</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20230801__20230801_zpS9lDtxA1W1"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityAddressAddressLine2">Suite 414</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityAddressCityOrTown_c20230801__20230801_zHxxobvD3ZMj"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityAddressCityOrTown">Fort Worth</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20230801__20230801_zphl8dS5StR8"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityAddressPostalZipCode_c20230801__20230801_zZShSGb9W00g"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:EntityAddressPostalZipCode">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&#8217;s telephone number, including area
code: <b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--CityAreaCode_c20230801__20230801_zJ0j6Rkjtlba"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:CityAreaCode">(817)</ix:nonNumeric></span> <span id="xdx_905_edei--LocalPhoneNumber_c20230801__20230801_zoY06hF6u486"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:LocalPhoneNumber">529-2300</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed since last
report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable</b></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--WrittenCommunications_c20230801__20230801_zG9Cr4sxsYn1"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--SolicitingMaterial_c20230801__20230801_zC4n3CSsfUR8"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--PreCommencementTenderOffer_c20230801__20230801_zTCXz8c0vc43"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20230801__20230801_zRcuHVa3mnsl"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b) of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    </b></span><b>Symbol(s)</b></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20230801__20230801_zmjrev8RThh1"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20230801__20230801_zsiDezpsrP55"><ix:nonNumeric contextRef="AsOf2023-08-01" name="dei:TradingSymbol">SMTI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The <span id="xdx_909_edei--SecurityExchangeName_c20230801__20230801_zMNmavGu5iR5"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">Emerging growth company <span style="font-size: 10pt; font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20230801__20230801_zAEg7S3yasi7"><ix:nonNumeric contextRef="AsOf2023-08-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entry into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><i style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2023,
Sanara MedTech Inc., a Texas corporation (the &#8220;Company&#8221;), entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;)
by and among the Company, as guarantor, Sanara MedTech Applied Technologies, LLC, a Texas limited liability company and wholly
owned subsidiary of the Company (the &#8220;Purchaser&#8221;), The Hymed Group Corporation, a Delaware corporation (&#8220;Hymed&#8221;),
Applied Nutritionals, LLC, a Delaware limited liability company (&#8220;Applied&#8221; and, together with Hymed, the &#8220;Sellers&#8221;),
and Dr. George D. Petito (the &#8220;Owner&#8221;), pursuant to which the Purchaser acquired certain assets of the Sellers and the Owner,
including, among others, the Sellers&#8217; and Owner&#8217;s inventory, intellectual property, manufacturing and related equipment,
goodwill, rights and claims, other than certain excluded assets, all as more specifically set forth in the Purchase Agreement (collectively,
the &#8220;Purchased Assets&#8221;), and assumed certain Assumed Liabilities (as defined in the Purchase Agreement), upon the terms and
subject to the conditions set forth in the Purchase Agreement (such transaction, the &#8220;Asset Purchase&#8221;). The Purchased Assets
include the rights to manufacture and sell CellerateRX Surgical Activated Collagen (Powder and Gel) (&#8220;CellerateRX Surgical&#8221;)
and HYCOL Hydrolyzed Collagen (Powder and Gel) (&#8220;HYCOL&#8221;) products for human wound care use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Purchased Assets
were purchased for an initial aggregate purchase price of $15.25 million, consisting of (i) $9.75 million in cash (the
&#8220;Cash Closing Consideration&#8221;), (ii) 73,809 shares of the Company&#8217;s common stock, par value $0.001 per share
(the &#8220;Stock Closing Consideration&#8221;), with an agreed upon value of $3.0 million and (iii) $2.5 million in cash (the &#8220;Installment
Payments&#8221;), to be paid in four equal installments on each of the next four anniversaries of the closing of the Asset Purchase (the
&#8220;Closing&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Hymed is a contract
manufacturer specializing in the research and development of natural, innovative products. Hymed utilizes collagen and glycosaminoglycan
chemistry for the human and veterinary markets with applications in wound care, joint/tissue support, eye care, surgery, dental and dermatology.
As a sister company to Hymed, Applied manufactures state-of-the-art products with formulas based on collagen, hyaluronic acid and glycosaminoglycan
chemistry. The Company licenses certain of its products from Applied through a sublicense (the &#8220;Sublicense Agreement&#8221;)
with CGI Cellerate RX, LLC (&#8220;CGI Cellerate RX&#8221;). Pursuant to the Sublicense Agreement, the Company has an exclusive,
world-wide sublicense to distribute CellerateRX Surgical and HYCOL products into the surgical and wound care markets. The Company pays
royalties based on the annual Net Sales (as defined in the Sublicense Agreement) of licensed products consisting of 3% of all collected
Net Sales each year up to $12.0 million, 4% of all collected Net Sales each year that exceed $12.0 million up to $20.0 million, and 5%
of all collected Net Sales each year that exceed $20.0 million. In connection with the Asset Purchase, Applied assigned its license
agreement with CGI Cellerate RX to the Purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the
Cash Closing Consideration, Stock Closing Consideration and Installment Payments, the Purchase Agreement provides that the Sellers are
entitled to receive up to an additional $10.0 million (the &#8220;Earnout&#8221;), which is payable to the Sellers in cash, upon the
achievement of certain performance thresholds relating to the Purchaser&#8217;s collections from net sales of a collagen-based product
currently under development. Upon expiration of the seventh anniversary of the Closing, to the extent the Sellers have not earned
the entirety of the Earnout, the Purchaser shall pay the Sellers a pro-rata amount of the Earnout based on collections from net sales
of the product, with such amount to be due credited against any Earnout payments already made by the Purchaser (the &#8220;True-Up
Payment&#8221;). The Earnout, minus the True-Up Payment and any Earnout payments already made by the Purchaser, may be earned at any
point in the future, including after the True-Up Payment is made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
customary representations, warranties and obligations of the parties, including, among others, certain confidentiality and nonsolicitation
covenants. The parties each have customary indemnification obligations and rights under the terms of the Purchase Agreement, including
with respect to breaches of certain representations and warranties and failure to observe and perform certain covenants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Purchase Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full
text of the Purchase Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K (this &#8220;Current Report&#8221;)
and is incorporated by reference into this Item 1.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement attached
as Exhibit 2.1 hereto is included to provide investors and security holders with information regarding its terms, and it is not intended
to provide any other factual information about the Company, the Sellers, the Owner, the Purchaser or their respective subsidiaries and
affiliates. The representations, warranties and covenants contained in the Purchase Agreement were made only for the purposes of the Purchase
Agreement and only as of the date of the Purchase Agreement or such other date as is specified in the Purchase Agreement and are qualified
by information in confidential disclosure schedules provided by the Purchaser and the Sellers in connection with the signing of the Purchase
Agreement. These confidential disclosure schedules contain information that modifies, qualifies and creates exceptions to the representations
and warranties and certain covenants set forth in the Purchase Agreement. Moreover, certain representations and warranties in the Purchase
Agreement were used for the purpose of allocating risk between the Company, the Sellers, the Purchaser and the Owner rather than establishing
matters as facts. Information concerning the subject matter of the representations and warranties may change after the date of the Purchase
Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s public disclosures. Accordingly, the
representations and warranties in the Purchase Agreement should not be relied upon as characterizations of the actual state of facts about
the Company, the Sellers, the Purchaser or the Owner, and the Purchase Agreement should be read in conjunction with the Company&#8217;s
Forms 10-K, Forms 10-Q and other documents that are filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><i style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><i style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional Services Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Asset Purchase and pursuant to the Purchase Agreement, effective August 1, 2023 (the &#8220;Effective Date&#8221;),
the Company entered into a professional services agreement (the &#8220;Services Agreement&#8221;) with the Owner, pursuant to
which the Owner, as an independent contractor, agreed to provide certain services to the Company, including, among
other things, assisting with the development of products already in development and assisting with research, development, formulation,
invention and manufacturing of any future products (the &#8220;Services&#8221;). As consideration for the Services, the Owner is entitled
to receive: (i) a base salary of $12,000 per month during the term of the Services Agreement, (ii) a royalty payment equal to three percent
(3%) of the actual collections from net sales of certain products the Owner develops or co-develops that reach commercialization, (iii)
a royalty payment equal to five percent (5%) for the first $50.0 million in aggregate collections from net sales of certain future products
and a royalty payment of two and one-half percent (2.5%) on aggregate collections from net sales of certain future products on any amounts
exceeding $50.0 million but up to $100.0 million, (iv) $500,000 in cash in the event that 510(k) clearance is issued for any future product
accepted by the Company and (v) $1.0 million in cash in the event that a U.S. patent is issued for a certain product; <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>provided
</i></span>that with respect to the incentive payments described in (iv) and (v) of the foregoing, the Owner shall not earn more
than $2.5 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Services Agreement
has an initial term of three years and is subject to automatic successive one-month renewals unless earlier terminated in accordance
with its terms. The Services Agreement may be terminated upon the Owner&#8217;s death or disability or by the Company or the
Owner &#8220;For Cause&#8221; (as defined in the Services Agreement); <i>provided</i>, however, that the base salary described in (i) of the foregoing paragraph shall survive termination
through the three-year initial term and the royalty payments and incentive
payments described in (ii)-(v) of the foregoing paragraph shall survive termination of the Services Agreement. The Services Agreement
contains customary representations, warranties and obligations of the parties, including, among others, certain confidentiality, indemnification,
noncompetition and nonsolicitation covenants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the Services
Agreement is a summary only and does not purport to be complete and is subject to, and qualified in its entirety by, the full text of
the Services Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report and is incorporated by reference into this Item
1.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><i style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the entry into the Purchase Agreement, on August 1, 2023, the Purchaser, as borrower, and the Company, as guarantor, entered into
a Loan Agreement (the &#8220;Loan Agreement&#8221;) with Cadence Bank (the &#8220;Bank&#8221;) providing for, among other things, an
advancing term loan in the aggregate principal amount of $12.0 million (the &#8220;Term Loan&#8221;), which was evidenced by an advancing
promissory note (the &#8220;Advancing Term Note&#8221;). Pursuant to the Loan Agreement, the Bank agreed to make, at any time and
from time to time prior to February 1, 2024, one or more advances to the Purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The proceeds of the
advances under the Loan Agreement will be used for working capital and for purposes of financing up to one hundred percent (100%)
of the Cash Closing Consideration and Installment Payments for the Asset Purchase and related fees and expenses, including any subsequent
payments that may be due to the Sellers after the Closing. On the Effective Date, the Bank, at the request of the Purchaser, made an
advance for $9.75 million. The proceeds from the advance were used to fund the Cash Closing Consideration for the Asset
Purchase.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Advances under
the Term Loan will begin amortizing in monthly installments commencing on August 5, 2024. All remaining unpaid balances under
the Term Loan are due and payable in full on August 1, 2028 (the &#8220;Maturity Date&#8221;). The Purchaser may prepay amounts
due under the Term Loan. All accrued but unpaid interest on the unpaid principal balance of outstanding advances is due and payable
monthly, beginning on September 5, 2023 and continuing monthly on the fifth day of each month thereafter until the Maturity Date.
The unpaid principal balance of outstanding advances bears interest, subject to certain conditions, at the lesser of the Maximum
Rate (as defined in the Loan Agreement) or the Base Rate, which is for any day, a rate per annum equal to the term secured overnight
financing rate (Term SOFR) (as administered by the Federal Reserve Bank of New York) for a one-month tenor in effect on such day plus
three percent (3.0%).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The obligations of the Purchaser
under the Loan Agreement and the other loan documents delivered in connection therewith are guaranteed by the Company and are secured
by a first priority security interest in substantially all of the existing and future assets of the Purchaser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Loan Agreement
contains customary representations and warranties and certain covenants that limit (subject to certain exceptions) the ability of the
Purchaser and the Company to, among other things, (i) create, assume or guarantee certain liabilities, (ii) create, assume or suffer
liens securing indebtedness, (iii) make or permit loans and advances, (iv) acquire any assets outside the ordinary course of business,
(v) consolidate, merge or sell all or a material part of its assets, (vi) pay dividends or other distributions on, or redeem or repurchase,
interest in an obligor, (vii) cease, suspend or materially curtail business operations or (viii) engage in certain affiliate transactions.
In addition, the Loan Agreement contains financial covenants that require the Purchaser to maintain (i) a minimum Debt Services Coverage
Ratio and (ii) a maximum Cash Flow Leverage Ratio, in each case, as defined and calculated according to the procedures set forth in the
Loan Agreement. Pursuant to the Loan Agreement, in the event that the Purchaser fails to comply with the financial covenants described
above, the Company is required to contribute cash to the Purchaser in an amount equal to the amount required to satisfy the financial
covenants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Loan Agreement also contains
customary events of default. If such an event of default occurs, the Bank would be entitled to take various actions, including the acceleration
of amounts due under the Loan Agreement and actions permitted to be taken by a secured creditor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the Loan
Agreement is a summary only and does not purport to be complete and is subject to, and qualified in its entirety by, the full text of
the Loan Agreement, a copy of which is filed as Exhibit 10.2 to this Current Report and is incorporated by reference into this Item 1.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2.01 </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion of Acquisition or Disposition of Assets.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth in Item
1.01 regarding the Asset Purchase is incorporated by reference into this Item 2.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2.03 </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth in Item
1.01 regarding the Loan Agreement and the Advancing Term Note is incorporated by reference into this Item 2.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unregistered Sales of Equity Securities.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth under
Item 1.01 with respect to the issuance of the Stock Closing Consideration to the Owner pursuant to the Purchase Agreement is incorporated
herein by reference. The issuance of the Stock Closing Consideration was undertaken in reliance upon the exemption from the registration
requirements of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to Section 4(a)(2) thereof and Rule
506 of Regulation D promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation FD Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">On August
2, 2023, the Company issued a press release announcing the Asset Purchase. A copy of the press release is furnished as Exhibit
99.1 to this Current Report and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The information included under
Item 7.01 (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise be subject to the liabilities of that
section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, whether made
before or after the date hereof and regardless of any general incorporation language in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex2-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Purchase Agreement, dated August 1, 2023, by and among Sanara MedTech Inc., Sanara MedTech Applied Technologies, LLC, The Hymed Group Corporation, Applied Nutritionals, LLC and Dr. George D. Petito. </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1**</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional Services Agreement, dated August 1, 2023, by and between Sanara MedTech Inc. and Dr. George D. Petito. </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2**</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement, dated August 1, 2023, between Sanara MedTech Applied Technologies, LLC, Sanara MedTech Inc. and Cadence Bank.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1 </span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release of Sanara MedTech Inc., issued August 2, 2023 (furnished pursuant to Item 7.01).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">* Certain schedules and exhibits to this
agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished
supplementally to the SEC or its staff upon request. Certain confidential information has been excluded pursuant to Item 601(b)(2)(ii)
of Regulation S-K. Such excluded information is not material and is the type that the Company treats as private or confidential.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**
Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule or exhibit
will be furnished supplementally to the SEC or its staff upon request. Certain confidential information has been excluded pursuant to
Item 601(b)(10)(iv) of Regulation S-K. Such excluded information is not material and is the type that the Company treats as private or
confidential.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    2,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara MedTech Inc</b>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael D. McNeil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Michael D. McNeil</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Financial Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwkAMhE/QO4R9LtofFeybFhWxihQRXxebymK7Kdn1p0fylm5bxDAQwsyXEcIXG1qrChkuyzyDE9ZNJS1CjiUy6iu6RLrdJeB2jjdlLEtt+/MHpuQYdMx0FM6lM/roUxksEghm48gphjBIJjEs9sLr/JR0qQrUVskKpC7gyNSwQiu5HT6c5Js01W1fdUY2inQC4SgY7A9EQRjBgZ7yRXw3kGWp8Px+PLFhejRdzcNYqmFVYe26zID+5X0BFMFJQg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex2-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
2.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN
INFORMATION CONTAINED IN THIS DOCUMENT, MARKED AT THE APPROPRIATE PLACE WITH FIVE ASTERISKS [*****], HAS BEEN OMITTED BECAUSE IT IS BOTH
(I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS CONFIDENTIAL.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ASSET
PURCHASE AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
ASSET PURCHASE AGREEMENT</B> (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of August 1, 2023, by and among <FONT STYLE="text-transform: uppercase">SanARA
MEDTECH Applied technologies, llc, </FONT>a Texas limited liability company (&ldquo;<U>Purchaser</U>&rdquo;), SANARA MEDTECH INC., a
Texas business corporation entering herein for the sole purpose of guaranteeing the performance and obligations of Purchaser (&ldquo;<U>Guarantor</U>&rdquo;),
and THE HYMED GROUP CORPORATION, a Delaware corporation (&ldquo;<U>Hymed</U>&rdquo;), APPLIED NUTRITIONALS, LLC, a Delaware limited liability
company (&ldquo;<U>Applied</U>&rdquo;) (Hymed and Applied each referred to as &ldquo;<U>Seller</U>&rdquo; and collectively as &ldquo;<U>Sellers</U>&rdquo;),
and DR. GEORGE D. PETITO (&ldquo;<U>Owner</U>&rdquo;) entering solely for Sections 1.2(b) and 1.3, Article 2, Sections 7.3 and 7.4, and
Article 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>Hymed develops certain products for use in human and veterinary markets with applications in wound care, joint/tissue support, eye
care, surgery, dental and dermatology (&ldquo;<U>Hymed Business</U>&rdquo;), and Applied develops products based on collagen, hyaluronic
acid and glycosaminoglycan chemistry (the &ldquo;<U>Applied Business</U>,&rdquo; and together with the Hymed Business, the &ldquo;<U>Businesses</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Owner is the owner, directly or indirectly, of Hymed and Applied;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>Sellers desire to sell to Purchaser, and Purchaser desires to purchase from Sellers, certain assets used or held for use in the operation
or conduct of the Businesses on the terms and conditions set forth in this Agreement (the &ldquo;<U>Acquisition</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>certain capitalized terms used in this Agreement are defined in Article 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE,</B> in consideration of the above and the mutual warranties, representations, covenants, and agreements set forth herein,
the parties agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PURCHASE
OF RIGHTS AND ASSETS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Agreement to Purchase and Sell</U>. Subject to the terms and conditions set forth herein and except for the Retained Assets, at the
Closing, but effective as of the Effective Time, Sellers and Owner shall sell, convey, transfer, assign, and deliver to Purchaser, and
Purchaser shall acquire, all right, title, and interest in and to the following itemized listing of properties and rights owned by Sellers
and specified in this Agreement (collectively, the &ldquo;<U>Rights and Assets</U>&rdquo;), free and clear of all Liens whatsoever:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
inventory used or held for use in the operation of the Businesses with respect to the Products (as later defined herein), as further
described in Section 1.2(d);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
title to all manufacturing and related equipment related to collagen human wound care, and products and associated usages as set forth
on <U>Schedule 1.1(b)</U> (each the &ldquo;<U>Current Products</U>&rdquo; and &ldquo;<U>Future Products</U>&rdquo; as noted on <U>Schedule
1.1(b)</U>, and collectively the &ldquo;<U>Products</U>&rdquo;), </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
certain intangible assets relating to the operation of the Businesses, specifically, all patents, patent applications, regulatory 510(k)s,
trademarks, tradenames and intellectual properties set forth on <U>Schedule 1.1(c)</U> hereto, and, proprietary rights, going concern
value, and the goodwill in or arising from the operation thereof (including, without limitation, goodwill associated with all trademarks
and tradenames listed in <U>Schedule 1.1(c)</U> collectively, the &ldquo;<U>Transferred IP</U>&rdquo;). Purchaser shall have primary
responsibility for transfer of UDI codes and similar regulatory information and Seller shall reasonably cooperate in furtherance of said
process; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
assignment of that certain Exclusive License Agreement dated May 18, 2018 by and between Applied and CGI Cellerate Rx, LLC (the &ldquo;<U>License
Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the transfer of the Rights and Assets shall not include the assumption of any Liability related to the Rights and Assets
unless expressly assumed by Purchaser in Section 1.6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Closing Consideration and Post-Closing Payments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Closing Consideration</U>. The initial aggregate purchase price for the Rights and Assets shall be Fifteen Million Two Hundred Fifty
Thousand Dollars ($15,250,000) (the &ldquo;<U>Purchase Price</U>&rdquo;). On the Closing Date, Purchaser shall deliver to Sellers and
Owner, as applicable, an amount equal to the following; (i) Nine Million Seven Hundred Fifty Thousand Dollars ($9,750,000) in cash by
wire transfer of immediately available funds to such account or accounts specified in writing by Sellers less any amounts required to
satisfy all third party indebtedness for purposes of releasing any Liens, and (ii) Three Million Dollars ($3,000,000) of common stock
of Guarantor (Trading Symbol - SMTI), the number of shares to be computed as of the Effective Time based upon the simple average closing
price of such common stock quoted on the Nasdaq Capital Market for the twenty (20) trading days immediately preceding the Effective Time
and rounded up to the nearest whole number to avoid the issuance of a fractional share (collectively the &ldquo;<U>Closing Payment</U>&rdquo;).
The balance of the Purchase Price shall be paid in four (4) equal annual installments of Six Hundred Twenty Five Thousand Dollars ($625,000)
with the first installment due on the first anniversary of the Effective Time and annually thereafter (collectively the &ldquo;<U>Installment
Payments</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Common Stock Sale Restrictions</U>. The number of Guarantor shares granted to Owner in Section 1.2(a)(ii) shall be subject to the
following restrictions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Only ten percent (10%) of the total shares received may be sold only after twelve (12) months from the Effective Time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
An additional forty percent (40%) of the total shares received may only be sold after eighteen (18) months from the Effective Time; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The remaining fifty percent (50%) of the total shares received may only be sold after twenty four (24) months from the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Earnouts</U>. Sellers shall also receive earnout payments in addition to the Purchase Price as follows; (i) Two Million Five Hundred
Thousand Dollars ($2,500,000) if and when Purchaser&rsquo;s collections from net sales of the Future Product [*****] which was
developed in conjunction with the Transferred IP (&ldquo;[*****]&rdquo;) equal Twenty Five Million Dollars ($25,000,000), (ii)
Two Million Five Hundred Thousand Dollars ($2,500,000) if and when Purchaser&rsquo;s collections from net sales of [*****] equal
Fifty Million Dollars ($50,000,000), (iii) Two Million Five Hundred Thousand Dollars ($2,500,000) if and when Purchaser&rsquo;s collections
from net sales of [*****] equal Seventy Five Million Dollars ($75,000,000), and (iv) Two Million Five Hundred Thousand Dollars
($2,500,000) if and when Purchaser&rsquo;s collections from net sales of [*****] equal One Hundred Million Dollars ($100,000,000)
(collectively the &ldquo;<U>Earnouts</U>&rdquo;). Upon expiration of the seventh (7<SUP>th</SUP>) anniversary from the Effective Date,
to the extent Sellers have not earned the entirety of the Earnouts, Purchaser shall pay Sellers a pro-rata amount of the Earnouts based
on collections from net sales of [*****], with such amount to be due credited with any payments of Earnouts already made by Purchaser.
By way of example, if collections from net sales at the 7<SUP>th </SUP>anniversary from the Effective Date equal Thirty Five Million
Dollars ($35,000,000), Sellers will have already received the payment in subsection (c)(i), therefore the pro-rata payout would equal
One Million Dollars ($1,000,000) [$10,000,000/$25,000,000 x $2,500,000]. The calculation and payment shall be performed and made by Purchaser
within sixty (60) days after expiration of the seventh (7<SUP>th</SUP>) anniversary from the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Inventory and Products</U>. Within three (3) business days after Sellers produce a balance sheet prepared in accordance with GAAP
for the most recent month-end prior to Closing, Purchaser shall deliver a payment to Sellers equal to the net book value of inventory
and Current Products not reasonably deemed obsolete upon inspection by Purchaser. Prior to Closing, representatives of Purchaser shall
work with Sellers to obtain an estimate and quality of the inventory and Current Products. For purposes of clarity, the payment made
for inventory and Current Products shall exclude any and all amounts for which Purchaser or its Affiliates have prepaid for any such
inventory and/or Current Products owned by Sellers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Retained Assets</U>. Notwithstanding the generality of any other provision herein to the contrary, the parties expressly agree that
Sellers shall retain all assets not otherwise identified for purchase in Section 1.1, and shall maintain the exclusive right to utilize
the Rights associated with the Products for all other purposes (except for collagen based human wound care) including, without limitation,
nutritional supplements, food, dental and non-collagen based human wound care (the &ldquo;Retained Assets&rdquo;). Sellers may hereafter
sell, transfer, license or assign any interest in the Retained Assets to any third party, without limitation. Further, the parties agree
that certain dual use equipment, supplies and inventory shall be shared between the parties as set forth in <U>Schedule 1.3</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4
<U>Allocation of Consideration</U>. With respect to each trade or business (within the meaning of Code Section 1060 and the treasury
regulations promulgated thereunder) acquired under this Agreement, all amounts constituting consideration within the meaning of, and
for the purposes of, Code Section 1060 and the treasury regulations thereunder shall be allocated among the Rights and Assets in the
manner required by Code Section 1060 and the treasury regulations issued thereunder and all applicable laws. Within one hundred eighty
(180) calendar days after the Closing Date, Purchaser shall prepare and provide Sellers with a schedule (the &ldquo;<U>Allocation Schedule</U>&rdquo;)
allocating all such consideration in the manner described by the preceding sentence. Sellers shall have thirty (30) days following receipt
of the Allocation Schedule during which to notify Purchaser of any dispute of any item contained therein, which notice shall set forth
in detail the basis for such dispute. In the event Sellers fail to notify Purchaser of any dispute during such thirty (30)-day period,
the Allocation Schedule delivered by Purchaser shall be final and binding upon the parties. Purchaser and Sellers shall cooperate in
good faith to resolve any such dispute as promptly as possible. Upon such resolution, a revised Allocation Schedule shall be prepared
in accordance with the agreement of Purchaser and Sellers and the allocation of consideration based thereon shall be final and binding
on the parties. If, however, Purchaser and Sellers are unable to resolve any dispute with respect to the Allocation Schedule within fifteen
(15) days of Sellers&rsquo; notice of objection, such dispute shall be resolved by an independent valuation firm selected by Purchaser
(the &ldquo;<U>Allocation Referee</U>&rdquo;). In resolving any such dispute, the Allocation Referee shall consider only those items
or amounts in the Allocation Schedule as to which the parties have disagreed. The Allocation Referee&rsquo;s determination of the disputed
items and the resulting Allocation Schedule shall be final and binding on the parties to this Agreement. The Allocation Referee shall
use commercially reasonable efforts to complete its work within thirty (30) days following its engagement. The fees and expenses of the
Allocation Referee shall be borne equally by Purchaser and Sellers. Each of the parties hereto shall (a) prepare and timely file all
Tax Returns, including, without limitation, Form 8594 (and all supplements thereto) in a manner consistent with the final and binding
Allocation Schedule and (b) otherwise act in accordance with the final and binding Allocation Schedule for all income Tax purposes. Purchaser
shall prepare a revised Allocation Schedule to the extent necessary to reflect any post-Closing payment made pursuant to or in connection
with this Agreement, and provide such revised Allocation Schedule to Sellers, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5
<U>Retained Liabilities</U>. Sellers shall retain all Liabilities of Sellers and all Liabilities directly or indirectly arising out of
or related to the operation of the Businesses prior to the Effective Time including any and all short and long term debt, and any payables
and accrued expenses, including but not limited to payables tied to any inventory or Current Products, if such Liabilities are known
disclosed or undisclosed, matured or unmatured, accrued, absolute, or contingent on and as of the Effective Time (collectively, the &ldquo;<U>Retained
Liabilities</U>&rdquo;). Without limiting the generality of the preceding sentence, Purchaser shall not assume or become liable for any
obligations or Liabilities of Sellers not specifically described in Section 1.6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6
<U>Assumed Liabilities</U>. Purchaser shall assume any liabilities of Sellers, as may be created after the Effective Date arising out
of or related to the Rights and Assets (the &ldquo;<U>Assumed Liabilities</U>&rdquo;), but not any assets unrelated to the Rights and
Assets or known before the Effective Date. Purchaser shall be liable for any cause of action by any party and/or any regulatory compliance
fee, fine, cost or penalty due to the Products arising after the Effective Date, even if based in whole or in parts on facts existing
prior to the Effective Date, including without limitation anything arising from the notices referenced in Section 2.7(b) below. Additionally,
Purchaser shall be liable for anticipated expenses related to the Future Products and testing and regulatory approval thereof, which
have been ordered but are not yet payable or invoiced. At this time, a reasonable estimate of said expenses is One Hundred Ten Thousand
Dollars ($110,000.00), with such amount subject to changes based on interim results of said testing and processes. Purchaser shall pay
the final amount when due and payable. Seller initiated an investigation for patent defense referenced in 2.5 below, and Purchaser shall
reimburse Seller for such expense up to $10,000.00 for any subsequent successful defense in the form of a non-appealable judgment obtained
by Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7
<U>Time and Place of Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The parties shall consummate the Acquisition (the &ldquo;<U>Closing</U>&rdquo;) via the electronic exchange of documents and signature
pages and other required documentation, in no event later than ten (10) days after the date specified in the header of this Agreement
(the date on which the Closing actually occurs is hereinafter referred to as the &ldquo;<U>Closing Date</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The parties hereto agree that the effective time and date of the transactions shall be 12:01 a.m., local time for the Businesses on the
Closing Date (the &ldquo;<U>Effective Time</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8
<U>Deliveries</U>. All deliveries, payments, and other transactions and documents relating to the Closing (a) shall be independent and
shall not be effective unless and until all are effective (except to the extent that the party entitled to the benefit thereof has waived
satisfaction or performance thereof as a condition precedent to the Closing), and (b) shall be deemed to be consummated simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9
<U>Termination of Existing Contracts</U>. As of the Effective Time, any and all agreements currently in effect and set forth on <U>Schedule
1.9</U> between the parties and/or its Affiliates shall terminate effective immediately notwithstanding any other terms or conditions
set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REPRESENTATIONS
AND WARRANTIES OF SELLERS AND OWNER</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sellers
and Owner jointly and severally represent and warrant the following to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Organization, Qualification, and Ownership</U>. Hymed is duly incorporated and validly existing as a business corporation under the
laws of the state of Delaware. Applied is duly organized and validly existing as a limited liability company under the laws of the state
of Delaware. Each Seller is duly qualified to do business and is in good standing in its state of organization and in each other state
or other jurisdictions in which either ownership or use of the rights, assets, and properties of each Seller (including the Rights and
Assets), as they are currently being used, or the conduct of the businesses of each Seller (including the Businesses) as currently conducted,
requires such qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Authority and Validity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each Seller has the full power and authority necessary to (i) execute, deliver, and perform its obligations under the Acquisition Documents
to be executed and delivered by it, (ii) carry on the Businesses as it has been and is now being conducted, and (iii) own and lease the
rights, properties, and assets which it now owns or leases (including the Rights and Assets). The execution, delivery, and performance
of the Acquisition Documents have been duly authorized by all necessary action of the governing body or owners of each Seller. The Acquisition
Documents to which each Seller is a party have been or will be, as the case may be, duly executed and delivered by duly authorized officers
of each Seller and constitute or will constitute the legal, valid, and binding obligations of each Seller, enforceable in accordance
with their respective terms, except as may be limited by bankruptcy, insolvency, or other laws affecting creditors&rsquo; rights generally,
or by the effect of rules of law and equitable limitations on the availability of specific remedies (regardless of whether such enforceability
is considered in a proceeding at law or in equity) (the &ldquo;<U>Enforceability Exceptions</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Owner has the full power and authority necessary to execute, deliver, and perform its obligations under the Acquisition Documents to
be executed and delivered by it. The Acquisition Documents to which Owner is a party have been or will be, as the case may be, duly executed
and delivered and constitute or will constitute the legal, valid, and binding obligations of Owner and enforceable in accordance with
their respective terms, except as may be limited by the Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Absence of Conflicting Agreements or Required Consents</U>. The execution, delivery, and performance by Sellers and the Owner of the
Acquisition Documents to be executed and delivered by it (a) will not require the consent of or notice to any Governmental Authority
or any other third party, (b) will not conflict with any provision of either Seller&rsquo;s organizational documents (including articles
of organization or operating agreements), (c) will not conflict with or result in a violation of any Law, ruling, judgment, order, or
injunction of any court or Governmental Authority to which each Seller or the Owner is subject or by which each Seller and the Owner,
or any of its rights, assets, or properties, (including the Rights and Assets) are bound, (d) will not conflict with, constitute grounds
for termination of, result in a breach of, constitute a default under, require any notice under, or accelerate or permit the acceleration
of any performance required by the terms of any contract, agreement, instrument, license, or permit to which each Seller or such Owner
is a party or by which each Seller or such Owner or any of its rights, assets, or properties (including the Rights and Assets), are bound,
and (e) will not create any Lien upon any of the Rights and Assets, or otherwise result in the acceleration of the maturity of any payment
date of any of the Assumed Liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<U>No Undisclosed Liabilities</U>. Sellers have no Liabilities with respect to the Businesses, or any of the Rights and Assets except
as incurred in the ordinary course of operating the Businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<U>Litigation and Claims</U>. Except as listed on <U>Schedule 2.5</U>, (a) there are no claims, lawsuits, actions, arbitrations, or administrative
or other proceedings pending by or against Sellers or the Owner with respect or related to the Businesses or the Rights and Assets, (b)
to the Knowledge of each Seller, no such claim, lawsuit, action, arbitration, or administrative or other proceeding is threatened, (c)
to the Knowledge of each Seller, there are no governmental or administrative investigations or inquiries pending that specifically involve
the Businesses or the operation thereof, or the Rights and Assets, (d) there are no judgments against or consent decrees binding on either
Seller or the Owner with respect to the Businesses or the Rights and Assets, or, to the Knowledge of either Seller, any licensed professional
employed by or contracted for, or otherwise relating to the Businesses, (except for attorney investigation for defense of patent tied
to one of the Products) and (e) no basis for any such matter exists that could reasonably be expected to have a material adverse effect
on the Businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
<U>No Violation of Law</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
With respect to the Rights and Assets, neither Sellers nor the Owner has been within the previous three (3) years or is not currently
in violation of any applicable Law, order, injunction, or decree, or any other requirement of any Governmental Authority or court binding
on it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
With respect to the Rights and Assets, neither Sellers nor the Owner is currently subject to any Liability or disability as the result
of a failure to comply with any requirement of a Law, order, injunction, or decree, or any other requirement of any Governmental Authority
or court, and neither Sellers nor the Owner has received any notice of such noncompliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
<U>Licenses, Authorizations and Patents</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Sellers and Owner, as applicable, are the holder of all valid licenses and other rights, permits, and authorizations required by Law
or any Governmental Authority necessary to operate the Businesses, including any patents, and FDA approvals related to Current Products.
Sellers and Owner, as applicable, have supplied a correct and complete list of all licenses, permits, patents for Current Products, authorizations,
and FDA approvals for Current Products, and true, complete, and correct copies of any documentation evidencing the foregoing have been
provided to Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
No violation, default, order, or deficiency exists with respect to any of the items described in this Section 2.7. Neither Sellers nor
Owner have received any notice of any action pending or recommended by any Governmental Authority having jurisdiction over the items
described in this Section 2.7, either to revoke, limit, withdraw, or suspend any license, right, or authorization of Sellers, Owner or
the Businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
<U>Securities Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Owner acknowledges that the information supplied by Owner in the warranties contained herein will be relied upon by Purchaser in concluding
that the common stock issued to Owner pursuant to Section 1.2(a)(ii) (&ldquo;Stock Consideration&rdquo;) has been issued pursuant to
Section 4(a)(2) of the Securities Act or another exemption from the registration requirement of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Owner is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
not receiving the Stock Consideration as a result of any &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; (as
those terms are defined in Regulation D); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
receiving the Stock Consideration for his own account with no intention of distributing the Stock Consideration or an amount thereof,
or any arrangement or understanding with any other Person regarding the distribution of such Stock Consideration or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Owner is sufficiently aware of Purchaser&rsquo;s business affairs and financial condition to reach an informed and knowledgeable decision
to receive the Stock Consideration. Owner acknowledges that information regarding Purchaser is publicly available via the SEC&rsquo;s
website (<U>www.sec.gov</U>). Owner has made his own investment decision to receive the Stock Consideration based on his own knowledge
and information which is publicly available, including Purchaser SEC documents, with respect to the Stock Consideration of Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
<U>Inventories</U>. All items of inventory and Products of Sellers consist, and will consist at the Closing, of items of a quality and
quantity usable and saleable in the ordinary course of business, and shall not be subject to any prepaid orders by third parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10
<U>Statements True and Correct</U>. No representation or warranty made by Sellers or Owner in this Agreement or in any statement, certificate,
or instrument to be furnished to Purchaser by Sellers pursuant to any Acquisition Document contains or will contain any untrue statement
of material fact or omits or will omit to state a material fact necessary to make these statements contained herein and therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
3</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REPRESENTATIONS
AND WARRANTIES OF PURCHASER</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchaser
hereby represents and warrants to Sellers and Owner as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Organization, Authority, and Capacity</U>. Purchaser is a limited liability company organized, validly existing, and in good standing
under the laws of the state of Texas. Purchaser has the full power and authority necessary to (i) execute, deliver, and perform its obligations
under the Acquisition Documents to be executed and delivered by it and (ii) carry on its business as it has been and is now being conducted
and to own and lease the rights, properties, and assets which it now owns or leases. Purchaser is duly qualified to do business and is
in good standing in each jurisdiction in which a failure to be so qualified or in good standing would have a material adverse effect
on its ability to perform its obligations under the Acquisition Documents to be executed and delivered by it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Authorization and Validity</U>. The execution, delivery, and performance of the Acquisition Documents to be executed and delivered
by Purchaser have been duly authorized by all necessary action by Purchaser. The Acquisition Documents to be executed and delivered by
Purchaser have been or will be, as the case may be, duly executed and delivered by Purchaser and constitute or will constitute the legal,
valid, and binding obligations of Purchaser, enforceable in accordance with their respective terms, except as may be limited by the Enforceability
Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Absence of Conflicting Agreements or Required Consents</U>. The execution, delivery, and performance by Purchaser of the Acquisition
Documents to be executed and delivered by Purchaser (i) do not require the consent of or notice to any Governmental Authority or any
other third party, (ii) will not conflict with any provision of Purchaser&rsquo;s organizational documents, and (iii) will not conflict
with or result in a violation of any Law, ruling, judgment, order, or injunction of any Governmental Authority to which Purchaser is
subject or by which Purchaser or any of its rights, assets, or properties are bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Transferred IP</U>. At all times after Closing, Purchaser and Guarantor shall use &ldquo;Commercially Reasonable Efforts&rdquo; efforts
to keep any and all of the Transferred IP specified on <U>Schedule 1.1(c)</U> fully paid and recognized by applicable Governmental Agencies
as the proper title holder of the foregoing with no limitations on use or loss of rights to same. For these purposes, &ldquo;Commercially
Reasonable Efforts&rdquo; shall mean the exercise of prudent scientific and business judgment and a level of effort and resources consistent
with the judgment, efforts and resources that the party who bears the performance obligation or a comparable third party in the industry
would employ for assets of similar strategic importance and commercial value that result from its own research efforts taking into consideration
conditions in effect at the time the party&rsquo;s obligations are carried out. The obligations of Purchaser and Guarantor under this
Section shall continue for the duration of the maximum period permitted by law applicable to each such item of Transferred IP (including
any renewal thereof). In the event of a breach of this Section, Sellers and Owners shall be entitled to seek all remedies available under
this Agreement, in law or in equity. The time limits under Article 8 below shall not apply to this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
4</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ADDITIONAL
AGREEMENTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Access to Information</U>. At all times prior to the Closing, Sellers will afford the authorized representatives of Purchaser and
its Affiliates access upon reasonable notice and during normal business hours to all of Sellers&rsquo; properties, assets, books, and
records that relate to or concern the Rights and Assets. Sellers will also furnish such parties with such additional financial, operating,
and other information relating to the Rights and Assets as such parties may from time to time reasonably request. Purchaser and its Affiliates
shall also be allowed access, upon reasonable notice, to consult with the officers, employees, accountants, counsel, and agents of Sellers
in connection with such investigation of the Rights and Assets. No such investigation shall diminish or otherwise affect any of the representations,
warranties, covenants, or agreements of any party under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>No-Shop</U>. Unless and until this Agreement is terminated pursuant to Article 7, Sellers and Owner shall not directly or indirectly
through any officer, director, employee, agent, intermediary, or otherwise, (a) solicit, initiate, or encourage submission of proposals
or offers from any Person relating to any purchase of an interest in the Rights and Assets, or (b) participate in any discussions or
negotiations regarding, or furnish to any other Person, any information with respect to, or otherwise respond to, cooperate or encourage,
any effort or attempt by any other Person to purchase any interest in Sellers, in the Rights and Assets, or (c) approve or undertake
any of the foregoing transactions without the prior written consent of Purchaser. If any Seller or any of its agents or intermediaries
receives an offer or proposal relating to any purchase of an interest in Sellers, of the Rights and Assets, the recipient shall notify
Purchaser of the receipt of such offer and shall disclose the terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Affirmative Covenants of Sellers and Owner</U>. From the date hereof until the earlier of the Closing Date or the termination of this
Agreement, unless the prior written consent of Purchaser shall have been obtained, and except as otherwise expressly contemplated herein,
Sellers and the Owner shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
use commercially reasonable efforts to preserve intact the rights, assets, properties, licenses, permits, patents, and FDA approvals,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
keep and maintain the Rights and Assets in their present condition, repair, and working order, except for normal depreciation and wear
and tear, and maintain all insurance, rights, and licenses therein,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
keep in full force and effect present insurance policies or other comparable insurance coverage insuring the Rights and Assets, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
notify Purchaser of (i) any event or circumstance which is reasonably likely to have a material adverse effect on the Rights and Assets
or would reasonably be likely to cause or constitute a breach of any of either Seller&rsquo;s representations, warranties, or covenants
contained herein, (ii) any unexpected change in the normal course of business or in the operation of the Rights and Assets, and (iii)
any governmental complaints, investigations, or hearings (or communications indicating that the same may be contemplated), adjudicatory
proceedings, budget meetings, or submissions involving any aspect of the Rights and Assets, and keep Purchaser fully informed of such
events and permit representatives of Purchaser and its affiliates to have prompt access to all materials prepared in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Negative Covenants of Sellers and Owner</U>. From the date hereof until the earlier of the Closing Date or the termination of this
Agreement, Sellers and the Owner will not do any of the following without the prior written consent of Purchaser, which consent shall
not be unreasonably withheld:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
take any action that would (i) adversely affect the ability of any party to the Acquisition Documents to obtain any consents required
for the transactions contemplated thereby, (ii) adversely affect the ability of any party hereto to perform their covenants and agreements
under the Acquisition Documents, or (iii) adversely affect the ability of any party to consummate the transactions contemplated by the
Acquisition Documents,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
impose, or suffer the imposition, on the Rights and Assets of any Lien, or permit any such Lien to exist,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
incur any Liability, except in the ordinary course of business and consistent with past practices,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
except for sales of inventory in the ordinary course of business and other than pursuant to the Acquisition Documents, sell, or enter
into any contract to sell, any interest in any of the Rights and Assets,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
take any action, or omit to take any action, which would cause any of the representations and warranties contained in Article 2 to be
untrue or incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Confidentiality, Public Announcements</U>. Each party hereto agrees (i) not to disclose any aspect of the discussions, negotiations,
terms, status, or conditions relating to the transactions contemplated herein to any third party other than their respective officers,
directors, authorized employees, and authorized representatives, and as necessary in order to obtain any consent required hereunder,
and then only on a need to know basis, (ii) to cause and require all such persons to whom such information is disclosed to abide by the
provisions of this Section 4.5, and (iii) not to issue any press release or other general public announcement (including in any trade
journal or other publication) of the transactions, in any case, without the prior written consent of the other party, in each case except
to the extent that disclosure may be required by Law, in which case the party required to made such disclosure will give the other party
prior written notice and an opportunity to review and comment upon such disclosure or press release prior to its disclosure or issuance.
Sellers acknowledge that only Purchaser may issue a press release after the execution of this Agreement that discloses the existence
of this Agreement, and may issue another press release promptly after the consummation of the Acquisition. Sellers hereby consent to
the issuance of such press releases. In the event that the Acquisition is not consummated, any information concerning Sellers and the
Businesses that Purchaser and its representatives may acquire during the course of negotiations, conducting due diligence, and transition
planning with respect to the Acquisition shall be treated as confidential, and in the event the Acquisition is not consummated, all such
information shall, upon request, be returned to Sellers or destroyed, with such destruction certified in writing by Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Bulk Transfer Act</U>. The parties hereby waive compliance with the bulk transfer provisions of the Uniform Commercial Code, or any
similar law enacted in any jurisdiction, to the extent that it may be applicable to the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Retained Liabilities</U>. Sellers shall promptly pay and discharge any and all Retained Liabilities, as and when due. Sellers further
covenant and agree that it will not take any action that is likely to adversely affect Purchaser&rsquo;s or its Affiliate&rsquo;s relationship
with any third-party related to the Rights and Assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Conditions to Closing</U>. Sellers (with respect to Article 5) and Purchaser (with respect to Article 6) agree to use their commercially
reasonable efforts to satisfy the conditions to the Closing by August 1, 2023, and if not by such time, as soon thereafter as possible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Risk of Loss</U>. Sellers shall retain all risk of condemnation, destruction, loss, or damage due to fire or other casualty from the
date of this Agreement until the Closing. If the condemnation, destruction, loss, or damage is such that the Rights and Assets are materially
affected, then Purchaser shall have the right to terminate this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Certain Tax Matters</U>. Purchaser, on the one hand, and Sellers, on the other hand, shall provide the other party to this Agreement,
at the expense of the requesting party, with such assistance as may reasonably be requested by any of them in connection with the preparation
of any Tax Return, any audit or other examination by any Governmental Authority, or any judicial or administrative proceedings relating
to Liability for Taxes, and each will retain for the applicable statute of limitations, and to provide the requesting party, any records
or information that may be relevant to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Reasonable Assistance</U>. To the extent that any rights under any contract, permit, or other Rights and Assets to be assigned to
Purchaser hereunder may not be assigned without the consent of another Person which, despite either Seller&rsquo;s commercially reasonable
efforts, has not been obtained prior to the Closing, and Purchaser has, in its sole discretion, waived the closing condition in Section
5.3, this Agreement shall not constitute an agreement to assign the same if an attempted assignment would constitute a breach thereof
or be unlawful. Sellers, at the request and sole cost and expense of Purchaser, shall use its commercially reasonable efforts at all
times from and after the Closing Date to assist Purchaser in obtaining any such required consent(s) as promptly as possible. If any such
consent shall not be obtained or if any attempted assignment would be ineffective or would impair Purchaser&rsquo;s rights under the
Rights and Assets in question so that Purchaser would not in effect acquire the benefit of all such rights, Sellers, to the maximum extent
permitted by Law and the specific Rights and Assets, and at the sole cost and expense of Purchaser, shall (a) act on and after the Closing
Date as Purchaser&rsquo;s agent in order to obtain the benefits thereunder, and (b) cooperate, to the maximum extent permitted by Law
and the specific Rights and Assets, with Purchaser in any other reasonable arrangement designed to provide such benefits to Purchaser,
including any sublease or subcontract or similar arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.12
<U>Retention of Rights by Sellers and Owner</U>. Whereas Purchaser is obtaining certain Rights and Assets from Owner and Sellers, and
whereas those Rights and Assets include certain patent rights that fall within a field of use that is of interest to Purchaser and that
also fall within a field of use that is of interest to Owner and Sellers, Purchaser, Owner and Sellers agree that Purchaser&rsquo;s field
of use shall include &ldquo;collagen compositions for human wound care&rdquo; and that Purchaser shall provide to Sellers and Owner a
fully paid up, irrevocable, transferrable, and exclusive license to all fields other than Purchaser&rsquo;s desired field of use for
all patent rights assigned to Purchaser pursuant to this Agreement (to include for example, use in treating non-human animals and the
like). Said license to Sellers and Owner shall include a first right, but not an obligation, to take action in the prosecution, prevention,
or termination of any infringement falling within the licensed field of use. The license shall provide that Sellers and Owner shall notify
Purchaser of any such action in advance, and keep Purchaser reasonably informed of the progress of any such actions. However, such actions
shall be undertaken and directed by Sellers and/or Owner&rsquo;s sole discretion and at Sellers&rsquo; and/or Owner&rsquo;s cost. Thus,
any and all compensation from any action brought by Sellers and/or Owner to enforce these rights shall be the sole property of Sellers
and/or Owner. The license shall further provide that Purchaser will cooperate fully in any action brought by Sellers and/or Owner seeking
to enforce the patent rights licensed to Sellers and/or Owner</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
5</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CONDITIONS
TO OBLIGATION OF PURCHASER</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligation of Purchaser to consummate the Acquisition is subject to the satisfaction or waiver by Purchaser, except as otherwise set
forth below, at or prior to the Closing, of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Representations and Warranties</U>. The representations and warranties of Sellers and the Owner set forth in this Agreement, or any
document or instrument delivered to Purchaser hereunder, shall be true and correct in all material respects as of the Closing Date with
the same force and effect as if such representations and warranties had been made at and as of the Closing Date; provided that, for purposes
of this Section 5.1, if any representation or warranty made by Sellers and Owner includes within its terms a materiality qualifier, such
representation or warranty shall be true and correct in all respects on and as of the Closing Date; provided further that, with respect
to any of such representations and warranties referring to a state of facts existing on a specified date prior to the Closing Date, it
shall be sufficient if at the Closing Date such representation and warranty continues to describe accurately the state of facts that
existed on the date so specified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Performance; Covenants</U>. All of the terms, covenants, and agreements of the Acquisition Documents to be complied with or performed
by Sellers at or prior to Closing shall have been complied with and performed in all material respects, including, but not limited to,
the delivery of the following documents:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
a certificate of good standing for Sellers issued by the state or other jurisdiction of its formation or incorporation, and operation,
as applicable, and dated within three (3) business days of the Closing Date,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
a Bill of Sale executed by Sellers, in the form attached hereto as <U>Exhibit 5.2(b)</U>,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
an IP Assignment Agreement executed by Sellers, the forms of which are attached hereto as <U>Exhibit 5.2(c)</U> (the &ldquo;<U>IP Assignment
and Assumption Agreement</U>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
a certificate dated as of the Closing Date signed by a duly authorized officer of Sellers certifying the satisfaction of the conditions
set forth in Section 5.1 and Section 5.4 and that Sellers have duly performed and complied in all material respects with all of the covenants
and agreements of this Agreement to be performed by it prior to Closing,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
written consents of all third parties necessary for the consummation of the transactions contemplated by the Acquisition Documents,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
a professional services agreement executed by Owner, and a professional services agreement executed by Anita Petito, each in the forms
substantially attached hereto as <U>Exhibit 5.2(f)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
any documents needed to evidence the assignment and assumption of the License Agreement and contract cancellations contemplated by Section
1.9, forms of which are attached hereto as <U>Exhibit 5.2(g)</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
such other documents as may be reasonably necessary to consummate the transactions contemplated by this Agreement, as requested by Purchaser
or its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Necessary Consents and Approvals</U>. To the extent required, Purchaser and Sellers shall have obtained all regulatory approvals,
governmental licenses, consents of Governmental Authorities, and permits to which Purchaser shall be legally entitled to continue to
use the Rights and Assets as currently used by the Businesses so long as it properly files necessary applications and cooperates with
state regulatory bodies. The parties shall have provided all necessary notices under applicable Law, and all waiting periods required
by Law shall have expired, necessary in order for Purchaser and Sellers to consummate the Acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>No Material Adverse Change</U>. There shall not have occurred any material adverse change in the Rights and Assets or in the Liabilities
in each case between the date hereof and the Closing Date, and a certificate of a duly authorized officer of Sellers shall have been
delivered to Purchaser to such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>No Injunction, Etc.</U> No action, proceeding, investigation, or legislation shall have been instituted, threatened, or proposed before
any court, Governmental Authority, or legislative body to enjoin, restrain, prohibit, or obtain substantial damages in respect of, or
which is related to or arises out of, this Agreement or the consummation of the Acquisition, or which is related to or arises out of
the business or operations of Sellers, if such action, proceeding, investigation, or legislation, in the reasonable judgment of Purchaser
or its counsel, would make it inadvisable to consummate such transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Due Diligence</U>. Purchaser shall in all respects be reasonably satisfied with the results of its due diligence investigation of
the Rights and Assets. Additionally, Purchaser shall in all respects be reasonably satisfied with its continuing review of matters contained
in the Schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Lien Releases</U>. Purchaser shall have received evidence, satisfactory to it, that Sellers have identified the Liens on the Rights
and Assets and discharged all such Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
6</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CONDITIONS
TO OBLIGATION OF SELLERS AND OWNER</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligation of Sellers and Owner to close the Acquisition is subject to the satisfaction or waiver by Sellers and Owner, except as otherwise
set forth below, at or prior to the Closing, of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Representations and Warranties</U>. The representations and warranties of Purchaser set forth in this Agreement, or any document or
instrument delivered to any party hereunder, shall be true and correct in all material respects as of the Closing Date with the same
force and effect as if such representations and warranties had been made at and as of the Closing Date; provided that, for purposes of
this Section 6.1, if any representation or warranty made by Purchaser includes within its terms a materiality qualifier, such representation
or warranty shall be true and correct in all respects on and as of the Closing Date; provided further that, with respect to any of such
representations and warranties referring to a state of facts existing on a specified date prior to the Closing Date, it shall be sufficient
if at the Closing Date such representation and warranty continues to describe accurately the state of facts that existed on the date
so specified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Performance; Covenants</U>. All of the terms, covenants, and agreements of this Agreement to be complied with or performed by Purchaser
at or prior to the Closing shall have been complied with and performed in all material respects, including, but not limited to delivery
of the following documents:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the Bill of Sale</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the IP Assignment and Assumption Agreement executed by Purchaser,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
a certificate dated as of the Closing Date signed by a duly authorized officer of Purchaser certifying the satisfaction of the conditions
set forth in Section 6.1 and that Purchaser has duly performed and complied in all material respects with all of the covenants and agreements
of this Agreement to be performed by Purchaser prior to Closing,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
a professional services agreement with Owner, and a professional services agreement with Anita Petito, executed by Purchaser, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
such other documents as may be reasonably necessary to consummate the transactions contemplated by this Agreement, as reasonably requested
by Sellers or its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>No Injunction, Etc.</U> No action, proceeding, investigation, or legislation shall have been instituted, threatened, or proposed before
any court, Governmental Authority, or legislative body to enjoin, restrain, prohibit, or obtain substantial damages in respect of, or
which is related to or arises out of, this Agreement or the consummation of the Acquisition, if such action, proceeding, investigation,
or legislation, would lead a reasonable person to conclude that it would be inadvisable to consummate such transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Payments</U>. Purchaser shall have delivered the Closing Payment to Sellers and Owner in accordance with Section 1.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
7</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TERMINATION
AND POST-CLOSING COVENANTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Right of Termination</U>. This Agreement and the Acquisition may be terminated at any time prior to the Closing Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
by the mutual written consent of Purchaser and Sellers,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
by Purchaser in the event that the conditions set forth in Article 5 shall not have been satisfied or waived by August 1, 2023, unless
such satisfaction shall have been frustrated or made impossible by any act or failure to act of Purchaser,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
By Sellers or Purchaser if the Closing shall not have occurred by August 1, 2023,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
By Purchaser in accordance with Section 4.9, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(e)
by either Purchaser or Sellers in the event (i) consent of any Governmental Authority required for consummation of the Acquisition and
the other transactions contemplated hereby shall have been denied by final, non-appealable action of such authority or if any action
taken by such authority is not appealed within the time limit for appeal or (ii) any Law or order permanently restraining, enjoining
or otherwise prohibiting the consummation of the Acquisition shall have become final and non-appealable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Effect of Termination</U>. Except as set forth in this Section 7.2, in the event of termination in accordance with Section 7.1, this
Agreement shall become void and of no further force or effect, without any liability on the part of any of the parties hereto or their
respective owners, directors, officers, employees, heirs, estates, or agents, except the obligations of each party to preserve the confidentiality
of documents, certificates, and information furnished to such party pursuant thereto and for any obligation or liability of any party
based on or arising from any breach or default by such party with respect to its representations, warranties, covenants, or agreements
prior to the effective date of termination. The provisions of Section 4.2, Section 7.2, Article 9 and Article 10 will survive any such
termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Non-Competition</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Sellers and Owner acknowledge that the Rights and Assets in its possession would enable it to establish goodwill with the patients, customers,
potential customers, and suppliers who provide products and services on behalf of the Businesses or who receive products and services
from the Businesses and that the Rights and Assets constitute a valuable asset of the Businesses. Sellers and Owner further acknowledge
that they have developed relationships with certain of the Businesses&rsquo; suppliers, contractors or potential contractors, consultants
or potential consultants, and sources or potential sources of product usage. Accordingly, Sellers and Owner agree that it and its Affiliates
will comply with the terms within this Section 7.3 for the period beginning on the Effective Date and ending on the fifth (5th) anniversary
thereof. During such five (5)-year period, Sellers and Owner agree that it and its Affiliates shall not, directly or indirectly, engage
in, render services to or become interested in any manner, as manager, employee, officer, consultant, owner, or partner, or through stock
ownership (other than holding less than two percent (2%) of the outstanding equity securities of a Person having securities that are
listed for trading on a national securities exchange), or otherwise, either alone or in association with others, in any business that
develops, provides and/or supplies collagen based products for human wound care use similar to those currently owned or under development
by Purchaser as of the Effective Date in the United States (the &ldquo;Restricted Territory&rdquo;) with respect to the Market (as later
defined). By way of example, and without limitation, Sellers and Owner may consult or contract with a company that participates in the
Market, if such consultation or contract does not relate to the Market, such as veterinary or other markets related to the Retained Assets.
The foregoing restrictive covenant shall not apply to any of the Retained Assets. During the five (5) year period beginning with the
Effective Date, Purchaser and its Affiliates shall not, directly or indirectly, utilize any of the Transferred IP in any market included
within the scope of the Retained Assets. For the avoidance of doubt, Purchaser and its Affiliates may utilize the Transferred IP on human
wounds including below the skin wounds and damaged skin as these applications are considered by the parties to be inclusive within the
general understanding of the term &ldquo;wound&rdquo; utilized within this Agreement and applied for human use only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Sellers and Owner acknowledge and agree that the restrictive covenants set forth above are reasonable and valid in time and scope and
in all other respects. The covenants set forth in this Agreement shall be considered and construed as separate and independent covenants.
Should any part or provision of any covenant be held invalid, void, or unenforceable in any court of competent jurisdiction, such invalidity,
voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The parties hereto agree that it is their intention that the restrictive covenants be enforced in accordance with their terms to the
maximum extent possible under applicable law. The parties further agree that, in the event any court of competent jurisdiction shall
find that any of the foregoing provisions is invalid or unenforceable, the invalid or unreasonable term shall be redefined, or a new
enforceable term provided, such that the intent of the parties in agreeing to the provisions of this Agreement will not be impaired and
the provision in question shall be enforceable to the fullest extent of the applicable laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Without limiting the remedies available to Purchaser, the parties hereto acknowledge that a breach of any of the covenants contained
herein may result in material, irreparable injury for which there is no adequate remedy at law, that it will not be possible to measure
damages for such injuries precisely and that, in the event of such a breach or threat thereof by Sellers, Owner or any Affiliate of Sellers
and/or Owner, Purchaser shall be entitled to obtain a temporary restraining order and/or a preliminary or permanent injunction restraining
Sellers and/or Owner from engaging in activities prohibited by this Agreement or such other relief as may be required to specifically
enforce any of the covenants hereof without the necessity of posting any bond.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
<U>Agreements Regarding Guarantor Common Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Owner irrevocably agrees, in consideration of the benefit that the transactions contemplated hereby will confer, that following the Closing,
Owner shall not transfer any shares of the common stock received as Stock Consideration (the &ldquo;<U>Lockup Securities</U>&rdquo;),
at any time during the periods commencing on the Effective Time and ending on the timeframes set forth in Section 1.2(b) (the &ldquo;<U>Lockup
Period</U>&rdquo;) without Guarantor&rsquo;s prior written consent. For purposes of this Section 7.4, &ldquo;transfer&rdquo; (and all
correlative terms) means, as to any Lockup Securities, a direct or indirect (including through the use of any derivative or swap instrument
or arrangement) sale, assignment, conveyance, gift, exchange, pledge, encumbrance, contract to sell, lease or other disposition or transfer
(or offer to do any of the foregoing) of such Lockup Securities, whether effected voluntarily, involuntarily or by operation of Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Owner agrees and consents to the entry of stop transfer instructions with Guarantor&rsquo;s transfer agent and registrar against the
transfer of the Lockup Securities, except in compliance with the restrictions set forth in this Agreement. In furtherance of the foregoing,
any book entries evidencing shares of Guarantor&rsquo;s common stock subject to the provisions of this Agreement shall include legends
legally required, including a legend to the effect that the shares of common stock have not been registered under the Securities Act
and are subject to certain legal and contractual restrictions on transfer (including lockup restrictions), and similar instructions shall
be provided to Guarantor&rsquo;s transfer agent. Guarantor will provide reasonable cooperation to facilitate any transfer by Owner of
the Lockup Securities (in accordance with the limitations and restrictions set forth herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Each certificate or book-entry notation representing any common stock of Guarantor issued hereunder shall bear the following legends
(in addition to any other legends required by law, Guarantor&rsquo;s governing documents or any other agreement to which such holder
of common stock in Guarantor is a party):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT, OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES
ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE
AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE
WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
8</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INDEMNIFICATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<U>Indemnification by Sellers and Owner</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to Sections 8.3 through 8.5, Owner (only as to the parts of this Agreement applicable to Owner as set forth in the preamble)
and Sellers shall jointly and severally indemnify, hold harmless, and defend Purchaser, and its officers, directors, agents, and Affiliates,
from and against any and all demands, claims, actions, or causes of action, assessments, losses, damages, recoupments and repayments,
liabilities, costs, and expenses (including, but not limited to, reasonable attorneys&rsquo; fees and costs of investigation) (collectively,
&ldquo;<U>Losses</U>&rdquo;), associated with, suffered, or incurred by reason of, or arising out of any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Retained Liabilities or the Retained Assets,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the inaccuracy in or breach of any representation or warranty of either Seller contained herein or in any Acquisition Document to be
true and correct when made or deemed made under the terms hereof, or the breach by either Seller of any warranty contained herein or
in any Acquisition Document,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the breach of any covenant or agreement of either Seller contained in this Agreement or any other Acquisition Documents,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
any Liability arising out of Purchaser&rsquo;s use of the Rights and Assets prior to the Effective Time, (subject to and except as provided
in Section 1.6 above); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
No claim for indemnification with respect to any alleged misrepresentation or breach of warranty may be made under Section 8.1(a)(ii)
after the thirtieth (30th) month from of the Closing Date; provided that, the right to indemnification shall extend beyond such period
(i) with respect to any specific claim for indemnification for which written notice, specifying in reasonable detail the nature of the
claim, was given to Seller during such period but shall expire on the expiration of the applicable statutes of limitations unless an
action has been brought with respect thereto, (ii) with respect to any claim brought for a misrepresentation or breach of Section 2.7,
until the Liability to which any such claim may relate is barred by all applicable statutes of limitations, and (iii) indefinitely with
respect to any claim brought for a misrepresentation or breach of Sections 2.1, 2.2, or 2.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Indemnification by Purchaser</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to Sections 8.3 through 8.5, Purchaser and Guarantor shall jointly and severally indemnify, hold harmless, and defend Sellers,
and any of Sellers&rsquo; officers, directors, agents, and at all times after the date hereof from and against any and all Losses suffered
or incurred by any such party by reason of, or arising out of any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Assumed Liabilities,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the failure of any representation or warranty contained in Article 3 hereof or in any Acquisition Document to be true and correct when
made or deemed made or the breach by Purchaser of any warranty contained in Article 3 hereof in any Acquisition Document or any document
or instrument delivered by Purchaser in connection therewith,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the breach of any covenant, payment term or agreement of Purchaser contained in this Agreement or the Acquisition Documents, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
any Liability arising out of Purchaser&rsquo;s use of the Rights and Assets subsequent to the Effective Time. (subject to and except
as provided in Section 1.6 above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
No claim for indemnification with respect to any alleged misrepresentation or breach of warranty may be made under Section 8.2(a)(ii)
after the thirtieth (30th) month from the Closing Date; provided that, the right to indemnification shall extend beyond such period (i)
with respect to any specific claim for indemnification for which written notice was given to Purchaser during such period, but shall
expire on the expiration of the applicable statutes of limitations unless an action has been brought with respect thereto, and (ii) indefinitely
with respect to any claim brought for a misrepresentation or breach of Sections 3.1, 3.2, or 3.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
<U>Notice and Opportunity to Defend</U>. If any party under this Agreement has notice of facts or circumstances that could reasonably
result in a claim for indemnification under this Article 8 for the benefit of such party (an &ldquo;<U>Indemnified Party</U>&rdquo;),
then such Indemnified Party promptly after obtaining notice thereof shall give the party from which indemnification may be sought (the
&ldquo;<U>Indemnifying Party</U>&rdquo;) written notice of any such claim. No Indemnified Party shall be subject to any liability for
a delay in the delivery of such notice to the extent such delay does not compromise or prejudice any right of the Indemnifying Party.
Following receipt of such notice, the Indemnifying Party may undertake the defense of such claim if (i) the Indemnifying Party gives
written notice to such Indemnified Party that the Indemnifying Party intends to undertake such defense and that the Indemnifying Party
will indemnify the Indemnified Party against all Losses resulting from or relating to such claim pursuant to this Article 8 and (ii)
the claimant making each claim does not seek an injunction or other equitable relief as a primary element of relief. If assumed by the
Indemnifying Party, the defense of the claim will be conducted actively and diligently by legal counsel reasonably acceptable to the
Indemnified Party or such Indemnified Party may re-undertake the defense thereof at the expense of the Indemnifying Party. If the Indemnifying
Party assumes the defense of a claim, the Indemnified Party may, by counsel of its choice, participate in such defense at their own expense.
The Indemnified Party shall furnish to the Indemnifying Party, in reasonable detail, such information as the Indemnified Party may have
with respect to such claim, including all records and similar materials that are reasonably required in the defense of such claim. If,
within ten (10) days after notice of any such claim, the Indemnifying Party has not notified the Indemnified Party of its intention to
defend the claim, then each Indemnified Party will (without further notice to the Indemnifying Party) have the right to undertake the
defense of such claim and the Indemnifying Party shall nonetheless bear the costs and Losses of the Indemnified Party to the extent the
Indemnifying Party is responsible for such costs and loses pursuant to the terms hereof. The Indemnifying Party may elect to participate
in such proceedings, negotiations, or defense at any time at its own expense. No Indemnified Party shall settle any such claim without
the consent of the Indemnifying Party, which consent shall not be unreasonably withheld. No Indemnifying Party shall settle any claim
it is defending under this Section 8.3 without the consent of the Indemnified Party, which consent will not be unreasonably withheld,
unless the settlement provides for (1) no relief other than monetary damages against which the Indemnified Party is fully indemnified
and (2) an unconditional release of the Indemnified Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>Indemnification Threshold and Right to Offset</U>. To the extent permitted by Law, the parties agree that no Indemnifying Party shall
be required to indemnify the Indemnified Party under Section 8.1(a)(ii) or 8.2(a)(ii) unless and until the amount of the Losses for which
a right of indemnification is provided under the relevant Section, when aggregated with all other Losses for which indemnification is
sought by any and all Indemnified Parties against any and all Indemnifying Parties, exceeds Twenty Five Thousand Dollars ($25,000), at
which time rights to indemnification for Losses may be asserted for the full amount of any and all such Losses. To the extent Purchaser
is the Indemnified Party, Purchaser may offset amounts owed for Losses incurred from the Installment Payments, Earnouts, and any royalties
otherwise which may be owed to Owner pursuant to the professional services agreement attached in <U>Exhibit 5.2(f)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
<U>Survival</U>. The representations and warranties of the parties contained in the Acquisition Documents or in any document or instrument
delivered in connection therewith shall survive the Closing, subject to the time limits on claims as provided in Sections 8.1(b) and
8.2(b), and shall not be extinguished thereby notwithstanding any investigation or other examination by any party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6
<U>Liability Cap</U>. Purchaser and Guarantor collectively on the one hand, and Owner on the other hand, shall have a maximum liability
under this Article 8 specifically and this Agreement generally of Three Million Dollars ($3,000,000), and Applied shall have a maximum
liability under this Article 8 and this Agreement generally of Seven Million Dollars ($7,000,000) (as applied to each, the &ldquo;<U>Liability
Cap</U>&rdquo;) for any and all damages reduced to final unappealable judgment. In no event shall any party hereto be liable for any
damages (incidental, consequential, punitive or otherwise) in excess of the Liability Cap, and for purposes of clarity, Hymed shall not
be obligated to fund any indemnification obligation which may otherwise be required pursuant to this Section. Further, Owner and Applied
shall provide copies of insurance policies which are in place to cover their respective Liability Cap upon written request of Purchaser.
Upon proof of said insurance, the collective Liability Cap of Purchaser and Guarantor under this Section shall increase to match the
aggregate of the respective Liability Caps of Owner and Applied in an amount equal to said insurance coverage of Owner and Applied, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
9</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CERTAIN
DEFINITIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<U>Definitions</U>. Except as otherwise provided herein, the capitalized terms set forth below (and words of similar origin) have the
following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquisition</U>&rdquo;
has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquisition
Documents</U>&rdquo; means this Agreement and the other documents and instruments to be delivered pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means a Person controlling, controlled by, or under common control with another Person, with &ldquo;control&rdquo; having the meaning
provided by Rule 405 of the Securities Act, as amended, as in effect on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agreement</U>&rdquo;
has the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Allocation
Referee</U>&rdquo; has the meaning set forth in Section 1.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Allocation
Schedule</U>&rdquo; has the meaning set forth in Section 1.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Assignment
and Assumption Agreement</U>&rdquo; has the meaning set forth in Section 5.2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Assumed
Liabilities</U>&rdquo; has the meaning set forth in Section 1.6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Businesses</U>&rdquo;
has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
has the meaning set forth in Section 1.7(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Payment</U>&rdquo; has the meaning set forth in Section 1.2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; has the meaning set forth in Section 1.7(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended, and its successor and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Time</U>&rdquo; has the meaning set forth in Section 1.7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Enforceability
Exceptions</U>&rdquo; has the meaning set forth in Section 2.2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exhibits</U>&rdquo;
means the Exhibits so marked, copies of which are attached to this Agreement. Such Exhibits are hereby incorporated by reference herein
and made a part hereof, and may be referred to in this Agreement and any other related instrument or document without being attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means generally accepted accounting principles as employed in the United States of America, applied consistently with prior periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Governmental
Authority</U>&rdquo; means any federal, state, or local governmental agency, department, or division, including any entity contracting
with any of the foregoing (such as carriers, fiscal intermediaries, and fiscal agents) with responsibility for regulating, licensing,
certifying, surveying, authorizing, permitting, paying, recouping overpayments, fining, excluding, or taking any enforcement action against
health care service providers providing the items and services that Sellers or the Businesses provide or otherwise having jurisdiction
over the Acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; has the meaning set forth in Section 8.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; has the meaning set forth in Section 8.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Knowledge
of Purchaser</U>&rdquo;, or words of similar import, means the actual knowledge of Purchaser&rsquo;s CEO as of the date hereof or the
Closing Date, and the knowledge that each such person would have reasonably obtained after making such inquiry with respect to the particular
matter in question as a prudent businessperson would have made or exercised in the management of his or her business affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Knowledge
of Sellers</U>&rdquo;, or words of similar import, means the actual knowledge of each of Dr. George D. Petito and Anita Petito as of
the date hereof or the Closing Date, and the knowledge that each such person would have reasonably obtained after making such inquiry
with respect to the particular matter in question as a prudent businessperson would have made or exercised in the management of his or
her business affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Law</U>&rdquo;
means any local, state, federal, or foreign code, law, ordinance, regulation, reporting, ruling or licensing requirement, rule, or statute
applicable to a Person or its assets, Liabilities or business, including those promulgated, interpreted or enforced by any Governmental
Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liability</U>&rdquo;
means any direct or indirect, primary or secondary, liability, indebtedness, obligation, fine, penalty, cost or expense (including costs
of investigation, collection and defense), claim, deficiency, guaranty or endorsement of or by any Person (other than endorsements of
notes, bills, checks, and drafts presented for collection or deposit in the ordinary course of business) of any type, whether accrued,
absolute or contingent, known or unknown, liquidated or unliquidated, matured or unmatured, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lien</U>&rdquo;
means any conditional sale agreement, covenant, default of title, easement, encroachment, encumbrance, hypothecation, infringement, lien,
mortgage, pledge, reservation, restriction, right of way, security interest, title retention or other security arrangement, or any adverse
right or interest, charge, or claim of any nature whatsoever of, on, or with respect to any right, title or interest in or to any right,
asset or property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
has the meaning set forth in Section 8.1(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Market</U>&rdquo;
means collagen based human wound care products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Owner</U>&rdquo;
has the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means a natural person or any legal, commercial or governmental entity, including any Governmental Authority, such as, but not limited
to, a corporation, general partnership, joint venture, limited partnership, limited liability company, trust, business association, group
acting in concert, or any person acting in a representative capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Price</U>&rdquo; has the meaning set forth in Section 1.2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser</U>&rdquo;
has the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Representative</U>&rdquo;
means, with respect to any Person, any director, manager, officer, employee or agent of such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Retained
Assets</U>&rdquo; has the meaning set forth in Section 1.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Retained
Liabilities</U>&rdquo; has the meaning set forth in Section 1.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rights
and Assets</U>&rdquo; has the meaning set forth in Section 1.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Schedules</U>&rdquo;
means the Schedules so marked, copies of which are attached to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933 and all regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Sellers</U>&rdquo;
has the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stock
Consideration</U>&rdquo; has the meaning set forth in Section 2.8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Tax</U>&rdquo;
means any federal, state, county, local, or foreign taxes, charges, fees, levies, imposts, duties, or other assessments, including income,
gross receipts, excise, employment, sales, use, transfer, recording license, payroll, franchise, severance, documentary, stamp, occupation,
windfall profits, environmental, federal highway use, commercial rent, customs duties, capital stock, paid-up capital, profits, withholding,
Social Security, single business, unemployment, disability, real property, personal property, registration, ad valorem, value added,
alternative or add-on minimum, estimated, or other tax or governmental fee of any kind whatsoever, imposed or required to be withheld
by the United States or any state, county, local or foreign government or subdivision or agency thereof, whether disputed or not, including
any interest, penalties, and additions imposed thereon or with respect thereto, and including any Liability for Taxes of another Person
pursuant to a contract, as a transferee or successor, under Treasury Regulation Section 1.1502-6 or analogous state, local, or foreign
law or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Tax
Return</U>&rdquo; means any return, report, filing, declaration or statement relating to Taxes that are required to be filed, recorded,
or deposited with any Governmental Authority, including any attachment thereto or amendment thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
<U>Use of Singular and Plural</U>. Any singular term in this Agreement shall be deemed to include the plural and any plural term the
singular. Whenever the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement, they
shall be deemed followed by the words &ldquo;without limitation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
10</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MISCELLANEOUS
PROVISIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
<U>Notices</U>. Any notice sent in accordance with the provisions of this Section 10.1 shall be deemed to have been received on the date
which is (a) the date of proper posting, if sent by certified U.S. mail or by Express U.S. mail or recognized overnight courier or (b)
the date on which sent, if sent by electronic mail, with confirmation and with the original to be sent by certified U.S. mail or recognized
overnight courier, addressed as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to Sellers:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Hymed Group Corporation</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applied
Nutritionals, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1817
Apple Tree Lane</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bethlehem,
Pennsylvania 18015</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Dr. George D. Petito</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189.35pt; text-align: justify; text-indent: -189pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 2.5in"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copy
                                            to Counsel</FONT></P>
                                  <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(which
shall not constitute notice):</FONT></P></TD>
  <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Corriere and Andres,
  LLC</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189.35pt; text-align: justify; text-indent: -189pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">433
E. Broad Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bethlehem,
Pennsylvania 18016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Edward J. Andres, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189.35pt; text-align: justify; text-indent: -189pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to Purchaser:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara MedTech Applied Technologies,
  LLC</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
Summit Avenue, Suite 414</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
Worth, Texas 76102 </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Zachary Fleming, CEO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189pt; text-align: justify; text-indent: -189pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189pt; text-align: justify; text-indent: -189pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189pt; text-align: justify; text-indent: -189pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189pt; text-align: justify; text-indent: -189pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify">Copy to Counsel</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(which shall not constitute notice):</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gachassin Law Firm (A limited
  liability company)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
E. Kaliste Saloom Road, Suite 6100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lafayette,
Louisiana 70508</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Benjamin Gaines, Esq. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change its address specified for notices herein by designating a new address by notice in accordance with this Section
10.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
<U>Expenses</U>. Each of the parties hereto shall bear and pay all costs and expenses incurred by it or on its behalf in connection with
the transactions contemplated hereunder. Each party represents and warrants to the other parties that neither it nor any of its employees,
Affiliates, agents or other representatives has incurred any Liability for brokerage or finders&rsquo; fees or agents&rsquo; commissions
or any similar payment in connection with the Acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
<U>Further Assurances</U>. Each party covenants that at any time, and from time to time, after the Closing, it will execute such additional
instruments and take such actions as may be reasonably requested by the other parties to confirm or perfect or otherwise to carry out
the intent and purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
<U>Waiver; Remedies Cumulative</U>. Any failure on the part of any party to comply with any of its obligations, agreements, or conditions
hereunder may be waived by any other party to whom such compliance is owed only by an agreement in writing signed by the parties against
whom enforcement of such waiver is sought. No waiver of any provision of this Agreement shall be deemed, or shall constitute, a waiver
of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver. The rights and remedies of the parties
to this Agreement are cumulative and not alternative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
<U>Assignment</U>. This Agreement shall not be assignable by any of the parties hereto without the written consent of all other parties;
provided that, Purchaser may assign its rights and obligations under this Agreement without the consent of the other parties to any direct
or indirect subsidiary or Affiliate of Purchaser or to any party that acquires (directly or indirectly) substantially all of the assets
or interests of Purchaser or any successor entity resulting from a merger or consolidation of or with Purchaser. No such assignment shall
relieve Purchaser or Guarantor of its obligations hereunder.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6
<U>Binding Effect</U>. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs,
legal representatives, executors, administrators, successors, and permitted assigns. This Agreement shall survive the Closing and not
be merged therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7
<U>Headings</U>. The Section and other headings in this Agreement are inserted solely as a matter of convenience and for reference, and
are not a part of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8
<U>Entire Agreement</U>. All Schedules and Exhibits attached to this Agreement are by reference made a part hereof. For purposes of this
Agreement, items disclosed on each Schedule must specifically reference the provision within the Agreement to which each disclosure relates.
This Agreement and the Exhibits, Schedules, certificates, and other documents delivered pursuant hereto or incorporated herein by reference,
contain and constitute the entire agreement among the parties and supersede and cancel any prior agreements, representations, warranties,
or communications, whether oral or written, among the parties relating to the transactions contemplated by this Agreement. Neither this
Agreement nor any provision hereof may be changed, discharged, or terminated orally, but only by an agreement in writing signed by the
party against whom or which the enforcement of such change, discharge or termination is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9
<U>Governing Law; Severability</U>. This Agreement shall be governed by and construed in accordance with the Laws of the state of Delaware,
without regard to any applicable conflicts of Laws. The provisions of this Agreement are severable and the invalidity of one or more
of the provisions herein shall not have any effect upon the validity or enforceability of any other provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10
<U>Counterparts</U>. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE TO IMMEDIATELY FOLLOW.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY BLANK.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANARA
    MEDTECH APPLIED TECHNOLOGIES, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
    MedTech Inc., its Manager</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Zachary Fleming</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachary
    Fleming, CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GUARANTOR:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANARA
    MEDTECH INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Zachary Fleming</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachary
    Fleming, CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLERS:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    HYMED GROUP CORPORATION</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dr. George D. Petito</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    George D. Petito, President</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPLIED
    NUTRITIONALS, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dr. George D. Petito</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    George D. Petito,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OWNER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dr. George D. Petito</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    George D. Petito</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
OF SCHEDULES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 1.1(b)</FONT></TD>
  <TD STYLE="text-align: justify; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Schedule 1.1(c)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transferred Intellectual Property</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 1.3</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Retained Assets</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Schedule 1.9</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Terminated Agreements</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Schedule 2.5</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Litigation and Claims</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
OF EXHIBITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 5.2(b)</FONT></TD>
  <TD STYLE="text-align: justify; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill of Sale</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit 5.2(c)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">IP Assignment and Assumption Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit 5.2(f)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr. George D. Petito Agreement; Anita Petito
  Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit 5.2(g)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assignment and Assumption Agreement (Contracts)
  and Contract Cancellations</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN
INFORMATION CONTAINED IN THIS DOCUMENT, MARKED AT THE APPROPRIATE PLACE WITH FIVE ASTERISKS [*****], HAS BEEN OMITTED IN RELIANCE ON
REGULATION S-K, ITEM 601(B)(10)(IV) BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS CONFIDENTIAL.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PROFESSIONAL
SERVICES AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PROFESSIONAL SERVICES AGREEMENT</B> (the &ldquo;Agreement&rdquo;) is signed by the Parties and to become effective as of the 1st day
of August, 2023 (the &ldquo;Effective Date&rdquo;), by and between <B>SANARA MEDTECH INC., a Texas Corporation</B> (&ldquo;Company&rdquo;),
and <B>DR. GEORGE D. PETITO </B>(&ldquo;Inventor&rdquo;). Company and Inventor are sometimes referred to herein, individually as &ldquo;Party&rdquo;
and collectively as the &ldquo;Parties.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>pursuant to that certain Asset Purchase Agreement between Company, Sanara MedTech Applied Technologies, LLC (&ldquo;SMAT&rdquo;),
entities owned by Inventor, and Inventor individually, dated August 1st, 2023 (&ldquo;Asset Purchase Agreement&rdquo;), SMAT has purchased
the rights to certain products that were owned, and were under development, by Inventor; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>Company desires to utilize Inventor&rsquo;s services to provide professional services, to continue development of products already
in development, and for the research, development, formulation, invention, and manufacturing of any future products (&ldquo;Services&rdquo;);
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>Inventor desires to be so engaged by Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, </B>for and in consideration of the mutual covenants in this Agreement, Company and Inventor agree and contract as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
I</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PURPOSE
OF AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1 <B><U>Purpose</U></B>. The purpose of this Agreement is to define the relationship between
Company and Inventor. It is agreed and understood by and between the Parties hereto that Inventor is associated with Company only for
the purposes and to the extent set forth herein, and Inventor shall be an independent contractor and not an employee of Company. This
Agreement shall not be construed as an agreement of employment, a partnership or any other form of business entity. It is further agreed
that Inventor is responsible for the payment of all taxes due and any other statutory obligations which may be created as a result of
this Agreement, and Company shall have no obligation whatsoever to provide any salaries, benefits or privileges of any kind or nature
to Inventor or Inventor&rsquo;s employees or contractors save and except for the compensation paid to Inventor in accordance with the
terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.3pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
II</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INVENTOR
OBLIGATIONS AND DUTIES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 <B><U>Services</U></B>. Inventor shall provide Services to and on behalf of Company and as
requested by Company, and the time, manner, and nature of such services shall be as mutually agreed in advance by the parties for the
purposes set forth in the Recitals. Inventor shall provide Services in a prompt and professional manner, using personnel of required
skill, experience, and qualification, in accordance with the terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.1pt; background-color: white"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.1pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2<B> <U>Rules
and Regulations</U></B>. Inventor agrees to abide by all rules, regulations and guidelines provided by Company. Company may from time
to time amend, add or delete rules, regulations or guidelines at the Company&rsquo;s sole discretion and such amendment will not affect
the enforceability or terms of this Agreement. In the event of a conflict between this Agreement and the rules, regulations and guidelines
provided by Company, the terms of this Agreement shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
III</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TERM
AND TERMINATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 <B><U>Term</U></B>. The term of this Agreement shall be for three (3) years, beginning on the
Effective Date (&ldquo;Initial Term&rdquo;). Thereafter, this Agreement shall automatically renew for successive period(s) of one (1)
month unless otherwise terminated herein (the &ldquo;Renewal Term(s)&rdquo;). (The Initial Term and the Renewal Term(s) collectively
being the &ldquo;Term&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2 <B><U>Termination</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) This
Agreement shall terminate upon the occurrence of any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (1) Death
of Inventor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Inventor&rsquo;s
inability to provide Services on account of disability and/or incapacity for a period of time greater than six (6) months;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (3) Termination
by Company &ldquo;For Cause&rdquo; (as defined herein);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (4) Termination
by Inventor &ldquo;For Cause&rdquo; (as defined herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) After
the Initial Term, either Party may terminate this Agreement at any time, without cause or penalty, by providing at least ninety (90)
days advance written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &ldquo;For
Cause&rdquo; shall mean the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) Applied
by Company, shall mean; (i) gross negligence by Inventor in the performance of Services; or (ii) breach of this Agreement and/or any
term and/or provision of this Agreement and failure to cure such breach after reasonable notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Applied
by Inventor, shall mean; (i) Company&rsquo;s failure to pay the consideration as set forth in this Agreement, (ii) Company&rsquo;s breach
of this Agreement and/or any term and/or provision of this Agreement and its failure to cure after reasonable notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3 <B><U>Obligations
Upon Termination</U></B>. Upon termination of this Agreement, Inventor shall be entitled to receive compensation accrued through the
date of termination, but not yet paid by Company. The provisions of Article 5 and Article 6, and any other rights or obligations which
by their nature survive termination or expiration of this Agreement, shall survive the expiration or earlier termination of this Agreement.
Upon the termination or expiration of this Agreement for any reason, Inventor shall (1) immediately return and deliver to Company any
and all Confidential Information (as defined below); (2) deliver to Company all documents, materials, and work product, whether or not
complete, prepared by or on behalf of Inventor in the course of performing the Services; (3) return to Company all Company-owned property,
equipment, or materials in his possession, and (4) certify in writing to Company he has complied with the requirements in this Section
3.3. If at any time after termination of Inventor&rsquo;s relationship with Company, for any reason, Company or Inventor determines that
Inventor has any Confidential Information in Inventor&rsquo;s possession or control, Inventor shall immediately return to Company all
such Confidential Information in Inventor&rsquo;s possession or control, including all copies and portions thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
IV</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPENSATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1 <B><U>Base
Compensation.</U></B> Company shall pay to Inventor base compensation of Twelve Thousand and 00/100 Dollars ($12,000.00) per month (&ldquo;Base
Compensation&rdquo;) during the Term of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2 <B><U>Royalties.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Company acknowledges that Inventor has an ongoing relationship with the Rochal Technologies,
LLC team (&ldquo;Rochal&rdquo;), and other businesses whereby Rochal provides research and regulatory compliance services for products
currently in development (&ldquo;Co-developed Products&rdquo;). Company will pay to Inventor a three percent (3%) royalty on the actual
collections from net sales of all products Inventor develops within the scope of this Agreement and Co-developed Products that reach
commercialization. The foregoing shall not apply to any Products as such term is defined in the Asset Purchase Agreement.</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Company will also compensate Inventor for the sale of [*****], [*****], and [*****] each of which was developed in conjunction
with the Transferred IP as defined in the Asset Purchase Agreement (each a &ldquo;Future Product&rdquo;, and collectively referred to
herein as the &ldquo;Future Products&rdquo;). Company will pay to Inventor a five percent (5%) royalty for the first $50,000,000 in aggregate
collections from net sales of the Future Products, and a two and one-half percent (2.5%) royalty on aggregate collections from net sales
of the Future Products on any amounts exceeding $50,000,000 but up to $100,000,000. For purposes of clarity, no royalty shall be due
to Inventor for any aggregate collections from net sales of the Future Products in excess of $100,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<B><U>Incentives. </U></B>Company will pay $500,000 in cash to Inventor in the event that 510(k) clearance is issued for any Future Product
accepted by the Company, and Company will pay $1,000,000 in cash to Inventor in the event that a US Patent is issued for [*****]
(regardless of the date the patent is issued) (&ldquo;Incentive Payments&rdquo;). The aggregate Incentive Payments which Contractor may
earn shall not exceed Two Million Five Hundred Thousand Dollars and No/100 ($2,500,000).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4 <B><U>Expense
Reimbursement</U></B>. Company shall reimburse Inventor for any reasonable travel expenses pre-approved by Company which are incurred
while providing Services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5 <B><U>Survival</U></B>.
Section 4.1 of this Agreement shall survive termination of this Agreement for a period of time through the end of the Initial Term only,
and Sections 4.2 and 4.3 shall survive termination or expiration of this Agreement whether during the Initial Term or any Renewal Term
(under Section 3.2 or otherwise) for any reason, and each such section shall inure to the benefit of Inventor&rsquo;s heirs in the event
of death of Inventor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
V</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDEMNIFICATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1 <B><U>Indemnification</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Inventor
shall indemnify, defend, and hold harmless Company and its officers, directors, employees, agents, affiliates, successors, and permitted
assigns against any and all losses, damages liabilities, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties,
fines, costs, or expenses of whatever kind, including attorneys&rsquo; fees, fees and the costs of enforcing any right to indemnification
under this Agreement incurred by Indemnified Party (collectively, &ldquo;Losses&rdquo;), relating to or arising out of any third party
claim, action, or proceeding arising out of or occurring in connection with Inventor&rsquo;s or any of its employees&rsquo; or contractors&rsquo;
negligence, willful misconduct, or breach of this Agreement.</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Company
shall indemnify, defend, and hold harmless Inventor and his employees, agents, affiliates, successors, and permitted assigns against
any and all Losses relating to or arising out of any third-party claim, action, or proceeding arising out of or occurring in connection
with Company&rsquo;s or any of its employees&rsquo; or contractors&rsquo; negligence, willful misconduct, or breach of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
VI</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CONFIDENTIALITY,
NONCOMPETITION &amp; NONSOLICITATION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1 <B><U>Confidentiality.
</U></B>As used in this Agreement, the term &ldquo;Confidential Information&rdquo; shall mean and/or include all business information
and trade secrets of any nature and in any form which at the time or times concerned is not generally known to those persons engaged
in the business of Company (other than by the act or acts of any employee or subcontractor not authorized by Company to disclose such
information) and which relates to any of the aspects of the past, present, or future business of Company. The term &ldquo;Confidential
Information&rdquo; includes, without limitation: financial information, budgets, plans, data, trade secrets, computer software, technical
information, research and development, product information, processes, customer lists, customer data, pricing information, sales information,
marketing information, bid information, job or project information, contracts, purchasing information, data processing, processes, formulas,
designs, drafts, drawings, systems, specifications, means, techniques, compilations, intellectual property, inventions and improvements,
research and development, operational methods, protocols, business plans and strategies, market information, supplier information, personnel
matters and records, and matters that are sensitive, business related, proprietary and confidential in nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2 <B><U>Prohibitions.
</U></B>With respect to Confidential Information of Company learned, generated, obtained, received, accessed, and/or conceived or developed
by Inventor in connection with Inventor&rsquo;s Services to Company, whether before or after the Effective Date of this Agreement, Inventor
agrees that, commencing on the Effective Date of this Agreement, and for so long hereafter as any Confidential Information shall remain,
wholly or partially, confidential or otherwise protectable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Inventor
shall not use or disclose any such Confidential Information, directly or indirectly, to any person not employed with Company;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Inventor
shall not use any such Confidential Information for the benefit of Inventor or any other person or entity in any way that may be competitive
with, or could be detrimental to, Company; and</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Upon
request by Company, and/or upon termination of this Agreement, Inventor shall promptly return any and all records, materials, memoranda,
data, Company issued computers, computer disks and programs, documents and/or things constituting, containing, or pertaining to any Confidential
Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3<B> <U>Noncompetition</U>.
</B>Inventor acknowledges that the Confidential Information in his possession would enable him to establish goodwill with the patients,
customers, potential customers, and suppliers who provide to and/or consume products and services from Company and that the Confidential
Information constitutes a valuable asset of the Company. Inventor further acknowledges that he has developed relationships with certain
of the Company&rsquo;s suppliers, contractors or potential contractors, consultants or potential consultants, and sources or potential
sources of product usage. Accordingly, Inventor agrees that he will comply with the provisions of this Section 6.3 for the period beginning
on the Effective Date and ending twenty four (24) months after expiration or termination of this Agreement for any reason (the &ldquo;<U>Restricted
Period</U>&rdquo;), and that Inventor shall not, directly or indirectly, engage in, render Services to or become interested in any manner,
as manager, employee, officer, consultant, owner, or partner, or through stock ownership (other than holding less than two percent (2%)
of the outstanding equity securities of a person having securities that are listed for trading on a national securities exchange), or
otherwise, either alone or in association with others, in any business that develops, provides and/or supplies collagen based products
for human wound care use similar to those owned or under development by Company as of the Effective Date in the United States (the &ldquo;<U>Restricted
Territory</U>&rdquo;), if it relates to the Products as defined under the Asset Purchase Agreement). By way of example, and without limitation,
Inventor may consult or contract with a company if such consultation or contract does not relate to collagen based human wound care,
such as veterinary or other markets related to the Retained Assets (as defined in Asset Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4 <B><U>Nonsolicitation</U></B>.
Inventor further agrees that during the Restricted Period, he shall not, without the prior written consent of Company, directly or indirectly,
solicit, divert, take away or attempt to solicit, divert, or take away any customer having business relations with the Company for the
purpose of providing products owned and/or under development by the Company within the Restricted Territory that are similar to and competitive
with the Products (as defined in the Asset Purchase Agreement) . Inventor further agrees that, during the Restrictive Period, he shall
not, directly or indirectly, induce or attempt to induce any customer or supplier or anyone else having business with the Company to
breach an existing contract with the Company or take any other action intended to damage the relationship between any customer, supplier,
or other person having business relations with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5 <B><U>Right
to Enforcement and Remedies</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (a) Inventor
acknowledges and agrees that the restrictive covenants set forth above are reasonable and valid in time and scope and in all other respects.
The covenants set forth in this Agreement shall be considered and construed as separate and independent covenants. Should any part or
provision of any covenant be held invalid, void, or unenforceable in any court of competent jurisdiction, such invalidity, voidness,
or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (b) The
Parties hereto agree that it is their intention that the restrictive covenants be enforced in accordance with their terms to the maximum
extent possible under applicable law. The Parties further agree that, in the event any court of competent jurisdiction shall find that
any of the foregoing provisions is invalid or unenforceable, the invalid or unreasonable term shall be redefined, or a new enforceable
term provided, such that the intent of the parties in agreeing to the provisions of this Agreement will not be impaired and the provision
in question shall be enforceable to the fullest extent of the applicable laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (c) Without
limiting the remedies available to Company, the Parties hereto acknowledge that a breach of any of the covenants contained herein may
result in material, irreparable injury for which there is no adequate remedy at law, that it will not be possible to measure damages
for such injuries precisely and that, in the event of such a breach or threat thereof by Inventor, Company shall be entitled to obtain
a temporary restraining order and/or a preliminary or permanent injunction restraining Inventor from engaging in activities prohibited
by this Agreement or such other relief as may be required to specifically enforce any of the covenants hereof without the necessity of
posting any bond.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (d) Inventor
also specifically acknowledges and agrees that Company shall be entitled to seek monetary damages and other remedies at law for breaches
of this Agreement in addition to any injunctive or other equitable relief. The rights and remedies hereunder are cumulative and not alternative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
VII</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>MISCELLANEOUS
PROVISIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1 <B><U>Notices</U></B>. Any notice or other communication required by this Agreement shall be
in writing and signed by the Party giving such notice. Such notice may either be served personally on the party entitled thereto or may
be mailed registered, or certified mail, postage prepaid, addressed to such party at such party&rsquo;s last known mailing address. Such
notice or other communication shall be deemed to have been given when so personally served, or upon mailing, as the case may be as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.35pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
MedTech Inc.</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
Summit Avenue, Suite 414</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
Worth, Texas 76102</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Zachary Fleming, CEO</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVENTOR:</B></FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1817
Apple Tree Lane</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bethlehem,
PA 18015</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Dr. George Petito</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2 <B><U>Assignment</U></B>.
Inventor acknowledges the services they provide are unique and personal. Accordingly, Inventor may not assign any of his rights or obligations
under this Agreement without consent of Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3 <B><U>Waiver</U></B>.
Any waiver by Company or Inventor of a breach of any provision of this Agreement shall not be deemed to be a waiver of any preceding
or subsequent breach of the same or any other provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4 <B><U>Resolution
of Disputes</U></B>. Except for any injunctive relief which may be sought by Company, any controversy, dispute, disagreement or claim
which arises out of or relates to this Agreement, or the breach thereof, if said dispute cannot be settled through direct discussions,
shall be settled by binding arbitration in accordance with the rules and procedures of alternative dispute resolution and arbitration
established by the Alternative Dispute Resolution Service of the American Health Lawyers Association (&ldquo;AHLA&rdquo;), and judgment
upon any award rendered may be entered in any court having jurisdiction thereof. Such arbitration shall be conducted before a single
AHLA arbitrator selected jointly by the parties, or in the event the parties are unable to agree, designated by the AHLA. In addition
to any other appropriate damages, the prevailing party in the arbitration shall be entitled to reasonable attorney&rsquo;s fees and the
other fees, costs, and expenses of the arbitration. The arbitration shall be held in Fort Worth, Texas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5 <B><U>Amendments</U></B>.
This Agreement contains the entire agreement and understanding of the Parties with respect to the subject matter hereof. No alterations,
amendments or modifications of this Agreement shall be binding on either Party unless first reduced to writing and signed by both Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6 <B><U>Severability</U></B>.
Should any part of this Agreement for any reason be declared invalid, such shall not affect the validity of any remaining portions hereof,
which remaining portions shall continue in force and effect as if this Agreement has been executed with such invalid portion eliminated.
The intention of the Parties is they would have executed the remaining portions of this Agreement without including any such part, parts
or portion which may for any reason hereafter be declared invalid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7 <B><U>Governing
Law</U></B>. This Agreement shall be governed by and construed in accordance with the laws of the State of Pennsylvania, without regard
to the conflict of laws thereof. In the event of any litigation arising hereunder, the prevailing party shall be entitled to recover
reasonable attorney&rsquo;s fees as awarded by the court, together with all costs of any such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8 <B><U>Entire
Agreement</U></B>. This Agreement constitutes the Parties&rsquo; entire agreement and understanding concerning the subject matter hereof
and supersedes and replaces all earlier or contemporaneous agreements, written or oral, between the parties concerning the same. For
purposes of clarity, under no circumstance shall any terms contained herein alter, nullify, and/or reduce the applicability of any terms
as set forth in the Asset Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9 <B><U>Authority</U></B>.
Inventor represents and warrants that (i) it has the full right, power and authority to enter into this Agreement, to grant the rights
granted under this Agreement, and to perform their respective obligations under this Agreement; (ii) when executed and delivered, this
Agreement will constitute the legal, valid, and binding obligation of Inventor, enforceable against Inventor in accordance with its terms,
except as may be limited by any applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws and equitable principles
related to or affecting creditors&rsquo; rights generally or the effect of general principles of equity; and (iii) it is not currently
bound by any agreement or arrangement that includes a noncompete or similar restrictive covenant, and does not anticipate becoming bound
by such an agreement or arrangement, that would prevent or hinder it from entering into or fulfilling its obligations and responsibilities
under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10 <B><U>No
Third-Party Beneficiaries</U></B>. The terms and provisions of this Agreement are intended solely for the benefit of the parties hereto
and their respective permitted successors or assigns, and it is not the intention of the parties to confer third-party beneficiary rights
upon any other person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.11 <B><U>Counterparts
and Facsimile Signatures</U></B>. This Agreement may be executed in two or more counterparts with the same effect as if all Parties hereto
had signed the same document. All counterparts shall be constructed together and shall constitute one agreement. Facsimile signatures
on this Agreement shall be deemed to be original signatures for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Signature
Page to Follow]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.65pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Parties hereto have executed this Agreement to be effective as of the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
    MEDTECH INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Zachary Fleming</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachary
    Fleming, CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVENTOR:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DR.
    GEORGE D. PETITO</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dr. George D. Petitio</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    George D. Petito</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of 9</I></B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>LOAN
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
LOAN AGREEMENT</B> (this &ldquo;Agreement&rdquo;) is executed effective as of August 1, 2023, by <B>SANARA MEDTECH APPLIED TECHNOLOGIES,
LLC</B>, a Texas limited liability company (&ldquo;Borrower&rdquo;), whose address for purposes hereof is 1200 Summit Avenue, Suite 414,
Fort Worth, Texas 76102, <B>CADENCE BANK</B>, a Mississippi state banking corporation (&ldquo;Bank&rdquo;), whose address for purposes
hereof is 1333 West Loop South, Suite 1700, Houston, Texas 77027, and <B>SANARA MEDTECH INC.</B>, a Texas corporation (&ldquo;Parent&rdquo;),
whose address for purposes hereof is 1200 Summit Avenue, Suite 414, Fort Worth, Texas 76102.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>W
I T N E S S E T H</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Borrower has requested that Bank extend to Borrower an advancing term loan in the principal amount of Twelve Million and No/100 Dollars
($12,000,000.00), which advancing term loan is to be guaranteed by Guarantor on the terms set forth herein and in the Guaranty, and Bank
is willing to extend such advancing term loan to Borrower on the terms and subject to the conditions hereinafter set forth;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, and in reliance upon the representations and warranties of Obligors hereinafter set
forth, the parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DEFINITIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, the following terms shall have the respective meanings assigned to them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Acquisition
Installment Payments:</U> The &ldquo;Installment Payments&rdquo; as such term is defined in Subsection 1.2(a) of that certain Asset Purchase
Agreement dated August 1, 2023, executed by Borrower, as Purchaser, The Hymed Group Corporation and Applied Nutritionals, LLC, as Sellers,
and Dr. George D. Petito, as Owner, as amended from time to time, and any payments in substitution therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advance:
</U>Any advance by Bank to, or for the benefit of, Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advancing
Term Loan:</U> That certain advancing term loan made available to Borrower in the principal amount of Twelve Million and No/100 Dollars
($12,000,000.00) and being more particularly described in <B>Section 2.1</B> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advancing
Term Loan Drawdown Termination Date:</U> February 1, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advancing
Term Loan Maturity Date:</U> August 1, 2028.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advancing
Term Loan Rate:</U> The Base Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advancing
Term Note:</U> That certain Promissory Note dated of even date with the effective date hereof, executed by Borrower and payable to the
order of Bank in the principal amount of the Advancing Term Loan, together with all modifications, renewals, extensions, amendments and
restatements thereof and substitutions therefor, and being more particularly described in <B>Section 2.1</B> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Affiliate:
</U>With respect to any Person (a) a Person that, directly or indirectly or through one or more intermediaries, Controls, is Controlled
by, or is under common Control with, such Person; (b) any Person of which such Person or such Person&rsquo;s spouse, sibling, parent
or child is an officer, director, shareholder, member, manager, securities holder, partner, or, in the case of a trust, a beneficiary
or trustee; and (c) any Person that is an officer, director, shareholder, member, manager, securities holder, partner, or, in the case
of a trust, a beneficiary or trustee of such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Base
Rate</U>: For any day, a rate per annum equal to the Term SOFR for a one-month tenor in effect on such day plus three percent (3.0%);
provided that in no event shall the Base Rate be greater than the Maximum Rate. Any change in the Base Rate due to a change in Term SOFR
shall be effective from and including the effective date of such change in the Term SOFR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Base
Rate Term SOFR Determination Day</U>: As defined in the definition of &ldquo;Term SOFR&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Beneficial
Ownership Certification:</U> A certification regarding beneficial ownership required by the Beneficial Ownership Regulation, which certification
shall be in form and substance satisfactory to Bank, and shall contain no information objectionable to Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Beneficial
Ownership Regulation:</U> 31 C.F.R. &sect; 1010.230.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Borrower
Security Agreements(s</U>): Individually or collectively, as applicable, all security agreements, pledges and collateral assignments
executed herewith or hereafter by Borrower in order to create or evidence a security interest of Bank in any assets owned or to be acquired
by Borrower, and all modifications, renewals, extensions, amendments, restatements and rearrangements thereof, and substitutions therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Business
Day</U>: Any day that is not a Saturday, Sunday or other day on which commercial banks in Houston, Texas are authorized or required to
remain closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
Flow Leverage Ratio:</U> The ratio of all Funded Debt (which for avoidance of doubt includes all Acquisition Installment Payments during
the following twelve (12) month period) to EBITDA during the preceding twelve (12) month period; <U>provided </U> <U> however</U>, that
for purposes of calculating the &ldquo;Cash Flow Leverage Ratio,&rdquo; EBITDA shall be calculated as follows: (i) for the fiscal quarter
ending September 30, 2023, EBITDA for the 2-month period ending on that date multiplied by 6; (ii) for the fiscal quarter ending December
31, 2023, EBITDA for the 5-month period ending on that date multiplied by 12/5; (iii) for the fiscal quarter ending March 31, 2024, EBITDA
for the 8-month period ending on that date multiplied by 1.5; (iv) for the fiscal quarter ending June 30, 2024, EBITDA for the 11-month
period ending on that date multiplied by 12/11; and (v) for the fiscal quarter ending September 30, 2024, and for each fiscal quarter
thereafter, EBITDA for the twelve (12) month period ending on that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Change
in Law:</U> The adoption or taking effect of, or any change in, any law, or any change in the interpretation, administration or application
of any law by any Governmental Authority, central bank or comparable agency charged with the interpretation, administration or application
thereof, or compliance by Bank with any request, guideline or directive (whether or not having the force of law) of any such authority,
central bank or comparable agency occurring after the effective date hereof, provided, however, that notwithstanding anything herein
to the contrary, the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder
or issued in connection therewith and all requests, rules, guidelines or directives promulgated by Bank for International Settlements,
the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States regulatory authorities, in each
case pursuant to Basel III, shall in each case be deemed to be a &ldquo;Change in Law&rdquo; regardless of the date enacted, adopted
or issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Collateral:
</U>&ldquo;Collateral&rdquo; as defined in any Security Agreement, any of the Financing Statements or any other Security Instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compliance
Certificate: </U>A certificate prepared by Borrower and delivered to Bank in conformity with <B><U>Exhibit A </U></B>to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Control:
</U>The possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person,
whether through the ability to exercise voting power, by contract or otherwise. &ldquo;Controlling&rdquo; and &ldquo;Controlled&rdquo;
have meanings correlative thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Corporate
Guarantor(s):</U> Individually or collectively, as applicable, Parent and any other Person which is not an individual hereafter executing
a Guaranty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Corporate
Obligor(s):</U> Individually or collectively, as applicable, Borrower and Corporate Guarantors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Debt
Service Coverage Ratio:</U> The ratio of (a) the sum of the following during the preceding twelve (12) month period: (i) EBITDA
minus (ii) capital expenditures, minus (iii) cash taxes, minus (iv) dividends and distributions, to (b) the sum of (i) the current
portion of long term debt plus, (ii) Acquisition Installment Payments during the following twelve (12) month period, (iii) interest
expense during the preceding twelve (12) month period; <U>provided </U> <U> however </U>, that for purposes of calculating the
&ldquo;Debt Service Coverage Ratio&rdquo; EBITDA and interest expense (collectively, the &ldquo;Annualized Components&rdquo;) shall
be calculated as follows: (i) for the fiscal quarter ending September 30, 2023, the Annualized Components for the 2-month period
ending on that date multiplied by 6; (ii) for the fiscal quarter ending December 31, 2023, the Annualized Components for the 5-month
period ending on that date multiplied by 12/5; (iii) for the fiscal quarter ending March 31, 2024, the Annualized Components for the
8-month period ending on that date multiplied by 1.5; (iv) for the fiscal quarter ending June 30, 2024, the Annualized Components
for the 11-month period ending on that date multiplied by 12/11; and (v) for the fiscal quarter ending September 30, 2024, and for
each fiscal quarter thereafter, the Annualized Components for the twelve (12) month period ending on that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Debtor
Relief Laws:</U> Any applicable liquidation, conservatorship, bankruptcy, moratorium, rearrangement, insolvency, reorganization, or
similar laws, whether state or federal, affecting the rights or remedies of creditors generally, as in effect from time to
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Default:
</U>The occurrence of any event which, with the giving of notice, lapse or expiration of time, or both, or other condition precedent,
will constitute an &ldquo;Event of Default&rdquo; under <B>Section 7.1</B> of this Agreement, regardless of whether any requirement for
the giving of notice, the lapse or expiration of time, or any other condition precedent to an Event of Default, if any, has been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Default
Rate:</U> A per annum rate equal to the lesser of (a) the Base Rate plus five percent (5.0%), or (b) the Maximum Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EBITDA:
</U>The sum of earnings before interest, taxes, depreciation, amortization, stock compensation expense and gains or losses on sales of
assets outside the ordinary course of business, each of these components being calculated in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Environmental
Laws:</U> Any and all Governmental Requirements relating to the environment or public or worker health or safety, including ambient air,
surface water, land surface or subsurface strata, or to emissions, discharges, releases or threatened releases of pollutants, contaminants,
chemicals or industrial, toxic or hazardous substances or wastes (including solid wastes, hazardous wastes or hazardous substances) or
noxious noise or odor into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, recycling, removal, transport or handling of pollutants, contaminants, chemicals or industrial, toxic or hazardous substances
or wastes (including petroleum, petroleum distillates, asbestos or asbestos-containing material, volatile organic compounds or polychlorinated
biphenyls).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ERISA:
</U>The Employee Retirement Income Security Act of 1974, as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Event
of Default:</U> Any event specified as an &ldquo;Event of Default&rdquo; in <B>Section 7.1</B> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financial
Statements:</U> Such balance sheets, income statements, profit and loss statements, reconciliations of capital and surplus, and statements
of cash flows of a Person, all of which shall be prepared in a manner consistent with prior periods and the historical customs and practices
of such Person, and in the case of each Corporate Obligor in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Financing
Statements:</U> The financing statements filed or to be filed with the appropriate offices for the perfection of a security interest
in any of the Collateral, including those assigned to Bank heretofore, concurrently herewith or hereafter, together with any continuation
statements or other amendments filed or to be filed in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Floor</U>:
A rate of interest equal to one half percent (0.50%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Forbidden
Activities</U>. The use, sale, possession, cultivation, manufacture, distribution or marketing of any controlled substances or other
contraband, including marijuana (whether for commercial, medical, or personal purposes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Funded
Debt:</U> The sum of all Acquisition Installment Payments during the following twelve (12) month period and all Indebtedness for borrowed
money (including, without limitation, capital lease and synthetic lease obligations, subordinated debt (including Subordinated Debt),
and unreimbursed drawings under letters of credit), or any other monetary obligation evidenced by a note, bond, debenture or other agreement
or similar instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>GAAP:
</U>Generally accepted accounting principles in the United States of America consistently applied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governmental
Authority:</U> The government of the United States of America or any other nation or any political subdivision thereof in which an Obligor
or any of the Collateral is located, and any other political subdivision, agency, or instrumentality exercising jurisdiction over an
Obligor or an Obligor&rsquo;s property or assets, including without limitation any state, county or city and any agency, authority, instrumentality,
regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative
powers or functions of or pertaining to government.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governmental
Requirements:</U> All statutes, laws, ordinances, rules, and regulations of any Governmental Authority applicable to an Obligor or an
Obligor&rsquo;s property or assets, or any site owned or operated by an Obligor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Guarantor(s):
</U>Individually or collectively, as applicable, Individual Guarantors and Corporate Guarantors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Guarantor
Security Agreement(s):</U> Individually or collectively, as applicable, all security agreements, pledges and collateral assignments executed
herewith or hereafter by a Guarantor in order to create or evidence a security interest of Bank in any assets owned or to be acquired
by such Guarantor, and all modifications, renewals, extensions, amendments, restatements and rearrangements thereof, and substitutions
therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Guarant(y/ies):
</U>Individually or collectively, as applicable, all guaranties of the Obligations, or any portion thereof, executed by any Person herewith
or hereafter, and all modifications, renewals, extensions, amendments, restatements, replacements and rearrangements thereof, and substitutions
therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indebtedness:
</U>The total liabilities of Borrower, including the indebtedness evidenced by the Note(s) and any subordinated indebtedness, calculated
in accordance with GAAP, and in a manner consistent with prior periods and Borrower&rsquo;s historical customs and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Index
Cessation Event</U>: In respect of Term SOFR:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) a
public statement or release by or on behalf of the Term SOFR Administrator that it has ceased or will cease to provide Term SOFR rates
permanently or indefinitely, provided that there is no successor administrator that will continue to provide Term SOFR, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) a
public statement or release by any regulatory supervisor with the relevant authority that Term SOFR will no longer be provided by any
administrator, or it has been deemed to no longer be a representative rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Individual
Guarantor(s):</U> Individually or collectively, as applicable, any Person who is an individual hereafter executing a Guaranty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Individual
Obligor(s):</U> Individually or collectively, as applicable, Individual Guarantors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loan(s):
</U>Individually or collectively, as applicable, the Advancing Term Loan and all modifications, renewals, extensions, amendments, restatements
and rearrangements thereof, and substitutions therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Material
Adverse Effect:</U> A material adverse effect on (a) the business, assets, operations, prospects or condition, financial or otherwise,
of an Obligor, (b) the ability of an Obligor to perform any of its obligations under this Agreement or any other Security Instrument
or (c) the rights of or benefits available to Bank under this Agreement or any other Security Instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Maximum
Rate:</U> On any day, the maximum non-usurious rate of interest permitted for that day by whichever of applicable federal or Texas (or
any jurisdiction whose usury laws are deemed to apply to the Loan(s) or any documents executed in connection therewith despite the intention
and desire of the parties to apply the usury laws of the State of Texas) laws permit the higher interest rate, stated as a rate per annum.
On each day, if any, that the Texas Finance Code establishes the Maximum Rate, the Maximum Rate shall be the &ldquo;weekly ceiling&rdquo;
(as defined in Section 303 of the Texas Finance Code) for that day. Bank may from time to time, as to current and future balances, implement
any other ceiling under the Texas Finance Code by notice to Borrower, if and to the extent permitted by the Texas Finance Code. Without
notice to Borrower or any other Person, the Maximum Rate shall automatically fluctuate upward and downward as and in the amount by which
such maximum nonusurious rate of interest permitted by applicable law fluctuates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Note(s):
</U>Individually or collectively, as applicable, the Advancing Term Note and all modifications, renewals, extensions, amendments, restatements
and rearrangements thereof, and substitutions therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Obligations:
</U>The obligations and liabilities of Borrower to Bank evidenced by this Agreement, the Note(s) or any other Security Instrument, and
any and all other Indebtedness, liabilities and obligations whatsoever of Borrower to Bank, whether direct or indirect, absolute or contingent,
primary or secondary, liquidated or unliquidated, due or to become due, whether now existing or hereafter arising, and whether in connection
with this or another transaction, and howsoever evidenced or acquired, whether joint or several or joint and several, including derivative-foreign
exchange transactions or any treasury management or other services provided by Bank or its Affiliates, successors or assigns (including,
without limitation, controlled disbursement, automated clearinghouse transactions, return items, overdrafts and interstate network services),
and whether evidenced by note, draft, acceptance, guaranty, open account, commercial credit card, stored value card, merchant card, letter
of credit, surety agreement, Rate Management Agreement or otherwise; it being contemplated by the parties hereto that Borrower may become
indebted to Bank in additional sums. The term &ldquo;Obligations&rdquo; shall expressly include any and all obligations, contingent or
otherwise, whether now existing or hereafter arising, of Borrower and of Borrower&rsquo;s Affiliates to Bank, or to any of its Affiliates
or successors, arising under or in connection with any Rate Management Agreement or Rate Management Transaction; provided, however, that
the definition of &ldquo;Obligations&rdquo; shall not create any guarantee by a Guarantor or Borrower of (or grant of security interest
by a Guarantor or Borrower to support, as applicable) any Excluded Swap Obligations (as defined in <B>Section 2.16</B> hereof) of such
Guarantor or Borrower for purposes of determining any obligations of such Guarantor or Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Obligor(s):
</U>Individually or collectively, as applicable, Borrower and Guarantor(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Organizational
Documents:</U> The Certificate of Formation, Certificate or Articles of Incorporation, Bylaws, Articles of Organization, Company Agreement
or Regulations, Certificate of Limited Partnership, Agreement of Limited Partnership, Partnership Agreement or other organizational document
of a Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Overline</U>:
&ldquo;Overline&rdquo; as defined in <B>Section 2.6</B> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Periodic
Term SOFR Determination Day</U>: As specified in the definition of &ldquo;Term SOFR&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Person:
</U>Any corporation, partnership, joint venture, limited liability company, association, trust, trustee, estate, individual, unincorporated
business entity or governmental department, administrative agency or instrumentality, or other entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan:
</U>Any plan subject to Title IV of ERISA and maintained by a Corporate Obligor or any such plan to which such Corporate Obligor is required
to contribute on behalf of its employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rate
Management Agreement:</U> Each agreement between Borrower or any of its Affiliates, on the one hand, and Bank or any of its Affiliates
or their successors, on the other hand, including but not limited to any ISDA Master Agreement, whether now existing or hereafter entered
into, which provides for a Rate Management Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Rate
Management Transaction:</U> Any transaction (including an agreement with respect thereto) now existing or hereafter entered into between
Borrower or any of its Affiliates, on the one hand, and Bank or any of its Affiliates or their successors, on the other hand, which is
(i) a rate swap, swap option, basis swap, forward rate transaction, commodity swap, commodity option, equity or equity index swap, equity
or equity index option, bond option, interest rate option, foreign exchange transaction, cap, floor, collar, currency swap, cross-currency
rate swap, currency option, credit protection transaction, credit swap, credit default swap, credit default option, total return swap,
credit spread, repurchase transaction, reverse repurchase transaction, buy/sell-back transaction, securities lending transaction, weather
index transaction or forward purchase or sale of a security, commodity or other financial instrument or interest (including an option
with respect to any of these transactions), or (ii) any type of transaction that is similar to any transaction referred to in clause
(i) above that is currently, or in the future becomes, recurrently entered into in the financial markets and which is a forward, swap,
future, option or other derivative on one or more rates, currencies, commodities, equity securities or other equity instruments, debt
securities or other debt instruments, economic indices or measures of economic risk or value, or other benchmarks against which payments
or deliveries are to be made, or any combination of the foregoing transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Regulation
U:</U> Regulation U of the Board of Governors of the Federal Reserve System as from time to time in effect and any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Regulation
X:</U> Regulation X of the Board of Governors of the Federal Reserve System as from time to time in effect and any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Request
for Advance:</U> A written request, in form and content acceptable to Bank, given by Borrower to Bank not later than 10:00 a.m. (Houston,
Texas time) on the Business Day of the proposed Advance, specifying the requested date and amount of such Advance, and including a certificate
of such individual responsible for financial and accounting matters as Bank may designate, certifying (a) that no Default has occurred,
and (b) such other matters as Bank may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Security
Agreement(s):</U> Individually or collectively, as applicable, the Borrower Security Agreements and the Guarantor Security Agreements,
and all modifications, renewals, extensions, amendments, restatements and rearrangements thereof, and substitutions therefor, and all
security agreements, pledges and collateral assignments hereafter executed in order to create or evidence a security interest of Bank
in any assets owned or to be acquired by any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Security
Instrument(s):</U> Individually or collectively, as applicable, this Agreement, the Note(s), the Security Agreements, the Financing Statements,
any Guaranties, any Subordination Agreements and such other documents, instruments or agreements evidencing, securing, guaranteeing,
or otherwise pertaining to the Loan(s) as may be, from time to time (whether heretofore, contemporaneously herewith or hereafter), executed
and delivered by an Obligor or any other Person to Bank, and all modifications, renewals, extensions, rearrangements, ratifications,
restatements and replacements of any of the foregoing. Notwithstanding the foregoing, or any provision of any &ldquo;Security Instrument&rdquo;
to the contrary, the term &ldquo;Security Instruments&rdquo; shall not include a Rate Management Agreement nor any swap agreement (as
defined in 11 U.S.C. Section 101, as in effect from time to time).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SOFR</U>:
A rate equal to the secured overnight financing rate as administered by the SOFR Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SOFR
Administrator</U>: The Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subject
Property</U>: Any real estate owned or leased by Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subordinated
Debt:</U> Subordinated indebtedness issued by Borrower on terms and conditions approved in writing by Bank, and subject to an enforceable
Subordination Agreement under which no party is in default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subordination
Agreements:</U> Any subordination agreements or intercreditor agreements executed concurrently herewith or hereafter by Bank with any
third Person, in order (a) to subordinate any debt or obligation of Borrower owed to such third Person to any debt or obligation of Borrower
owed to Bank, or (b) to agree on priority in rights of payment or lien position, all as same may be modified, amended, renewed or extended
from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsidiary:
</U>With respect to any Person (the &ldquo;parent&rdquo;) at any date, any corporation, limited liability company, partnership, association
or other entity the accounts of which would be consolidated with those of the parent in the parent&rsquo;s consolidated Financial Statements
if such Financial Statements were prepared in accordance with GAAP as of such date, as well as any other corporation, limited liability
company, partnership, association or other Person (a) of which securities or other ownership interests representing more than fifty percent
(50%) of the equity or more than fifty percent (50%) of the ordinary voting power or, in the case of a partnership, more than fifty percent
(50%) of the general partnership interests are, as of such date, owned, Controlled or held, or (b) that is, as of such date, otherwise
Controlled, by the parent or one or more Subsidiaries of the parent or by the parent and one or more Subsidiaries of the parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term
SOFR</U>: For any calculation with respect to a Base Rate Loan on any day, the forward-looking term rate based on SOFR for a tenor of
one month on the day (such day, the &ldquo;<U>Base Rate Term SOFR Determination Day</U>&rdquo;) that is two (2) U.S. Government Securities
Business Days prior to such day, as such rate is published by the Term SOFR Administrator; <U>provided</U>, however, that (a) if as of
5:00 p.m. (New York City time) on any Base Rate Term SOFR Determination Day the forward-looking term rate based on SOFR for the applicable
tenor has not been published by the Term SOFR Administrator, then Term SOFR will be the forward-looking term rate based on SOFR for such
tenor as published by the Term SOFR Administrator on the first preceding Business Day for which such forward-looking term rate based
on SOFR for such tenor was published by the Term SOFR Administrator so long as such first preceding Business Day is not more than three
(3) Business Days prior to such Base Rate Term SOFR Determination Day; (b) if the relevant Term SOFR is not available, for any reason
whatsoever including any Index Cessation Event, then Bank in its sole discretion will select a commercially reasonable alternative for
Term SOFR, provided that if an industry Term SOFR Recommended Rate alternative exists then Bank shall use such industry alternative;
and (c); if Term SOFR determined as provided above shall ever be less than the Floor, then Term SOFR shall be deemed to be the Floor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term
SOFR Administrator</U>: CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term SOFR Reference Rate
selected by Bank in its reasonable discretion).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term
SOFR Recommended Rate</U>: The rate (inclusive of any spreads or adjustments) recommended as the replacement for Term SOFR by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) the
Term SOFR Administrator or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) a
committee officially endorsed or convened, by the Federal Reserve Board, or the Federal Reserve Bank of New York, or the regulatory supervisor
of the Term SOFR Administrator, for the purpose of recommending a replacement for Term SOFR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term
SOFR Reference Rate</U>: The forward-looking term rate based on SOFR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>U.S.
Government Securities Business Day</U>: Any day except for a Saturday, Sunday or day on which the Securities Industry and Financial Markets
Association (SIFMA), or successor entity recommends that the fixed income departments of its members be closed for the entire day for
purposes of trading in the U.S. Government Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>THE
LOAN(S)</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 <U>Advancing Term Loan</U>. Subject to, and upon the terms, conditions, covenants and agreements
contained herein, and in reliance upon the covenants, agreements, representations and warranties of Obligor(s) set forth herein, and
provided that at the time of any proposed borrowing hereunder no Default exists, Bank agrees to make, at any time and from time to time
prior to the Advancing Term Loan Drawdown Termination Date, one or more Advances to Borrower up to the aggregate maximum principal amount
of Twelve Million and No/100 Dollars ($12,000,000.00), which Advances shall be evidenced by the Advancing Term Note. In no event shall
the aggregate of all Advances under the Advancing Term Note exceed Twelve Million and No/100 Dollars ($12,000,000.00). Principal amounts
evidenced by the Advancing Term Note which are repaid may not be reborrowed. Bank&rsquo;s business records shall be <I>prima facie</I>
evidence of the unpaid principal amount of the Advancing Term Note, and the amount of accrued but unpaid interest. The principal of and
interest to accrue on the Advancing Term Note shall be due and payable as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Accrued but unpaid interest on the unpaid principal balance of the Advancing Term Note shall be due and payable monthly as it accrues,
beginning on September 5, 2023, and continuing regularly and monthly on the fifth (5th) day of each month thereafter until the
Advancing Term Loan Maturity Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Beginning on August 5, 2024, the unpaid principal balance of the Advancing Term Note shall be due and payable in equal monthly installments
in an amount equal to the unpaid principal balance of the Advancing Term Note outstanding on the Advancing Term Loan Drawdown Termination
Date divided by eighty-four (84), the first such installment to be due and payable on August 5, 2024, and a like installment to be due
and payable on the fifth (5th) day of each month thereafter until and including July 5, 2025; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Beginning
on August 5, 2025, the unpaid principal balance of the Advancing Term Note shall be due and payable in equal monthly installments in
an amount equal to the unpaid principal balance of the Advancing Term Note outstanding on the Advancing Term Loan Drawdown Termination
Date divided by sixty (60), the first such installment to be due and payable on August 5, 2025, and a like installment to be due and
payable on the fifth (5th) day of each month thereafter until the Advancing Term Loan Maturity Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
On the Advancing Term Loan Maturity Date all remaining unpaid principal, together with all accrued but unpaid interest, shall mature
and become due and payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Advance under the Advancing Term Note, and all renewals, extensions, modifications and rearrangements of the Advancing Term Note, if
any, shall be deemed to have been made pursuant to this Agreement and, accordingly, shall be subject to the terms, conditions and provisions
hereof, and Borrower shall be deemed to have ratified, as of the date of each Advance under the Advancing Term Note, and any renewal,
extension, modification or rearrangement thereof, all the representations, covenants, warranties, promises and agreements set forth herein.
Bank shall never be required to modify, renew, extend or rearrange the Advancing Term Note, regardless of whether any Default has ever
occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2 <U>Advances
by Bank; Automatic Debit; Proceeds</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Purpose
and Use of Advances.</U> Subject to the further terms and conditions hereof, Bank will advance the proceeds of the Loan(s) as necessary
for the purposes set out in <B>Section 6.6</B> below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>No
Default</U>. Bank may, but shall never be required to, make or continue any Advance after a Default which has not been cured to the satisfaction
of Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Request
for Advance.</U> Notwithstanding the foregoing or any provision hereof to the contrary, Bank may require that each Advance be made pursuant
to a Request for Advance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Automatic
Debit.</U> To effectuate any payment due under this Agreement, the Note(s), any other Security Instrument or a Rate Management Agreement,
Bank is hereby authorized to initiate debit entries to any deposit account of Borrower maintained with Bank, and to debit the same to
such account. This authorization to initiate debit entries shall remain in full force and effect until Bank has received written notification
of its termination in such time and in such manner as to afford Bank a reasonable opportunity to act on it. The parties hereto acknowledge
and agree (i) that such debit entries may cause an overdraft of any such account which may result in Bank&rsquo;s refusal to honor items
drawn on any such account until adequate deposits are made to any such account; (ii) that Bank is under no duty or obligation to initiate
any debit entry for any purpose; and (iii) that if a debit is not made because any such account does not have a sufficient available
balance, or otherwise, the payment may be late or past due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Sweep;
Application of Payments.</U> Bank is hereby authorized to sweep the collected balance of good funds from Borrower&rsquo;s accounts periodically
for application to (i) the outstanding principal balance of each Loan, at such times and in such manner as Bank, in its sole discretion,
deems appropriate, and (ii) any payments due under any Rate Management Agreement with Bank or its Affiliates or their successors. Bank
may apply any payments received from any source against any portion of the Obligations in such priority and fashion as Bank may deem
appropriate; provided, however, that any amounts received from any source that is not a Qualified ECP Guarantor, as defined in <B>Section
2.16 </B>hereof, shall not be applied to any portion of the Excluded Swap Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3 <U>Interest</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Advancing
Term Loan</U>. Subject to <B>Subsection (b)</B> below, the unpaid principal balance of the Advancing Term Note shall bear interest at
the lesser of the Advancing Term Loan Rate or the Maximum Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Default
Rate</U>. Notwithstanding any provision of this Agreement to the contrary, (i) while an Event of Default pursuant to <B>Section 7.1(a)
</B>is continuing or (ii) (A) while any Event of Default other than pursuant to <B>Section 7.1(a)</B> is continuing and (B) Bank has
given Borrower notice that Bank has exercised its right to increase the rate of interest, the unpaid principal balance of each Note shall
bear interest at the Default Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<U>Place and Timing of Payment</U>s. All payments shall be made to Bank at its office set forth in the preamble of this Agreement, without
offset or deduction. Payments received after Bank&rsquo;s cut-off times established from time to time or on a day that is not a Business
Day will be credited as of the next Business Day. Whenever any payment under a Note becomes due and payable on a day that is not a Business
Day, if no Event of Default then exists, the maturity of the payment shall be extended to the next succeeding Business Day, except that
if the result of the extension would be to extend the payment into another calendar month, the payment must be made on the immediately
preceding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 <U>Late Payments</U>. If any payments due under a Note or this Agreement are not timely made,
Borrower shall also pay to Bank, upon demand, a late charge equal to five percent (5.0%) of each payment past due for ten (10) or more
days. This late charge shall not apply to payments due at maturity or by acceleration of a Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6 <U>Optional and Mandatory Prepayments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Fees
and Prepaid Charges Fully Earned.</U> All loan fees and other prepaid charges are earned fully as of the date of the applicable Loan
and will not be subject to refund, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Advancing
Term Note to Remain in Effect.</U> Borrower may pay all or a portion of the Advancing Term Note before it is due; provided, however,
that each Note shall remain in full force and effect until, at a time when no amounts, principal, interest or otherwise, are then owing,
Borrower releases Bank in writing from any obligation to make Advances pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Application
of Prepayments.</U> Prepayment of a Note in full shall consist of payment of the remaining unpaid principal balance together with all
accrued but unpaid interest and all other amounts, costs and expenses for which Borrower is responsible under such Note or any other
agreement with Bank pertaining to such Note before such amounts are due, whether such prepayment arises from a voluntary or involuntary
prepayment, acceleration of maturity, or any other cause or reason. Prepayment in part shall consist of payment of any portion of the
unpaid principal balance before it is due, whether such prepayment arises from a voluntary or involuntary prepayment, acceleration of
maturity, or any other cause or reason. Unless otherwise agreed by Bank in writing and provided that Borrower is current on all amounts
due, payments applied to a Note before Bank&rsquo;s creation of a billing statement for the next payment due will be applied entirely
to principal, and payments applied to a Note after the creation of such billing statement will be applied according to that billing statement.
Unless otherwise agreed by Bank in writing and provided that Borrower is current on all amounts due, payments applied to a Note before
Bank&rsquo;s creation of a billing statement for the next payment due shall not relieve Borrower of the obligation to continue making
uninterrupted payments under such Note. All payments of principal are to be applied to the outstanding principal balance of each Note
at such times and in such manner as Bank, in its sole discretion, deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Rate
Management Agreements Independent.</U> All Rate Management Agreements, if any, between Borrower and Bank or its Affiliates are independent
agreements governed by the written provisions of such Rate Management Agreements, which will remain in full force and effect, unaffected
by any repayment, prepayment, acceleration, reduction, increase or change in the terms of any Note, except as otherwise expressly provided
in such Rate Management Agreements, and any payoff statement from Bank relating to a Note shall not apply to such Rate Management Agreements
except as otherwise expressly provided in such payoff statement. Any prepayment shall be without prejudice to Borrower&rsquo;s obligations
under any Rate Management Agreement, which shall remain in full force and effect subject to the terms of such Rate Management Agreement
(including provisions that may require a reduction, modification or early termination of a Rate Management Transaction, in whole or in
part, in the event of such prepayment, and may require Borrower to pay any fees or other amounts for such reduction, modification or
early termination), and no such fees or amounts shall be deemed a penalty hereunder or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Overlines.
</U>If at any time the then outstanding principal under the Advancing Term Note exceeds the face amount of the Advancing Term Note, Borrower
agrees to pay the excess amount (each an &ldquo;Overline&rdquo;) immediately upon demand by Bank. Overlines shall bear interest at the
rate set forth in <B>Section 2.3</B>. If not sooner paid, interest on Overlines shall be paid on the fifth (5<SUP>th</SUP>) day of each
month, until the Advancing Term Loan Maturity Date. Upon request of Bank, Borrower shall execute a promissory note payable to the order
of Bank to represent the amount of any Overline; however, Borrower acknowledges and agrees that the records of Bank and this Agreement
shall constitute conclusive evidence of any Overline and the obligation of Borrower to repay any Overline, with interest. All Overlines
for which Bank has not demanded payment earlier, and all unpaid and accrued interest on Overlines not due and payable earlier, shall
be due and payable on the Advancing Term Loan Maturity Date. Borrower acknowledges and agrees that Bank is not obligated to fund any
Advance that would create an Overline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
<U>Upfront Fee</U>. In consideration of Bank&rsquo;s agreement, subject to the terms and conditions hereof, to make Advances hereunder,
both on or about the date hereof and in the future, Borrower shall pay to Bank upon the execution hereof an upfront fee in the amount
of Thirty Thousand Dollars ($30,000). In no event shall this fee be, or be deemed to be, compensation for the use, forbearance or detention
of money. Further, in no event shall this fee, together with all amounts constituting interest under applicable laws and payable in connection
with this Agreement and the other Security Instruments, exceed the Maximum Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8 <U>Interest
Computation</U>. All interest hereunder shall be computed on the basis of a year of 360 days, and in each case shall be payable for the
actual number of days elapsed (including the first day but excluding the last day). All interest hereunder on any Loan shall be computed
on a daily basis based upon the outstanding principal amount of such Loan as of the applicable date of determination. The Term SOFR shall
be determined by Bank, and such determination shall be conclusive absent manifest error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
<U>Security</U>. Payment of the Obligations and performance of the covenants set forth in the Security Instruments will be guaranteed
according to the terms of the Guaranties, and secured by the Collateral, subject only to security interests in favor of Bank or as otherwise
permitted hereunder. As any Collateral is sold or otherwise disposed of, Obligor(s) will faithfully and promptly deposit the proceeds
thereof in Obligor(s)&rsquo; accounts at Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10 <U>Additional
Security Instruments</U>. Obligor(s) agree to execute, acknowledge and deliver to Bank, or to cause to be executed, acknowledged and
delivered to Bank, such instruments, Security Agreements, deeds of trust, assignments of rents and leases, control agreements, lockbox
agreements, blocked account agreements, assignments of insurance and proceeds, Guaranties, statements, and assignments, in form and substance
acceptable to Bank, as in the discretion of Bank or counsel for Bank may be deemed necessary to enforce and grant to Bank, and to perfect
in the appropriate jurisdictions, the security interests, liens, assignments and mortgages on the Collateral, including without limitation,
any machinery or equipment or other goods purchased with the proceeds of a Loan. Borrower hereby authorizes Bank to file, at Borrower&rsquo;s
expense, financing statements and amendments thereto and other records, without the signature of Borrower thereon, to the maximum extent
permitted by applicable law, in order to perfect, amend or continue Bank&rsquo;s interest in the Collateral. With respect to any Collateral
for which a certificate of title is issued, upon Bank&rsquo;s request, the original negotiable certificate of title shall be delivered
to Bank, and Bank&rsquo;s security interest shall be duly noted thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11 <U>Cross
Collateralization</U>. Subject to <B>Section 2.12</B>, all Collateral now or hereafter securing any of the Obligations hereunder also
shall secure any and all other Obligations now or hereafter owing by Borrower to Bank or its Affiliates or successors, including without
limitation any and all obligations, contingent or otherwise, whether now existing or hereafter arising, of Borrower and its Affiliates
to Bank, or to any of its Affiliates or successors, arising under or in connection with any Rate Management Agreements or Rate Management
Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12 <U>Cross-Collateralized
Loans Secured by Property in Special Flood Hazard Area</U>. The parties covenant and agree that if any prior, current, or future loans
or debts, other than the Notes, between Borrower and Bank (herein, the &ldquo;Other Debts&rdquo;), are cross-collateralized and secured
through this Agreement, and such Other Debts are also secured by any means by a building, structure, or by real estate (herein, the &ldquo;Secured
Property&rdquo;) located in an area designated as a special flood hazard area (SFHA&rdquo;) by the Administrator of the Federal Emergency
Management Agency (herein, the &ldquo;SFHA Debts&rdquo;), the following provisions of this <B>Section 2.12</B> become effective immediately
upon such Secured Property becoming located in a SFHA (the &ldquo;SFHA Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Collateral
Release</U>. Notwithstanding any language to the contrary in this Agreement or any other Security Instrument, Bank releases and disclaims
in full that portion of its security interest securing the Notes that is comprised of collateral secured by a SFHA Debt document or a
SFHA Debt contract or agreement between Borrower and Bank. As of the SFHA Date, Bank shall not retain, via a cross-collateralization
provision in any Security Instrument or otherwise, a security interest for the Notes in any SFHA Debt or the collateral securing any
SFHA Debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>No
Other Changes to the Scope of the Collateral</U>. Beyond the changes to the scope of Bank&rsquo;s security interest for the Notes rendered
by the preceding <B>Subsection 2.12(a)</B>, no other aspect of Bank&rsquo;s collateral or security interest for the Notes, as defined
or established by the Security Instruments, is modified by this <B>Section 2.12</B>. The provisions of this <B>Section 2.12</B> do not
affect, to any extent, the scope of the collateral or security interest securing the Notes, other than the changes set forth in <B>Subsection
2.12(a)</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>This
<B>Section 2.12 </B>Shall Control for All Conflicts</U>. To the extent that the scope of Bank&rsquo;s security interest for the Notes,
as modified by the provisions of this <B>Section 2.12</B>, does not align with the scope of the security interest as defined by any other
provision of the Security Instruments, the parties agree that the provisions of this <B>Section 2.12</B> shall control for all purposes
in any conflicts regarding the scope of the Bank&rsquo;s security interest taken for the Notes after the date this Agreement is executed
by the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>No
Other Rights or Remedies Affected</U>. Except as modified herein, nothing shall otherwise impair, alter or diminish the effect, lien
or encumbrance of this Agreement or any other Security Instrument or any of the rights and remedies of the holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Effective
Date of this Section</U>. <B>The provisions of this Section 2.12 shall not become effective prior to the SFHA Date.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13 <U>Other
Collateral</U>. Collateral securing other loans from Bank to Borrower may also secure a Loan. To the extent collateral previously has
been given to Bank by any Person that may secure a Loan, whether directly or indirectly, it is specifically agreed that, to the extent
prohibited by law, all such collateral consisting of household goods will not secure any Loan. In addition, if any collateral requires
the giving of a right of rescission under the Truth in Lending Act for any Loan, such collateral also will not secure any Loan unless
and until all required notices of that right have been given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14 <U>Capital
Adequacy Charge</U>. If Bank shall have determined that any Change in Law does or shall have the effect of reducing the rate of return
on Bank&rsquo;s capital as a consequence of its obligations hereunder to a level below that which Bank could have achieved but for such
Change in Law (taking into consideration Bank&rsquo;s policies with respect to capital adequacy) by a material amount, then from time
to time, after submission by Bank to Borrower of a written demand therefor together with the certificate described below, Borrower shall
pay to Bank such additional amount or amounts as will compensate Bank for such reduction, such written demand to be made with reasonable
promptness following such determination. A certificate of Bank claiming entitlement to payment as set forth above shall be conclusive
in the absence of manifest error. Such certificate shall set forth the nature of the occurrence giving rise to such reduction, the amount
of the additional amount or amounts to be paid to Bank, and the method by which such amount was determined. In determining such amount,
Bank may use any reasonable averaging and attribution method, applied on a non-discriminatory basis. Borrower shall pay Bank the amount
shown as due on any such certificate within ten (10) days after receipt thereof. Failure or delay on the part of Bank to demand compensation
pursuant to this section shall not constitute a waiver of Bank&rsquo;s right to demand such compensation; <U>provided</U> that Borrower
shall not be required to compensate Bank pursuant to this section for any increased costs or reductions incurred more than two hundred
seventy (270) days prior to the date that Bank notifies Borrower of the Change in Law giving rise to such increased costs or reductions
and of Bank&rsquo;s intention to claim compensation therefor; <U>provided further</U> that, if the Change in Law giving rise to such
increased costs or reductions is retroactive, then the 270-day period referred to above shall be extended to include the period of retroactive
effect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15 <U>Taxes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>No
Deduction for Certain Taxes</U>. Any and all payments to Bank shall be made, in accordance with the provisions of this Agreement, free
and clear of and without deduction for any and all present or future taxes, levies, imposts, deductions, charges, or withholdings and
all liabilities with respect thereto, excluding, in the case of Bank, taxes imposed on its income and franchise taxes imposed on it by
the jurisdiction under the laws of which Bank is organized or any political subdivision of such jurisdiction (all such nonexcluded taxes,
levies, imposts, deductions, charges, withholdings, and liabilities being hereinafter referred to as &ldquo;Taxes&rdquo;). If an Obligor
shall be required by law to deduct any Taxes from or in respect of any sum payable to Bank, (i) the sum payable shall be increased as
may be necessary so that, after making all required deductions, Bank receives an amount equal to the sum it would have received had no
such deductions been made; (ii) such Obligor shall make such deductions; and (iii) such Obligor shall pay the full amount deducted to
the relevant taxation authority or other authority in accordance with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Other
Taxes</U>. In addition, each Obligor agrees to pay any present or future stamp or documentary taxes or any other excise or property taxes,
charges, or similar levies which arise from any payment made by such Obligor, or from the execution, delivery, or registration of, or
otherwise with respect to, this Agreement, a Note or any other Security Instrument, or any documents, instruments or agreements executed
in connection herewith (hereinafter referred to as &ldquo;Other Taxes&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Indemnification</U>.
OBLIGORS INDEMNIFY BANK FOR THE FULL AMOUNT OF TAXES OR OTHER TAXES PAID BY BANK AND ANY LIABILITY (INCLUDING PENALTIES, INTEREST, AND
EXPENSES) ARISING THEREFROM OR WITH RESPECT THERETO, WHETHER OR NOT SUCH TAXES OR OTHER TAXES WERE CORRECTLY OR LEGALLY ASSERTED. EACH
PAYMENT REQUIRED TO BE MADE IN RESPECT OF THIS INDEMNIFICATION SHALL BE MADE BY AN OBLIGOR TO BANK WITHIN THIRTY (30) DAYS FROM THE DATE
SUCH OBLIGOR RECEIVES WRITTEN DEMAND THEREFOR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16 <U>Provisions
Relating to Excluded Swap Obligations.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Excluded
Swap Obligation.</U> &ldquo;Excluded Swap Obligation&rdquo; means, with respect to a Guarantor, any Swap Obligation if, and to the extent
that, all or a portion of the guarantee of such Guarantor of, or the grant by such Guarantor of a security interest to secure, as applicable,
such Swap Obligation (or any guarantee thereof) is or becomes illegal or unlawful under the Commodity Exchange Act or any rule, regulation,
or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof), by virtue of such
Guarantor&rsquo;s failure for any reason to constitute an &ldquo;eligible contract participant,&rdquo; as defined in the Commodity Exchange
Act and the regulations thereunder at the time the Guaranty of such Guarantor, or the grant of such security interest by such Guarantor
becomes or would become effective with respect to such Swap Obligation or (ii) in the case of a Swap Obligation subject to a clearing
requirement pursuant to Section 2(h) of the Commodity Exchange Act (or any successor provision thereto), because a Guarantor is a &ldquo;financial
entity,&rdquo; as defined in Section 2(h)(7)(C)(i) of the Commodity Exchange Act (or any successor provision thereto), at the time the
Guaranty of such Guarantor, or the grant of such security interest by such Guarantor becomes or would become effective with respect to
such related Swap Obligation. If a Swap Obligation arises under a master agreement governing more than one Swap Obligation, such exclusion
shall apply only to the portion of such Swap Obligation that is attributable to Swap Obligations for which such Guaranty or security
interest or joint and several liability, as applicable, is or becomes illegal or unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Swap
Obligations.</U> &ldquo;Swap Obligations&rdquo; means, with respect to any Person, any and all obligations of such Person, whether absolute
or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications
thereof and substitutions therefor), under (i) any and all Swap Agreements, and (ii) any and all cancellations, buy backs, reversals,
terminations or assignments of any Swap Agreement transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Commodity
Exchange Act.</U> &ldquo;Commodity Exchange Act&rdquo; means the Commodity Exchange Act (7 U.S.C. &sect; 1 et seq.), as amended from
time to time, and any successor statute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Qualified
ECP Guarantor.</U> &ldquo;Qualified ECP Guarantor&rdquo; means, in respect of any Swap Obligation, (i) each Corporate Obligor that has
total assets exceeding $10,000,000 at the time the relevant obligation or Guaranty or grant of the relevant security interest becomes
or would become effective with respect to such Swap Obligation or (ii) such entity as constitutes an &ldquo;eligible contract participant&rdquo;
under the Commodity Exchange Act or any regulations promulgated thereunder and can cause another person to qualify as an &ldquo;eligible
contract participant&rdquo; at such time by entering into a keepwell under Section 1a(18)(A)(v)(II) of the Commodity Exchange Act or
() an Individual Obligor who meets the definition of &ldquo;eligible contract participant&rdquo; at such time under the Commodity Exchange
Act or any regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Keepwell
of Guarantors.</U> Each Guarantor, at any and all times during which such Guarantor qualifies as a Qualified ECP Guarantor, hereby absolutely,
unconditionally and irrevocably undertakes to provide such funds or other support as may be needed from time to time by each other Guarantor
who is not a Qualified ECP Guarantor at such time (a &ldquo;Non-ECP Loan Guarantor&rdquo;) to honor all of such Non-ECP Loan Guarantor&rsquo;s
obligations under any Guaranty in respect of Swap Obligations (provided, however, that a Guarantor, when a Qualified ECP Guarantor, shall
only be liable under this section for the maximum amount of such liability that can be hereby incurred without rendering the obligations
of such Guarantor, when a Qualified ECP Guarantor, under this section or otherwise under this Agreement or such Guarantor&rsquo;s Guaranty,
voidable under applicable law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations
of a Guarantor, when a Qualified ECP Guarantor, under this section shall remain in full force and effect until termination of such Guarantor&rsquo;s
Guaranty in accordance with the terms of such Guaranty. Each Guarantor, when a Qualified ECP Guarantor, intends that this section constitute,
and this section shall be deemed to constitute, a &ldquo;keepwell, support, or other agreement&rdquo; for the benefit of each other Non-ECP
Loan Guarantor for all purposes of Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Swap
Agreement.</U> For purposes of this <B>Section 2.16</B>, &ldquo;Swap Agreement&rdquo; means any agreement, contract or transaction that
constitutes a &ldquo;swap&rdquo; within the meaning of Section 1a(47) of the Commodity Exchange Act, including any agreement with respect
to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more
rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic,
financial or pricing risk or value or any similar transaction or any combination of these transactions; provided that no phantom stock
or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants
of Borrower or any of its Subsidiaries shall be a &ldquo;Swap Agreement.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17 <U>Accord
and Satisfaction</U>. Borrower agrees not to send Bank payments marked &ldquo;paid in full,&rdquo; &ldquo;without recourse,&rdquo; or
similar language. If Borrower sends such payment, Bank may accept it without losing any of Bank&rsquo;s rights under this Agreement,
any Note or any other Security Instrument, and Borrower will remain obligated to pay any further amounts owed or that may become owed
to Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ADVANCES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of this Agreement and until the Obligations have been paid and performed in full, unless compliance with the provisions of the
following sections shall have been waived in writing by Bank, Obligors agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 4.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 <U>Conditions Precedent to Initial Extension of Credit</U>. Any obligation of Bank to make
the initial Advance hereunder is subject to receipt by Bank of the following, in form and substance satisfactory to Bank:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Documents</U>.
All of the documents, instruments and agreements required or contemplated hereunder from the appropriate parties, including without limitation
this Agreement, the Notes, such Security Agreements, UCC Financing Statements, UCC Amendments and Releases of Liens encumbering the Collateral
as Bank may reasonably request, and the other Security Instruments;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Tax and Ownership Information</U>. A completed and signed (i) W-9 Request for Taxpayer Identification Number and Certification for
each Obligor, and (ii) Beneficial Ownership Certification for Borrower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Organizational
Documents</U>. Organizational Documents of each Corporate Obligor, and such certificates and other documents as Bank may reasonably request
relating to the existence, good standing and authority to do business of each such Corporate Obligor or to the authorization, execution
and delivery of this Agreement or the other Security Instruments, the Requests for Advances and other matters relevant hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Litigation</U>.
A list and summary of all pending or threatened litigation against each Obligor certified by such representative of such Obligor as Bank
may request;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Additional
Information</U>. Any and all additional information, documents, certificates or instruments as Bank may reasonably request, including
without limitation all leases, insurance policies and/or certificates, liens searches, instruments evidencing or securing any subordinated
indebtedness of an Obligor and such subordination agreements as Bank may request with respect to any outstanding indebtedness of an Obligor,
all of which shall be in form and content reasonably acceptable to Bank; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Fees
and Expenses</U>. Payment or reimbursement, as applicable, of any fees payable to Bank and any expenses incurred by Bank in connection
with the negotiation, preparation and completion of this Agreement, the other Security Instruments or any Rate Management Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2 <U>Conditions Precedent to All Extensions of Credit</U>. Any obligation of Bank to make any
Advance hereunder (including the initial Advance) is subject to (a) Bank&rsquo;s discretion, (b) the performance by Obligors of all of
their respective obligations under this or any other agreement between any of them and Bank, (c) no Default existing or occurring, (d)
Bank&rsquo;s continued satisfaction, in Bank&rsquo;s sole discretion, with the businesses, operations, or condition (financial or otherwise)
of each Obligor, (e) no material adverse change occurring in the business, assets, operations, prospects or condition, financial or otherwise,
of an Obligor, and (f) the satisfaction of the following further conditions (but no Advance made before receipt of all of such items
shall be deemed to be a waiver of such conditions with respect to any subsequent Advance):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Accuracy
of Representations</U>. Borrower representing and warranting, and acknowledging and agreeing that each application by Borrower for an
Advance will be deemed to be a representation and warranty by Borrower as of the date of such application, that (i) the representations
and warranties contained in this Agreement and the other Security Instruments are true and correct in all material respects on and as
of the date hereof, and will be true and correct in all material respects on and as of the applicable date of each Advance; (ii) all
conditions to Advances hereunder have been satisfied, except as set forth in writing by Borrower in any request for an Advance, and waived
in writing by Bank; and (iii) no Default has occurred and is continuing hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Priority
of Security Interests</U>. The creation, attachment and perfection of liens and security interests in all of the Collateral in favor
of Bank, and/or evidence satisfactory to Bank that Borrower has made arrangements for prompt delivery to Bank of the original negotiable
certificates of title to any titled vehicles owned or to be acquired by Borrower so that Bank&rsquo;s security interest may be duly noted
thereon, and the maintenance of the Collateral free and clear of all liens, claims and encumbrances except those of Bank, and as otherwise
expressly permitted hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <U>Due
Diligence and Related Items</U>. Receipt by Bank of the following, in form and substance satisfactory to Bank:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Request for Advance</U>. If required by Bank, a Request for Advance;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Collateral
Audit</U>. Results satisfactory to Bank of any audit of the Collateral; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Landlord
Waivers and Access Agreements</U>. If requested by Bank, to the extent not previously delivered, Landlord Waivers or Access Agreements
from each owner of each location at which any of the Collateral is currently or hereafter located, in form and content acceptable to
Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3 <U>Advance
Not A Waiver</U>. No Advance shall constitute a waiver of any condition to Bank&rsquo;s obligation to make further Advances, nor, in
the event Obligor(s) are unable to satisfy any condition, shall any Advance have the effect of precluding Bank from thereafter declaring
such inability to be an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4 <U>No
Liability of Bank</U>. Bank shall have no liability, obligation, or responsibility whatsoever with respect to any Obligor except to advance
funds pursuant and subject to this Agreement and the conditions set forth herein. Bank shall not be obligated to inspect or review the
Collateral, or the terms of any contracts or agreements constituting a portion of the Collateral, nor be liable for the performance or
default of an Obligor, or any other party, or for the performance of any obligation of an Obligor whatsoever. Nothing, including without
limitation any Advance or acceptance of any document or instrument, shall be construed as a representation or warranty, express or implied,
to any Person by Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AFFIRMATIVE
COVENANTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of this Agreement and until the Obligations have been paid and performed in full, unless compliance with the provisions of the
following sections shall have been waived in writing by Bank, Obligors agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Financial Statements</U>. Obligor(s) will furnish the following to Bank:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Quarterly
Financial Statements of Borrower.</U> As soon as available, but in any event within sixty (60) days after the last day of each fiscal
quarter of Borrower, <U>including</U> yearend, quarterly Financial Statements of Borrower, certified by such representative of Borrower
as Bank may request, prepared in conformity with GAAP and consisting of at least a balance sheet as of the close of such period and profit
and loss statements for the fiscal quarter then ended and for the period from the beginning of the fiscal year to the close of such period;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Annual
Financial Statements of Corporate Guarantor(s).</U> As soon as available, but in any event within one hundred twenty (120) days after
the last day of each fiscal year of each Corporate Guarantor, annual audited Financial Statements of such Corporate Guarantor (consisting
of at least a balance sheet and related statements of income, retained earnings, and cash flows) prepared in conformity with GAAP, and
certified (with an unqualified opinion) by an independent certified public accountant acceptable to Bank;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Quarterly
Financial Statements of Corporate Guarantor(s).</U> As soon as available, but in any event within sixty (60) days after the last day
of each fiscal quarter of each Corporate Guarantor, <U>other </U> <U> than</U> yearend, quarterly Financial Statements of such Corporate
Guarantor, certified by such representative of such Corporate Guarantor as Bank may request, prepared in conformity with GAAP,
similarly to the statements referred to in <B>Subsection (b)</B> above (subject to normal year-end adjustments), and consisting of
at least a balance sheet as of the close of such period and profit and loss statements for the fiscal quarter then ended and for the
period from the beginning of the fiscal year to the close of such period;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Compliance
Certificate.</U> As soon as available, but in any event within sixty (60) days after the last day of each fiscal quarter, a Compliance
Certificate in the form attached hereto as <B><U>Exhibit A</U></B> certified by such representative of Borrower as Bank may request,
calculating the financial covenants required to be maintained pursuant to this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Additional
Information.</U> Such other financial and other information concerning any Obligor or the Collateral as Bank shall reasonably request
from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2 <U>Financial
Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Minimum
Debt Service Coverage Ratio</U>. Subject to <B>Subsections 4.2(c)</B> and <B>4.2(d)</B> hereof, commencing with the fiscal quarter ending
September 30, 2023, Borrower will maintain a minimum Debt Service Coverage Ratio of 1.2 to 1.0. This covenant shall be calculated as
of the last day of each fiscal quarter of Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Maximum
Cash Flow Leverage Ratio</U>. Subject to <B>Subsections 4.2(c)</B> and <B>4.2(d)</B> hereof, Borrower will maintain a maximum Cash Flow
Leverage Ratio of not more than (a) 4.5 to 1.0 as of the last day of the fiscal quarter ending on September 30, 2023, (b) 4.0 to 1.0
as of the last day of each fiscal quarter ending on December 31, 2023, and March 31, 2024, (c) 3.5 to 1.0 as of the last day of each
fiscal quarter ending on June 30, 2024, and September 30, 2024,and (d) 3.0 to 1.0 as of the last day of each fiscal quarter thereafter.
This covenant shall be calculated as of the last day of each fiscal quarter of Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Equity
Covenant Cure Guaranty</U>. Notwithstanding anything to the contrary contained in <B>Subsections 4.2(a) </B>and <B>4.2(b) </B>and/or
<B>Section 7.1</B>, in the event that Borrower fails to comply with the financial covenants in <B>Subsections 4.2(a) </B>and/or <B>4.2(b)</B>,
no later than the tenth (10<SUP>th</SUP>) Business Day subsequent to the date the Compliance Certificate calculating such covenants is
required to be delivered pursuant to <B>Subsection 4.1(d)</B>, Parent will contribute cash in the form of immediately available funds
to the capital of Borrower in an amount equal to the amount required to satisfy the financial covenants in <B>Subsections 4.2(a) </B>and/or
<B>4.2(b)</B>, and upon the receipt by Borrower of such cash amount (the &ldquo;Covenant Cure Amount&rdquo;), the covenants in <B>Subsections
4.2(a) </B>and <B>4.2(b) </B>shall be recalculated by increasing EBITDA by an amount equal to the Covenant Cure Amount. If, after giving
effect to the foregoing recalculations, Borrower shall then be in compliance with the requirements of such financial covenants, Borrower
shall be deemed to have satisfied the requirements of such covenants as of the relevant date of determination with the same effect as
though there had been no failure to comply therewith at such date, and the applicable breach or default of any or all of such covenants
that had occurred shall be deemed cured for the purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Equity
Payment Cure Guaranty</U>. Notwithstanding anything to the contrary contained in <B>Section 7.1</B>, in the event that Borrower fails
to make a payment due under the Note or this Agreement, no later than the fifth (5<SUP>th</SUP>) Business Day subsequent to the date
such payment was due, Parent will contribute cash in the form of immediately available funds to the capital of Borrower in an amount
equal to the amount of the missed payment, and upon the receipt by Borrower of such cash amount (the &ldquo;Payment Cure Amount&rdquo;),
the Payment Cure Amount shall be paid to Bank for application to the missed payment. If the Payment Cure Amount is applied to the missed
payment within five (5) Business Days after the date such payment was due, Borrower shall be deemed to have made the payment on the due
date therefor with the same effect as though there had been no failure to make the payment on a timely basis, and the payment default
that had occurred shall be deemed cured for the purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3 <U>Depository
and Disbursement Relationship</U>. Commencing within thirty (30) days after the effective date hereof and for so long as any Obligations
remain outstanding and unpaid, or Bank has any obligation to advance funds hereunder, each Corporate Obligor will establish and maintain
its primary banking depository and disbursement relationship with Bank. Each operating account established by a Corporate Obligor after
the date hereof shall be established and maintained with Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4 <U>Insurance</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Required
Insurance.</U> Borrower will maintain insurance with financially sound and responsible companies, in such form, in such amounts and against
such risks (including, without limitation, public liability, worker&rsquo;s compensation, commercial liability, casualty, hazard or property
damage providing special form of loss coverage on Borrower&rsquo;s assets, and business interruption insurance) as is customarily carried
by companies engaged in the same or similar businesses, operating like properties and similarly situated, plus any additional insurance,
including endorsements covering specific exclusions, required in the Security Instruments or requested by Bank. Bank shall have the right
to specify the maximum amount of deductibles Bank deems acceptable for each insurance policy. Bank shall be named as loss payee, on a
&ldquo;lender&rsquo;s loss payable&rdquo; basis, on each policy of property insurance, and as an additional insured on each policy of
liability insurance. Each policy of property insurance shall provide coverage on a replacement cost basis. Each policy of insurance shall
provide that the insurer waives all rights of subrogation against Bank and that coverage under such policy is primary to any other insurance
carried by Bank. Borrower will have the right to place any such insurance with any insurance carrier reasonably acceptable to Bank. Upon
execution of this Agreement, Borrower will furnish to Bank (i) a summary of the insurance coverages of Borrower, together with certificates
showing Bank as an additional insured or loss payee with waiver of subrogation provisions, as specified above, all such policies to be
non-cancelable without thirty (30) days prior written notice to Bank, (ii) supplements to such summary from time to time as the amounts
or terms of such insurance coverage change, and (iii) upon request, copies of the applicable policies and proof of payment of the premiums
therefor. Borrower will provide Bank with immediate written notice of the cancellation of any insurance of Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b) <U>COLLATERAL
PROTECTION INSURANCE.</U> BORROWER IS REQUIRED TO (I) KEEP THE COLLATERAL INSURED AGAINST DAMAGE IN THE AMOUNT BANK SPECIFIES, (II) PURCHASE
THE INSURANCE FROM AN INSURER THAT IS AUTHORIZED TO DO BUSINESS IN TEXAS OR AN ELIGIBLE SURPLUS LINES INSURER, AND (III) NAME BANK AS
THE PERSON TO BE PAID UNDER THE POLICY IN THE EVENT OF A LOSS. BORROWER IS REQUIRED TO DELIVER TO BANK A COPY OF THE POLICY AND PROOF
OF THE PAYMENT OF PREMIUMS. IF BORROWER FAILS TO MEET ANY REQUIREMENT LISTED IN THIS SECTION, BANK MAY OBTAIN COLLATERAL PROTECTION INSURANCE
ON BEHALF OF BORROWER AT BORROWER&rsquo;S EXPENSE AND SUCH AMOUNTS SHALL BE ADDED TO THE OBLIGATIONS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5 <U>Field
Audits and Appraisals; Inspection of Property, Books, Records and Collateral</U>. At all reasonable times and as often as may be reasonably
requested by Bank, each Corporate Obligor will permit Bank, and any person appointed by Bank to act for it and on its behalf, at Borrower&rsquo;s
sole cost and expense (a) to examine and make copies of each such Corporate Obligor&rsquo;s corporate and financial books and records,
and other books, records, and properties, specifically including but not limited to all contracts, statements, invoices, bills and claims
for labor, material, and services, (b) to discuss such Corporate Obligor&rsquo;s affairs, finances and accounts with the officers, agents
and employees of such Corporate Obligor and such Corporate Obligor&rsquo;s independent certified public accountants, (c) to enter upon
any premises at which any Collateral is located and inspect the Collateral and all books and records related thereto, and (d) to conduct
such appraisals of the Collateral as Bank or any Governmental Authority may reasonably require. In addition, Borrower shall conduct,
and Bank is hereby authorized to conduct, in each case at Borrower&rsquo;s sole cost and expense, such environmental site assessments,
testing and monitoring, as may be requested by any Governmental Authority or by Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Notice; Litigation</U>. Each Obligor will promptly give written notice to Bank, in each case at Bank&rsquo;s address set forth above,
of (a) the occurrence of any Default or Event of Default, (b) any legal, judicial or regulatory proceedings affecting an Obligor, the
Collateral, or any properties or assets of an Obligor, being commenced or threatened, (c) any dispute between an Obligor and any Governmental
Authority, or between an Obligor and any other Person, which could reasonably be expected to have, or lead to, or result in, any Material
Adverse Effect, (d) any material damage to the Collateral (including without limitation any fire or other casualty) affecting any material
part of the Collateral, specifying the nature and extent of damage and whether such damage is being repaired in due course, (e) any notice
of taking or eminent domain action or proceeding affecting any material part of the Collateral, (f) any other action, event or condition
of any nature of which an Obligor has knowledge which could reasonably be expected to have, or lead to, or result in, any Material Adverse
Effect, (g) any additions to or changes in the locations of an Obligor&rsquo;s business, (h) any change in the Chairman of the Board
of a Corporate Obligor, (i) any change in the ownership of Borrower which requires a change in the information included in the Beneficial
Ownership Certification most recently delivered to Bank, (j) all actions taken in order to comply with <B>Section 4.10</B> and to prevent
Forbidden Activities, (k) the formation or acquisition by Borrower of any new Subsidiary, (l) any investment in or capital contribution
to any Person, or (m) the voluntary or involuntary bankruptcy of, or any assignment for the benefit of creditors or the seeking of any
relief under any Debtor Relief Law by, an Obligor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Application of Advances</U>. Borrower shall disburse all Advances for the purposes specified herein. Bank shall have the right, but
not the obligation, to disburse and directly apply the proceeds of any Advance to the satisfaction of any of Borrower&rsquo;s covenants,
duties or agreements hereunder. Bank may disburse any portion of any Advance at any time, and from time to time, to Persons other than
Borrower for the purposes specified in this Agreement irrespective of the provisions of <B>Article II</B>, and the amount of Advances
to which Borrower shall thereafter be entitled shall be correspondingly reduced. Bank may advance and incur such expenses for the protection
of the Collateral, at such times and in such amounts as Bank may reasonably determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8 <U>Discharge
of Liens and Encumbrances</U>. Borrower will promptly pay or cause to be paid when due all costs and expenses incurred in connection
with the Collateral and will keep the Collateral free and clear of any liens, charges, or claims other than the liens of Bank and other
liens expressly permitted hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9 <U>Subsidiary
Guaranties and Pledges</U>. (a) Subject to the provisions of <B>Subsection 4.9(b)</B>, within five (5) Business Days after Bank&rsquo;s
written request, Borrower will (i) cause each present and future Subsidiary to execute a Guaranty in form and content acceptable to Bank,
and pledge all of such Subsidiary&rsquo;s assets (subject only to liens approved by Bank in its reasonable discretion) to secure payment
of such Guaranty and the Obligations, and (ii) pledge or cause to be pledged one hundred percent (100%) of the equity interests in each
such Subsidiary, free and clear of any liens, charges, or claims, to secure payment of the Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Notwithstanding
the provisions of <B>Subsection 4.9(a)</B>, except as provided in the last sentence of this subsection, (i) no foreign Subsidiary shall
become a Guarantor, and (ii) only sixty-five percent (65%) of the issued and outstanding equity interests entitled to vote (within the
meaning of Treas. Reg. Section 1.956-2(c)(2)) and one hundred percent (100%) of the issued and outstanding equity interests not entitled
to vote (within the meaning of Treas. Reg. Section 1.956-2(c)(2)) in each foreign Subsidiary directly owned by Borrower or any domestic
Subsidiary shall be pledged. Upon the occurrence and during the continuance of any Event of Default Borrower will, upon the written request
of Bank, cause each foreign Subsidiary (i) to execute a Guaranty in form and content acceptable to Bank, (ii) to pledge all of such Subsidiary&rsquo;s
assets (subject only to liens approved by Bank in its reasonable discretion) to secure payment of such Guaranty and the Obligations,
and (iii) to have the balance of its equity interests pledged, free and clear of any liens, charges, or claims, to Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10 <U>Compliance
with Laws; Forbidden Activities</U>. Borrower shall not use or occupy any Subject Property or Collateral, or permit the use or occupancy
of any Subject Property or Collateral, for any Forbidden Activities or otherwise in violation of any Governmental Requirements, regardless
of whether such use or occupancy is permitted under any conflicting Governmental Requirements. Each lease, license, sublease or other
agreement for use, occupancy or possession of any Subject Property or Collateral (each a &ldquo;lease&rdquo;) shall prohibit the use
or occupancy of any Subject Property or Collateral for any Forbidden Activities. Promptly upon request, Borrower shall provide to Bank
written certification of compliance with this Section including certification, to the best of Borrower&rsquo;s knowledge after due inquiry,
as to whether the Subject Property or any Collateral is being used or occupied for any Forbidden Activities. If Borrower becomes aware
that any Subject Property or Collateral is being used or occupied for any Forbidden Activities, Borrower shall, subject to the terms
of the applicable lease, terminate the applicable lease and take all commercially reasonable actions to discontinue such activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11 <U>Additional
Information</U>. Each Obligor acknowledges that Bank is subject to federal and state regulations requiring Bank to obtain, verify, and
record information that identifies Bank&rsquo;s customers, including all Obligors. Promptly following any request therefor, each Obligor
shall provide information and documentation reasonably requested by Bank for purposes of compliance with applicable &ldquo;know your
customer&rdquo; requirements under the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Beneficial
Ownership Regulation or other applicable anti-money laundering laws, including but not limited to a Beneficial Ownership Certification
form acceptable to Bank. In addition, Borrower will promptly deliver to Bank an updated and signed Beneficial Ownership Certification
upon any change in the ownership of Borrower which requires a change in the information included in the Beneficial Ownership Certification
most recently delivered to Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12 <U>Errors
and Omissions; Additional Documents.</U> Each Obligor hereby agrees that immediately upon the written request of Bank, such Obligor will
execute and/or deliver, and cause to be executed and/or delivered, such additional Notes, Guaranties, Security Agreements, or other Security
Instruments as Bank may request, or will correct or cause to be corrected any Note, Guaranty, Security Agreement or other Security Instrument
already executed or delivered. Any additional documents, instruments, agreements, revisions or corrections will be in conformity with
the terms and conditions set forth in this Agreement. Any written request by Bank for additional documents, instruments or agreements
or for revisions or corrections shall be conclusive evidence of the necessity for such additional documents, instruments, agreements,
revisions or corrections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13 <U>Maintenance
of Corporate Existence and Properties</U>. Each Corporate Obligor will (a) engage solely in the business presently operated by it, without
material change therein, (b) maintain its corporate existence, in its current form and current jurisdiction of organization, (c) maintain
its good standing and authority to do business in each jurisdiction in which it is organized or required to be qualified to do business,
and (d) keep and maintain all franchises, licenses, permits and properties useful or necessary in the conduct of its business in good
order and condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14 <U>Compliance
with Governmental Requirements</U>. Each Obligor shall timely comply with all Governmental Requirements (including without limitation
all Environmental Laws) and shall promptly furnish to Bank true and complete copies of any official notice or claim by any Governmental
Authority pertaining to the operation of the business of an Obligor or to the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15 <U>Payment
of Taxes</U>. Each Obligor will pay when due all taxes, assessments and other liabilities levied or assessed upon such Obligor&rsquo;s
income, assets and/or properties (real and personal) or upon such Obligor&rsquo;s business, except those being contested in good faith
and against which such Obligor has set up adequate reserves in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16 <U>ERISA
Compliance</U>. All Plans will be maintained in compliance with all applicable provisions of ERISA and the regulations issued thereunder,
as well as with all other applicable federal, state and local statutes, ordinances and regulations. All reports and other documents required
to be filed with any Governmental Authority or distributed to Plan participants or beneficiaries will be filed or distributed in accordance
with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17 <U>Accounts
Receivable and Payable</U>. Each Corporate Obligor will pay its accounts payable and will maintain its accounts receivable in a manner
consistent with prudent business practices, including normal terms and conditions for payment for companies engaged in similar operations
in similar jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18 <U>Post-Closing
Delivery of UCC Amendments</U>. As of the date of execution of this Agreement by Bank, Obligors have not provided to Bank the following
items (collectively, the &ldquo;UCC Amendments&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UCC
                                            Amendment releasing Guarantor as a Debtor from UCC Financing Statement No. 21-0030782649,
                                            filed by Go Fund Advance, as Secured Party; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UCC
                                            Amendment releasing Guarantor as a Debtor from UCC Financing Statement No. 21-005340432,
                                            filed by CT Corporation System, as Representative, as Secured Party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligors
represent and warrant that the secured parties named above were not authorized to file the UCC Financing Statements listed above as to
Guarantor, and therefor such Financing Statements are not effective as to Guarantor under Subsection 9.510(a) of the Texas Business and
Commerce Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligors
will diligently pursue the UCC Amendments following the execution hereof, either by delivery from the named secured parties, or pursuant
to the procedure for the filing by debtors of Termination Statements pursuant to Section 5.13 of the Texas Business and Commerce Code
(although the UCC Amendments are only amendments to release Guarantor as a Debtor, and not Termination Statements). Obligors covenant
and agree to deliver to Bank on or before September 1, 2023, file-stamped copies of each of the UCC Amendments, in form and content
acceptable to Bank. If Obligors fail to deliver to Bank on or before September 1, 2023, each of the UCC Amendments, in form and
content acceptable to Bank, such failure shall constitute an immediate Event of Default, and Bank shall be entitled to exercise any and
all rights and remedies provided for in the Security Instruments without notice to Obligors or any other party, except such notice as
is required by law. Bank may in its sole discretion extend the due date in this <B>Section 4.18</B> upon written notice to Obligors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19 <U>Post-Closing
Restructure of Licensing and Sublicensing Pledge Items</U>. Obligors covenant and agree to deliver to Bank on or before August 11, 2023,
each of the following (the &ldquo;Post-Closing Items&rdquo;), each in form and content acceptable to Bank:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
                                            of Formation of CGI Cellerate Rx, LLC;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
                                            of Existence of CGI Cellerate Rx, LLC in its state of formation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
                                            of Good Standing of CGI Cellerate Rx, LLC in its state of formation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
                                            Agreement of CGI Cellerate Rx, LLC;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UCC
                                            Lien Search for CGI Cellerate Rx, LLC in its state of formation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
                                            W-9 for CGI Cellerate Rx, LLC</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IP
                                            Sublicense Agreement from CGI Cellerate Rx, LLC to Cellerate LLC</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
                                            Agreement duly executed by CGI Cellerate Rx, LLC, substantially in the form of the Borrower
                                            Security Agreement executed in connection herewith;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cellerate
                                            LLC Consent to Pledge of IP Sublicense Agreement</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guarantor
                                            Guaranty to Bank of payment and performance under the License to CGI Cellerate Rx, LLC and
                                            the Sublicense to Cellerate LLC;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
                                            of Manager of CGI Cellerate Rx, LLC; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
                                            of Secretary of Guarantor.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Obligors fail to deliver to Bank on or before August 11, 2023, each of the Post-Closing Items, in form and content acceptable to Bank,
such failure shall constitute an immediate Event of Default, and Bank shall be entitled to exercise any and all rights and remedies provided
for in the Security Instruments without notice to Obligors or any other party, except such notice as is required by law. Bank may in
its sole discretion extend the due date in this <B>Section 4.19</B> upon written notice to Obligors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>NEGATIVE
COVENANTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of this Agreement and until the Obligations have been paid and performed in full, unless compliance with the provisions of the
following sections shall have been waived in writing by Bank, Obligor(s) agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1 <U>Limitations
on Liens</U>. No Corporate Obligor will create, assume or suffer to exist any mortgage, lien, pledge, charge, security interest or other
encumbrance of any kind upon any of its properties or assets, whether now owned or hereafter acquired, except (a) liens created by this
Agreement, the other Security Instruments or otherwise in favor of Bank, (b) liens for taxes, assessments and other governmental charges
not yet due and payable, (c) deposits to secure the payment of workmen&rsquo;s compensation, unemployment insurance or other social security
benefits or obligations or other obligations of a like general nature incurred in the ordinary course of business and in accordance with
such Corporate Obligor&rsquo;s historical customs and practices, provided that the payment and performance of any such obligations are
not past due or otherwise in default, (d) landlords&rsquo;, warehousemen&rsquo;s, carriers&rsquo;, or other like liens arising by operation
of law in the ordinary course of business securing obligations which are not past due or otherwise in default, (e) inchoate liens arising
under ERISA to secure current service pension liabilities as they are incurred under the provisions of Plans from time to time in effect,
provided such liabilities are not past due or otherwise in default, or (f) liens expressly permitted in the Security Instruments or otherwise
consented to by Bank in writing on or after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2 <U>Limitations
on Liabilities</U>. No Corporate Obligor will create, assume or suffer to exist any liabilities, contingent or otherwise, whether by
guaranty, endorsement, agreement to purchase or repurchase, agreement to lease, agreement to supply or advance funds (including, without
limitation, agreements to maintain working capital, solvency or other balance sheet conditions or agreements to purchase any equity interest
or make capital contributions or otherwise) without Bank&rsquo;s prior written consent, except (a) as expressly permitted hereunder,
(b) for endorsements of instruments for collection in the ordinary course of business, and (c) trade accounts payable in the ordinary
course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3 <U>Negative
Pledges</U>. No Corporate Obligor will enter into, incur, or permit to exist any agreement or other arrangement that prohibits, restricts,
or imposes any condition upon the ability of a Corporate Obligor or any Subsidiary to create, incur, or permit to exist any mortgage,
lien or security interest upon any of its property or assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Limitations on Fundamental Changes; Disposition of Assets</U>. Borrower will not (a) form or acquire any new Subsidiary, (b) make
an investment in or capital contribution to any Person, or (c) transfer any equity interests held by Borrower. No Corporate Obligor will
(a) acquire any assets outside the ordinary course of business, (b) enter into any merger or consolidation, (c) liquidate or dissolve
itself (or suffer any liquidation or dissolution), (d) convey, sell, lease, charter or otherwise dispose of all or any material part
of its property, assets or business (other than the sale of inventory in the ordinary course of business), (e) cease, suspend or materially
curtail business operations, (f) enter into any arrangement, directly or indirectly, whereby a Corporate Obligor would sell or transfer
any real or personal property either now owned or hereafter acquired, and then or thereafter lease as lessee such properties or any part
thereof or any other property to be used for substantially the same purpose, (g) acquire, or agree to acquire, during any fiscal year,
in any transaction or series of transactions, assets or properties of an aggregate purchase price which could reasonably be expected
to result in an Event of Default, (h) change its form or jurisdiction of organization, or (i) amend its Organizational Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5 <U>Restricted Payments</U>. Borrower will not pay any dividend or distribution, nor purchase,
acquire, retire, or redeem any interest in a Corporate Obligor, whether now or hereafter issued or outstanding, without prior written
consent of Bank</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6 <U>Loans and Advances</U>. No Corporate Obligor will make or permit to remain outstanding any
loans, advances or extensions of credit to any Person or Persons, other than trade credit extended to customers who are not Affiliates
of any Obligor, on standard terms in the ordinary course of business and in accordance with such Corporate Obligor&rsquo;s historical
customs and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7 <U>Nature
of Business</U>. No Corporate Obligor will, without the prior written consent of Bank, (a) engage in any lines of business or business
ventures other than those in which it is presently engaged or that are directly related thereto, (b) change in any material respect its
methods of operation or accounting or manner of doing business, or (c) change its name, tax identification number, corporate form or
jurisdiction of organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8 <U>Transactions
with Affiliates</U>. No Corporate Obligor will engage in any transaction with an Affiliate on terms less favorable to such Corporate
Obligor than would be obtainable at the time in comparable transactions with Persons not affiliated with such Corporate Obligor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9 <U>ERISA</U>.
No Corporate Obligor will engage in any transaction prohibited by ERISA. No Plan will incur an accumulated funding deficiency. No Corporate
Obligor will incur any liability for excise tax or penalty due to the Internal Revenue Service or any liability to the Pension Benefit
Guaranty Corporation; and no &ldquo;reportable events&rdquo; (as that phrase is defined in Section 4043 of ERISA) will occur with respect
to any Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10 <U>Subordinated
Indebtedness</U>. Except as expressly permitted herein and in any Subordination Agreement, no Corporate Obligor will amend, modify or
obtain or grant a waiver of any provision of any document or instrument evidencing or securing any subordinated indebtedness of an Obligor,
nor purchase, redeem, retire or otherwise acquire for value, deposit any monies with any Person with respect to, or make any payment
or prepayment of the principal of or any other amount owing in respect of, any subordinated indebtedness of an Obligor, except to the
extent permitted under the applicable Subordination Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Government Regulation.</U> No Obligor will (a) be or become subject at any time to any law, regulation, or list of any government
agency (including, without limitation, the U.S. Office of Foreign Asset Control) that prohibits or limits Bank from making any Advance
or extension of credit to Borrower or from otherwise conducting business with any Obligor, or (b) fail to provide documentary and other
evidence of any Obligor&rsquo;s identity as may be requested by Bank at any time to enable Bank to verify such Obligor&rsquo;s identity
or to comply with any applicable law or regulation, including, without limitation, Section 326 of the USA Patriot Act of 2001, 31 U.S.C.
Section 5318.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12 <U>Anti-Corruption.
</U>Neither any Obligor, nor, to the knowledge of Borrower, any director, officer, employee, agent, or Affiliate of any Obligor has (a)
used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity,
(b) made any direct or indirect unlawful payment to any government official or employee from corporate funds, (c) violated or is in violation
of any provision of the U.S. Foreign Corrupt Practices Act of 1977 or the Bribery Act 2010 of the United Kingdom or similar law of the
European Union or any European Union Member State or similar law of a jurisdiction in which any Obligor conducts business and to which
any Obligor is lawfully subject or (d) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>REPRESENTATIONS
AND WARRANTIES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to induce Bank to enter into this Agreement, Obligor(s) hereby represent and warrant to Bank that the following representations
and warranties are true and correct, and shall remain true and correct at all times prior to the full and final payment and performance
of the Obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Corporate Authority</U>. Each Corporate Obligor (which for purposes of this </FONT><B>Section 6.1</B> shall include each general partner
of each Corporate Obligor) (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization,
(b) is duly licensed, qualified to do business and in good standing in each jurisdiction in which the ownership of its assets or the
conduct of its business requires such licensing and qualification, and (c) has all powers and all permits, licenses, consents and authorizations
necessary to own and operate such Corporate Obligor&rsquo;s assets and to carry on such Corporate Obligor&rsquo;s business as presently
conducted. The execution, delivery and performance of this Agreement by each Obligor, the borrowings hereunder and the execution, delivery
and performance of this Agreement and the other Security Instruments (a) have been duly authorized by proper corporate proceedings, and
(b) will not contravene, or constitute a default under, any provision of applicable law or regulation or of any Organizational Document
of any Corporate Obligor, or of any note, mortgage, security agreement, pledge, indenture, contract, agreement or other instrument, or
any judgment, order or decree, binding upon any Obligor or any Obligor&rsquo;s property. Except for any consent or approval which has
been duly obtained, no consent or approval of any shareholder, partner, member or other equity owner of any Corporate Obligor, or of
any other Person, is required in connection with the execution, delivery or performance of this Agreement or any other Security Instrument,
or the creation of any of the liens or security interests contemplated herein or therein. Each of this Agreement, the Note(s), the other
Security Instruments and the several agreements and instruments contemplated hereby and thereby, when duly executed and delivered by
the party or parties thereto, will constitute the legal, valid and binding obligation of each Obligor signatory thereto, and will be
enforceable in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2 <U>Financial Statements</U>. The Financial Statements which have been delivered to Bank are
true, complete and correct in all material respects, and fairly present the financial position of the applicable Obligor, as of the date(s)
thereof, and such Obligor&rsquo;s results of operations and cash flows for the period(s) then ended. The Financial Statements of each
Corporate Obligor have been prepared in accordance with GAAP, and in a manner consistent with prior periods and the historical customs
and practices of such Corporate Obligor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Absence of Undisclosed Liabilities or Obligations</U>. All material obligations, investments and liabilities, contingent or otherwise,
of each Obligor are truly, completely and accurately disclosed in the Financial Statements. No adverse change has occurred in the business,
assets, operations, prospects or condition, financial or otherwise, of an Obligor since the date of the most recent Financial Statements
of such Obligor delivered to Bank. No Obligor is party to any agreement or a party to any litigation or proceeding (and no litigation
or proceeding is threatened) or otherwise subject to any restriction that would prevent or impair the performance of such Obligor&rsquo;s
obligations under this Agreement or any Security Instrument. None of the information supplied by any Obligor contains a material misstatement
of fact or omits any material fact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Title</U>. Borrower has, and until the Obligations are fully and finally paid will continue to have, good and indefeasible title to
all of its assets and property (including without limitation the Collateral), free and clear of all liens, mortgages, security interests
and other encumbrances, except those in favor of Bank, or as otherwise expressly permitted herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5
<U>Liens and Security Interests; <I>Pari Passu</I> Obligations</U>. The security interests, mortgages and liens attaching to the Collateral
will constitute at all times valid, perfected and enforceable security interests, mortgages and liens in favor of Bank, subject to no
other lien, mortgage, security interest or other encumbrance, except those of Bank or as otherwise expressly permitted in this Agreement.
Before funding any Advance, Obligor(s) will have taken, or will have participated with Bank in taking, all necessary action (including
making all necessary filings) to provide Bank with perfected security interests, mortgages and liens in the Collateral under the laws
of all applicable jurisdictions, subject only to liens and security interests expressly permitted hereunder. The Obligations of Borrower
hereunder rank at least <I>pari passu</I> with all other Indebtedness of Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6
<U>Use of Proceeds</U>. Each Loan is or will be for business, commercial, investment or other similar purposes, and not for personal,
family, household or agricultural use. No Loan is or will be subject to Regulation Z issued by the Board of Governors of the Federal
Reserve System, Title I (Truth-In-Lending Act) or Title V (General Provisions) of the Consumer Credit Protection Act, or the Real Estate
Settlement Procedures Act of 1974 (RESPA), and no disclosures are or will be required to be given under such regulations and federal
laws in connection with any Loan. The funds advanced by Bank under the Advancing Term Note will be used solely for working capital and
to finance up to one hundred percent (100%) of the cash consideration for the acquisition from The Hymed Group Corporation, Applied Nutritionals,
LLC and George Petito of certain intellectual property, copyrights, processes, rights, trade dress, necessary 510(k)s, products, inventory,
equipment, tooling and records, and related fees and expenses including subsequent payments that may be due to the sellers after closing
under the purchase agreement. Borrower represents and warrants that no portion of the proceeds of any Loan shall be used directly or
indirectly to purchase ineligible securities, as defined by applicable regulations of the Federal Reserve Board, underwritten by Bank
or any Affiliate of Bank during the underwriting period and for thirty (30) days thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7 <U>Litigation</U>. Except as set forth on <B>Schedule 6.7</B>, there is no action, suit or
proceeding pending, or to the knowledge of any Obligor threatened, against any Obligor or before any court, governmental department,
administrative agency or instrumentality which, if such action, suit or proceeding were adversely determined, (a) would subject an Obligor
to any liability not fully covered by insurance, or (b) could reasonably be expected to result in a Material Adversely Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8 <U>Solvency</U>.
Each Obligor (a) is solvent with assets of a value that exceeds the amounts of such Obligor&rsquo;s liabilities, (b) is able to meet
such Obligor&rsquo;s debts as they mature, and (c) in such Obligor&rsquo;s reasonable opinion, has adequate capital to conduct the businesses
in which such Obligor is engaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.9 <U>Subsidiaries
and Investments</U>. Except as set forth on <B>Schedule 6.9</B>, no Corporate Obligor has any Subsidiaries or investments in any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.10 <U>No Event of Default</U>. No Default or Event of Default has occurred and is continuing.
No Obligor is in default of any of its obligations under any agreements with any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11 <U>Tax
Returns</U>. Each Obligor has filed all United States tax returns and all city, state and foreign tax returns required to be filed by
such Obligor and has paid all taxes which have become due pursuant to any such return or pursuant to any assessment received by such
Obligor. All such returns properly reflect any United States income tax, foreign tax, state tax and city tax of the applicable Obligor
for the periods covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.12
<U>Insurance</U>. Each Corporate Obligor has maintained and now maintains (a) insurance of such types (including, without limitation,
public liability, worker&rsquo;s compensation, commercial liability, casualty, hazard or property damage providing all risk coverage
on such Corporate Obligor&rsquo;s assets, and business interruption insurance), and in such amounts as is customary in the industry,
and (b) adequate insurance protection against all liabilities, claims and risks against which it is customary to insure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.13
<U>Real Property / Collateral Locations</U>. Set forth <B>Schedule 6.13</B> is a true, complete and correct list of (a) each location
owned or leased by a Corporate Obligor, and (b) each location at which any Collateral is stored. Until the Obligations have been fully
and finally paid, all of the Collateral will be located at one of the locations set forth on <B>Schedule 6.13.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14 <U>Intellectual
Property</U>. Each Corporate Obligor owns, or is licensed to use, all trademarks, tradenames, copyrights, patents and other intellectual
property material to its business, and the use thereof by such Corporate Obligor does not infringe upon the rights of any other Person,
except for any such infringements that could not reasonably be expected to result in a Material Adverse Effect. Set forth on <B>Schedule
6.14</B>, is a true, complete and correct list of all trademarks, tradenames, copyrights, patents and other intellectual property material
to the business of each Corporate Obligor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.15 <U>Environmental
Matters</U>. Each Obligor has complied, and remains in compliance, in all material respects with the provisions of all Environmental
Laws applicable to such Obligor or any of such Obligor&rsquo;s owned or operated facilities, sites or other properties, businesses and
operations, including those which relate to the reporting by such Obligor of all sites owned or operated by such Obligor where solid
wastes, hazardous or toxic wastes or hazardous or toxic substances have been treated, stored, disposed of or otherwise handled. No release
(as defined under applicable Environmental Laws) at, from, in or on any site owned or operated by an Obligor has occurred which, if all
relevant facts were known to the relevant Governmental Authorities (a) would require remediation to avoid deed record notices, restrictions,
liabilities or other duties, or (b) would result in other consequences that would not be applicable if that release had not occurred.
Neither an Obligor nor any agent or contractor of an Obligor has transported or arranged for the transportation of any solid wastes,
hazardous or toxic wastes or hazardous or toxic substances to, or disposed or arranged for the disposition of any solid wastes, hazardous
or toxic wastes or hazardous or toxic substances at, any off-site location that could lead to any claim against an Obligor, as a potentially
responsible party or otherwise, for any fines, clean-up costs, remedial work, damage to natural resources, personal injury or property
damage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.16 <U>Compliance
with Laws</U>. No Obligor (a) is in violation of any law, ordinance, statute, or governmental rule or regulation to which such Obligor
is subject, or (b) has failed to obtain any license, permit, franchise, or other governmental authorization necessary in connection with
the ownership or operation of such Obligor&rsquo;s assets, property, business or operations. In furtherance and not in limitation of
the foregoing, Obligor(s) represent and warrant that each Plan is in compliance in all material respects with the applicable provisions
of ERISA and, to the best of each Obligor&rsquo;s knowledge, no &ldquo;reportable event,&rdquo; as such term is defined in Section 4043
of ERISA, has occurred with respect to any Plan. Each Obligor, and each Subsidiary or Affiliate of an Obligor, is in compliance in all
material respects with all federal, state and local laws, rules and regulations applicable to its properties, operations, business, and
finances, including, without limitation, any federal or state laws relating to liquor (including 18 U.S.C. &sect; 3617, et seq.) or narcotics
(including 21 U.S.C. &sect; 801, et seq.) and/or any commercial crimes. Neither any Obligor, nor any Subsidiary or Affiliate of an Obligor,
nor any of their directors, officers, brokers or other agents acting or benefiting in any capacity in connection with a Loan or any other
capital raising transaction involving Bank or Bank&rsquo;s Affiliates, is a Designated Person. Borrower shall not, directly or indirectly,
use the proceeds of a Loan, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or
other Person (a) to fund any activities or business of or with any Designated Person, or in any country or territory, that at the time
of such funding is the subject of any sanctions under any Sanctions Laws and Regulations, or (b) in any other manner that would result
in a violation of any Sanctions Laws and Regulations by any party to this Agreement. None of the funds or assets that are used to pay
any amount due pursuant to this Agreement or any other Security Instrument shall constitute funds obtained from transactions with or
relating to Designated Persons or countries which are the subject of sanctions under any Sanctions Laws and Regulations. As used above,
&ldquo;Sanctions Laws and Regulations&rdquo; means (a) any sanctions, prohibitions or requirements imposed by any executive order (an
&ldquo;Executive Order&rdquo;) or by any sanctions program administered by the U.S. Department of the Treasury Office of Foreign Assets
Control (&ldquo;OFAC&rdquo;) and/or (b) any sanctions measures imposed by the United Nations Security Council, European Union or the
United Kingdom. &ldquo;Designated Person&rdquo; means a person or entity (a) listed in the annex to, or otherwise the subject of the
provisions of, any Executive Order, (b) named as a &ldquo;Specially Designated National and Blocked Person&rdquo; (&ldquo;SDN&rdquo;)
on the most current list published by OFAC at its official website or any replacement website or other replacement official publication
of such list, or is otherwise the subject of any Sanctions Laws and Regulations, or (c) in which an entity or person on the SDN list
has 50% or greater ownership interest or that is otherwise Controlled by an SDN.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.17 <U>Governmental Approvals</U>. No approvals of any governmental department, administrative
agency, instrumentality or authority having jurisdiction over an Obligor, or an Obligor&rsquo;s property, are necessary in connection
with the execution, delivery or performance of the Security Instruments, the perfection of the liens and security interests provided
for thereby, or the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.18 <U>Regulations
U and X</U>. No Advance will be used, directly or indirectly, for the purpose of purchasing or carrying, or for payment in full or in
part of Indebtedness which was incurred for the purpose of purchasing or carrying, any &ldquo;margin stock,&rdquo; as such term is defined
in Regulation U. No part of the proceeds of a Loan will be used for any purpose which violates Regulation X.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19
<U>Investment Company Act of 1940</U>. No Corporate Obligor is an investment company within the meaning of the Investment Company Act
of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.20 <U>Assumed
Names</U>. Except as set forth on <B>Schedule 6.20</B>, (a) within the past five (5) years no Obligor has conducted its business under
any corporate, trade, assumed, fictitious or other name, and (b) following the date hereof no Obligor will conduct its business under
any other corporate, trade, assumed, fictitious or other name without thirty (30) days prior written notice to Bank, and execution and/or
delivery of such additional documents as Bank may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.21 <U>Beneficial
Ownership</U>. As of the date of this Agreement, the information included in the Beneficial Ownership Certification is true and correct
in all respects. The information included in any Beneficial Ownership Certification delivered to Bank after the date of this Agreement
will be true and correct in all respects as of the date of delivery to Bank of such Beneficial Ownership Certification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22 <U>Execution
Outside the State of Florida</U>. This Agreement and all of the other Security Instruments executed in connection herewith have not been
executed in the state of Florida.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DEFAULT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Default</U>. The occurrence of any of the following events or conditions shall constitute an &ldquo;Event of Default&rdquo; under
this Agreement, and under each Note:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Failure
(i) to pay any principal of or interest on a Note, when due or declared due, or (ii) to pay any fee or any other amount (other than an
amount referred to in <B>clause (i)</B> of this <B>Subsection (a)</B>) payable under this Agreement or any other Security Instrument,
when and as the same shall become due and payable, or (iii) of an Obligor to pay when due any debt, liability or obligation owed to Bank,
Bank&rsquo;s parent, or any Affiliate or Subsidiary of Bank&rsquo;s parent, or to perform any other obligation under any document, instrument
or agreement evidencing or securing any debt, liability or obligation to Bank, Bank&rsquo;s parent, or any Affiliate or Subsidiary of
Bank&rsquo;s parent, or (iv) to make any other payment or required prepayment of any other Indebtedness of an Obligor, or (v) to comply
with <B>Section 4.1</B>, <B>4.2</B>, <B>4.3</B>, <B>4.4</B>, <B>4.5</B>, <B>4.6</B>, <B>4.7</B>, <B>4.8</B>, <B>4.9</B>, <B>4.10</B>,
<B>4.11</B>, <B>4.18</B> or <B>4.19</B>, or (vi) to comply with <B>Article V</B>, or (vii) by an Obligor or any other party to a Subordination
Agreement to comply with the terms of any Subordination Agreement or any instrument evidencing or securing Subordinated Debt, or (viii)
by an Obligor to comply with any real property lease or other agreement with respect to any facility at which any Collateral is located,
which failure continues beyond any applicable cure period;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Failure
of an Obligor to observe or perform (or to furnish adequate evidence of performance of) any of the covenants, terms or agreements of
this Agreement, any other Security Instrument or any other agreement with Bank;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Any
representation or warranty made by an Obligor in this Agreement, any other Security Instrument or any certificate, financial or other
statement furnished to Bank is untrue, incorrect or misleading in any material respect as of the date made or furnished, or becomes untrue,
incorrect or misleading at any time prior to the full and final payment of the Obligations, and the termination of any obligation by
Bank to make Advances hereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Default
occurring, or an Obligor seeking to disaffirm its obligations, under any of the Security Instruments;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Any
security interest, lien or assignment purported to be created by any Security Instrument shall (other than in accordance with the terms
hereof and thereof) (i) cease to be in full force and effect, or (ii) cease to give Bank the liens, rights, powers and privileges purported
to be created or granted under such Security Instrument (including a perfected first priority security interest in and lien on all of
the Collateral thereunder), or (iii) be asserted by any Obligor not to be a valid, perfected, first priority security interest in or
lien on any Collateral covered or purported to be covered thereby;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) An
Obligor failing to observe or perform any term, condition or agreement with respect to any obligation for borrowed money or leased assets
or in any instrument or agreement evidencing, securing or relating to any indebtedness of such Obligor, which failure continues beyond
any applicable notice, grace or cure period;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Ron
Nixon (or any successor acceptable to Bank) shall cease to serve as Chairman of the Board of Directors of any Corporate Obligor, unless
a successor acceptable to Bank is elected or appointed within ten (10) Business Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Reserved;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
entry of any judgment against an Obligor, or any attachment or other levy against the property of an Obligor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Dissolution,
death, liquidation, termination of existence, insolvency, business failure or winding up of an Obligor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) Failure
of an Obligor to pay when due any debt, liability or obligation owed to Bank, Bank&rsquo;s parent, or any Affiliate or subsidiary of
Bank&rsquo;s parent, or to perform any other obligation or otherwise default under any document, instrument or agreement evidencing or
securing any debt, liability or obligation to Bank, Bank&rsquo;s parent, or any Affiliate or subsidiary of Bank&rsquo;s parent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) The
occurrence or existence of any default, event of default, termination event or other similar condition or event (however described) under
any swap agreement (as defined in 11 U.S.C. Sec. 101, as in effect from time to time) to which Borrower is a party;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) Bank
deems payment or performance of the Obligations to be insecure, or the Collateral taken as a whole becomes, in the judgment of Bank,
impaired, unsatisfactory or insufficient in character or value, or Bank in good faith believes that the prospect of payment or performance
of the Obligations is materially impaired;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) An
involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other
relief in respect of an Obligor or any Obligor&rsquo;s debts, or of a substantial part of any Obligor&rsquo;s assets, under any Debtor
Relief Law now or hereafter in effect, or (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar
official for an Obligor or for a substantial part of any Obligor&rsquo;s assets, and, in any such case, such proceeding or petition shall
continue undismissed for thirty (30) days, or an order or decree approving or ordering any of the foregoing shall be entered; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) Any
Obligor shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under
any Debtor Relief Law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate
manner (not to exceed ten (10) Business Days), any proceeding or petition described in <B>Subsection (n)</B> of this section, (iii) apply
for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for an Obligor or
for a substantial part of any Obligor&rsquo;s assets, (iv) file an answer admitting the material allegations of a petition filed against
it in any such proceeding, (v) make a general assignment for the benefit of creditors, (vi) admit in writing its inability to pay its
debts as they mature, or (vii) take any action for the purpose of effecting any of the foregoing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
may remedy any Default, without waiving same, or may waive any Default without waiving any prior or subsequent Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2 <U>Termination
of Obligation to Fund</U>. Any obligation of Bank to extend credit or make Advances shall immediately terminate upon (a) the occurrence
of any event, fact or circumstance that could reasonably be expected to result in a Material Adverse Effect, (b) Bank deeming payment
or performance of any of the Obligations to be impaired or insecure, or (c) any Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3 <U>Optional
Acceleration</U>. Upon the occurrence of any Event of Default set forth in <B>Section 7.1 (a), (b), (c), (d), (e), (f), (g), (h), (i),
(j), (k), (l)</B> or <B>(m)</B>, Bank, at its option, without notice to an Obligor or to any other Person, may declare the Obligations
(including without limitation all unpaid principal and accrued but unpaid interest, but expressly excluding any Obligations related to
any Rate Management Agreement or Rate Management Transaction) to be forthwith due and payable, whereupon the same (other than Obligations
related to any Rate Management Transaction) shall become due and payable without any presentment, demand, protest, notice of protest,
notice of intent to accelerate, notice of acceleration, or notice of any kind (except notice required by law which cannot be waived),
all of which are hereby waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4 <U>Automatic Acceleration</U>. Upon the occurrence of any Event of Default set forth in <B>Section
7.1 (n)</B> or <B>(o)</B>, the Obligations (including without limitation all unpaid principal and accrued but unpaid interest, but expressly
excluding any Obligations related to any Rate Management Agreement or Rate Management Transaction) shall be immediately and automatically
due and payable without any presentment, acceleration, demand, protest, notice of protest, notice of intent to accelerate, notice of
acceleration, or notice of any kind (except notice required by law which cannot be waived), all of which are hereby waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5 <U>Rate
Management Agreements</U>. Each Obligor understands, acknowledges and agrees that any Event of Default hereunder shall also constitute
an Event of Default under each Rate Management Agreement, and Bank shall have all rights and remedies following the occurrence of an
Event of Default under this Agreement and under each Rate Management Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6 <U>Right
of Setoff</U>. Upon the occurrence and during the continuance of any Event of Default, Bank is hereby authorized at any time and from
time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand,
provisional or final) at any time held and other indebtedness at any time owing by Bank to or for the credit or the account of Borrower
against any and all of the Obligations now or hereafter existing or arising, irrespective of whether Bank shall have made any demand
under this Agreement or any other Security Instrument, and although such Obligations may be unmatured. Bank agrees promptly to notify
Borrower after any such setoff and application made by Bank, provided that the failure to give such notice shall not affect the validity
of such setoff and application. The rights of Bank under this <B>Section 7.6</B> are in addition to other rights and remedies (including,
without limitation, other rights of setoff) which Bank may have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7 <U>Performance
by Bank</U>. If Borrower shall fail to perform any covenant, duty or agreement contained in any Security Instrument, Bank may perform
or attempt to perform such covenant, duty or agreement on behalf of Borrower. In such event, Borrower shall, at the request of Bank,
promptly pay any and all amounts expended by Bank in such performance or attempted performance to Bank, together with interest thereon
at the Default Rate from the date of such expenditure until paid. Notwithstanding the foregoing, it is expressly agreed that Bank shall
not have any liability or responsibility for the performance of any obligation of Borrower under this Agreement or any other Security
Instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VIII</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>MISCELLANEOUS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1 <U>Indemnification;
Release of Bank</U>. <B>Obligor(s), jointly and severally, shall indemnify and hold Bank and each Affiliate of Bank, and their respective
officers, directors, employees, counsel, agents, representatives, Controlling persons and attorneys-in-fact (each, an &ldquo;Indemnified
Person&rdquo;) harmless from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits,
costs, charges, expenses and disbursements (including attorneys&rsquo; fees) of any kind or nature whatsoever which may at any time (including
at any time following repayment of the Obligations) be imposed on, incurred by or asserted against any such Indemnified Person (including,
but not limited to, those incurred in connection with the investigation of, preparation for or defense of any pending or threatened claim
or any other action or proceeding, including any insolvency proceeding or appellate proceeding) in any way relating to or arising out
of this Agreement, any document contemplated hereby or referred to herein, or the transactions contemplated hereby or entered into by
the parties hereto, or any action taken or omitted by any such Indemnified Person under or in connection with any of the foregoing, including
any use by Borrower or any other Person of any Subject Property or Collateral for any Forbidden Activities; and the foregoing indemnity
shall apply to any investigation, litigation or proceeding (including any insolvency proceeding or appellate proceeding) related to or
arising out of this Agreement, whether or not any Indemnified Person is a party thereto (all the foregoing, collectively, the &ldquo;Indemnified
Liabilities&rdquo;). For avoidance of doubt, the &ldquo;Indemnified Liabilities&rdquo; expressly include any claim by any Governmental
Authority, including any governmental action for seizure or forfeiture of any Subject Property or Collateral (with or without compensation
to Bank, and whether or not any Subject Property or Collateral is taken free of or subject to Bank&rsquo;s lien or security interest).
<U>The Indemnified Liabilities shall also include all negligent acts and omissions of each Indemnified Person; provided, that Obligor(s)
shall not have any obligation hereunder to any Indemnified Person for any claims, damages, losses, liabilities, costs or expenses to
the extent, but only to the extent, caused (as determined by a final, nonappealable judgment in a court of competent jurisdiction) by
the willful misconduct or gross negligence of the Person seeking indemnification. Obligor(s) hereby release the Indemnified Persons for
any claims, damages, losses, liabilities, costs or expenses to the extent, but only to the extent, caused by the negligence of any Indemnified
Person.</U> The obligations under this section are all payable on demand, and shall survive satisfaction of all other Obligations, and
the termination, release or expiration of this Agreement and the documents executed in connection herewith.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2 <U>Interest</U>. It is the intention of the parties hereto to comply with applicable usury
laws; accordingly, it is agreed that notwithstanding any provision to the contrary in this Agreement, a Note, the other Security Instruments
or any of the documents securing payment thereof or otherwise relating thereto, in no event shall this Agreement or such instruments
or documents require the payment or permit the collection of interest, as defined under applicable usury laws, in excess of the Maximum
Rate. If any such excessive interest is contracted for, charged or received under this Agreement, a Note, the other Security Instruments
or the terms of any of the documents securing payment thereof or otherwise relating thereto, or if the maturity of any Obligations to
Bank is accelerated in whole or in part, or in the event that all or part of the principal of or interest on a Note shall be prepaid,
so that under any of such circumstances the amount of interest contracted for, charged or received under this Agreement, a Note, the
other Security Instruments or any of the documents securing payment thereof or otherwise relating thereto, on the amount of principal
actually outstanding from time to time under a Note, shall exceed the Maximum Rate, then in any such events (a) the provisions of this
section shall govern and control, (b) no Obligor shall be obligated to pay the amount of such interest to the extent that it is in excess
of the maximum amount of interest permitted to be contracted for by, charged to or received from the Person obligated thereon under applicable
usury laws, (c) any such excess which may have been collected either shall be applied as a credit against the then unpaid principal amount
on a Note or refunded to the Person paying the same, at the holder&rsquo;s option, and (d) the effective rate of interest shall be automatically
reduced to the Maximum Rate. It is further agreed that, without limitation of the foregoing, all calculations of the rate of interest
contracted for, charged or received under this Agreement, the Note(s), the other Security Instruments or such other documents which are
made for the purpose of determining whether such rate exceeds the Maximum Rate shall be made, to the extent permitted by applicable usury
laws, by amortizing, prorating, allocating and spreading in equal parts during the period of the full stated term of the applicable Note,
all interest at any time contracted for, charged or received from an Obligor or otherwise by the holder or holders of such Note in connection
with the Note(s), the other Security Instruments or this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3 <U>Expenses</U>. Borrower will pay on demand (a) all costs and expenses of Bank and its Affiliates
(including fees, expenses and disbursements of counsel for Bank and its Affiliates) in connection with the preparation, negotiation,
interpretation, operation and administration of this Agreement, the Note(s), any other Security Instrument or any Rate Management Agreement,
or any waiver, modification, renewal, extension or amendment of any provision of any of the foregoing, and (b) all costs and expenses
of enforcement of this Agreement, the Note(s), any other Security Instrument or any Rate Management Agreement, and collection of the
Obligations (including fees, expenses and disbursements of counsel for Bank and its Affiliates). Borrower agrees to pay on demand and
to indemnify Bank from and hold it harmless against any filing or recording fees, taxes, assessments, or charges made by any Governmental
Authority by reason of the execution, delivery, recordation or filing by Borrower or Bank of this Agreement, any other Security Instrument
and any document, instrument or agreement executed or delivered in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>No Waiver; Cumulative Remedies</U>. No failure by Bank to exercise, and no delay by Bank in exercising, any right, power or privilege
hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right, power or privilege hereunder preclude
any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies provided herein
and under the Security Instruments are cumulative and not exclusive of any rights or remedies provided by law or in any other agreement,
and may be pursued separately, successively or concurrently against Obligor(s) (or any of them) and/or the Collateral, at the sole discretion
of Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
<U>Successors</U>. This Agreement shall be binding upon Obligor(s) and their respective successors and assigns and shall inure to the
benefit of Bank and its successors and assigns. No Obligor may assign any rights or obligations under this Agreement or any other Security
Instrument without the prior written consent of Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6
<U>Notices</U>. All notices, requests and demands shall be given to or made to Bank or an Obligor, as applicable, at such party&rsquo;s
address set forth in the preamble of this Agreement, as such address may be updated from time to time in writing from one party to another.
All notices and other communications given under the provisions of this Agreement shall be deemed to have been given (a) when sent, if
sent by registered or certified mail or overnight courier, or (b) when actually received, if sent by hand delivery, in each case addressed
to such party as provided herein or according to the most recent records of the notifying party. Notwithstanding the foregoing, actual
notice to Borrower shall always be effective no matter how given or received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.7 <U>Form
and Substance</U>. All documents, certificates, insurance policies, and other items required under this Agreement to be executed and/or
delivered to Bank shall be in form and substance satisfactory to Bank, in Bank&rsquo;s sole and absolute discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.8 <U>Survival
of Agreements</U>. All agreements, covenants, representations and warranties made herein shall survive the execution and delivery of
the Note(s) and the other Security Instruments and the modification, renewal, extension or rearrangement thereof, shall continue in full
force and effect until the Loan(s) have been paid in full and any obligation of Bank to make any additional Advance has terminated, and
shall not be affected by any investigation made by any party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.9 <U>Severability</U>. Whenever possible, each provision of this Agreement shall be interpreted
in such manner as to be effective, valid and enforceable under applicable law, but if any provision of this Agreement shall be prohibited
by, or invalid or unenforceable under, applicable law, then (i) the parties hereto agree that they will amend such provisions by the
minimal amount necessary to bring such provisions within the ambit of enforceability, and (ii) the court may, at the request of any party,
revise, reform or reconstruct such provisions in a manner sufficient to cause them to be enforceable. Bank is relying and is entitled
to rely upon each and all of the provisions of this Agreement. In no event shall any prohibition against, or the invalidity or unenforceability
of, any provision hereof affect the validity or enforceability of any other provision hereof, and if any provision or provisions of this
Agreement should be held to be invalid or ineffective, then all other provisions hereof shall continue in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.10 <U>Controlling
Document</U>. In the event of actual conflict in the terms and provisions of this Agreement, a Note or any other Security Instrument,
the terms and provisions of this Agreement will control. Further, in the event of actual conflict in the terms and provisions of <B>Section
2.12</B> of this Agreement and any other term or provision of this Agreement, the terms and provisions of <B>Section 2.12</B> shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.11 <U>Amendment</U>.
This Agreement may not be amended except in writing signed by the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.12 <U>Descriptive
Headings</U>. Descriptive headings of the several articles and sections of this Agreement are inserted for convenience of reference only,
and shall in no way alter, modify, define or be used in construing, and do not constitute a part of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.13 <U>Sharing
of Information; Participations</U>. Each Obligor agrees that Bank may provide information or knowledge Bank may have about each Obligor,
this Agreement, the Note(s), or the other Security Instruments to Bank&rsquo;s parent, or any of such parent&rsquo;s Subsidiaries or
Affiliates or their successors, or to any one or more purchasers or potential purchasers of the Note(s) or any interest or participation
therein or in the other Security Instruments. Each Obligor acknowledges and agrees that Bank may at any time sell, assign or transfer
one or more interests or participations in all or any part of its rights or obligations in the Note(s) or this Agreement to one or more
purchasers or participants, whether or not related to Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.14 <U>Governing
Law; Venue; Jurisdiction</U>. THIS AGREEMENT, THE NOTE(S) AND THE OTHER SECURITY INSTRUMENTS SHALL BE GOVERNED BY, AND CONSTRUED AND
INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF TEXAS (WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES), AND THE LAWS OF THE UNITED
STATES OF AMERICA APPLICABLE IN TEXAS, EXCEPT TO THE EXTENT TO WHICH TEXAS LAW DICTATES THAT THE LAWS OF ANOTHER STATE ARE TO GOVERN
CERTAIN PROCEDURAL AND SUBSTANTIVE MATTERS RELATING ONLY TO THE CREATION, PERFECTION AND/OR FORECLOSURE OF THE LIENS AND SECURITY INTERESTS
CREATED HEREIN OR IN THE OTHER SECURITY INSTRUMENTS, OR TO THE ENFORCEMENT OF BANK&rsquo;S RIGHTS AND REMEDIES AGAINST THE COLLATERAL,
IN WHICH EVENT THE LAWS OF SUCH OTHER STATE SHALL GOVERN. VENUE FOR ANY LITIGATION BETWEEN OR AMONG THE PARTIES HERETO WITH RESPECT TO
THE SUBJECT MATTER OF THIS AGREEMENT SHALL BE HARRIS COUNTY, TEXAS. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO PERSONAL JURISDICTION IN
TEXAS AND WAIVES ALL OBJECTIONS TO PERSONAL JURISDICTION IN TEXAS AND VENUE IN HARRIS COUNTY FOR PURPOSES OF SUCH LITIGATION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.15 <U>Waiver
of Jury</U>. <B>EACH PARTY HEREBY KNOWINGLY, VOLUNTARILY, IRREVOCABLY, UNCONDITIONALLY AND INTENTIONALLY WAIVES ANY RIGHT TO HAVE A JURY
PARTICIPATE IN RESOLVING ANY DISPUTE (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT,
THE NOTE(S) OR THE OTHER SECURITY INSTRUMENTS. THIS PROVISION IS A MATERIAL INDUCEMENT TO BANK TO PROVIDE THE FINANCING CONTEMPLATED
HEREIN. EACH OBLIGOR HEREBY CERTIFIES THAT NEITHER ANY REPRESENTATIVE OR AGENT OF BANK NOR BANK&rsquo;S COUNSEL HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT BANK WOULD <U>NOT</U>, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THIS WAIVER.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.16 <U>Waiver
of Special Damages</U><B>. TO THE MAXIMUM EXTENT NOT PROHIBITED BY LAW, EACH PARTY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO CLAIM OR RECOVER
IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT, THE NOTE(S) OR THE OTHER SECURITY INSTRUMENTS
ANY SPECIAL, EXEMPLARY, PUNITIVE OR CONSEQUENTIAL DAMAGES, OR DAMAGES OTHER THAN, OR IN ADDITION TO, ACTUAL DAMAGES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.17 <U>USA
Patriot Act Notification</U>. The following notification is provided to Borrower pursuant to Section 326 of the USA Patriot Act of 2001,
31 U.S.C. Section 5318:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMPORTANT
INFORMATION ABOUT PROCEDURES FOR OPENING A NEW ACCOUNT. To help the government fight the funding of terrorism and money laundering activities,
Federal law requires all financial institutions to obtain, verify, and record information that identifies each person or entity that
opens an account, including any deposit account, treasury management account, loan, other extension of credit, or other financial services
product. What this means for a Borrower: When a Borrower opens an account, if such Borrower is an individual, Bank will ask for such
Borrower&rsquo;s name, taxpayer identification number, residential address, date of birth, and other information that will allow Bank
to identify such Borrower, and, if such Borrower is not an individual, Bank will ask for such Borrower&rsquo;s name, taxpayer identification
number, business address, and other information that will allow Bank to identify such Borrower. Bank may also ask, if such Borrower is
an individual, to see such Borrower&rsquo;s driver&rsquo;s license or other identifying documents, and, if such Borrower is not an individual,
to see such Borrower&rsquo;s legal organizational documents or other identifying documents.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.18 <U>Electronic
Signatures and Electronic Records</U>. Delivery of an executed signature page of this Agreement and each other Security Instrument by
facsimile or other electronic mail transmission shall be effective as delivery of a manually executed counterpart hereof. Each party
to this Agreement consents to the use of electronic and/or digital signatures by one or more parties on this Agreement and each other
Security Instrument. This Agreement and any other Security Instruments may be signed electronically or digitally in a manner specified
solely by Bank. Delivery of an executed counterpart of a signature page of this Agreement and any other Security Instrument(s) by electronic
means shall be effective as delivery of a manually executed counterpart of this Agreement or such Security Instrument(s). The parties
agree not to deny the legal effect or enforceability of any Security Instrument solely because (a) the Security Instrument is entirely
in electronic or digital form, including any use of electronically or digitally generated signatures or (b) an electronic or digital
record was used in the formation of the Security Instrument or (c) the Security Instrument was subsequently converted to an electronic
or digital record by one or more parties. The parties agree not to object to the admissibility of any Security Instrument in the form
of an electronic or digital record, or a paper copy of an electronic or digital document, or a paper copy of a document bearing an electronic
or digital signature, on the grounds that the record or signature is not in its original form or is not the original of the Security
Instrument or the Security Instrument does not comply with Chapter 26 of the Texas Business and Commerce Code. Each Obligor represents
and warrants that such Obligor has executed each Security Instrument to which it is a party manually in person, and that such Obligor
will deliver to Bank a manually signed original &ldquo;wet signature&rdquo; counterpart of each such Security Instrument upon Bank&rsquo;s
request and/or as soon as reasonably possible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.19 <U>Counterparts</U>. This Agreement and each other Security Instrument may be executed in any
number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed
to be an original, and all of which, when taken together, shall constitute but one and the same agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.20 <U>Statute
of Frauds; No Oral Agreements</U>. <B>THIS AGREEMENT AND ALL DOCUMENTS AND INSTRUMENTS REFERENCED HEREIN OR EXECUTED IN CONNECTION HEREWITH
REPRESENT THE FINAL AGREEMENT BETWEEN OR AMONG OBLIGOR(S) AND BANK, AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS,
OR SUBSEQUENT ORAL AGREEMENTS BETWEEN OR AMONG OBLIGOR(S) AND BANK. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN OR AMONG OBLIGOR(S)
AND BANK.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Signature
Page Follows]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, this Loan Agreement is executed effective as of the date first set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BORROWER</U>:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
    MEDTECH APPLIED TECHNOLOGIES, LLC</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sanara
    MedTech Inc.</B>,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its
    Manager</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BANK</U>:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CADENCE
    BANK</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/Emily
    Loomis</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emily
    Loomis,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
    Vice President</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>GUARANTOR</U>:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
    MEDTECH INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
6.7 &ndash; Litigation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
6.9 &ndash; Subsidiaries and Investments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
6.13 &ndash; Real Property / Collateral Locations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: -81pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
6.14 - Trademarks, Tradenames, Copyrights, Patents and other Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Schedule
6.20 &ndash; Assumed and Other Names</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
A: Compliance Certificate </B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature
Page of Loan Agreement</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 45; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="width: 250px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Sanara
MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>FORT
WORTH, TX / GlobeNewswire / August 2, 2023 / Sanara MedTech Inc</B>. Based in Fort Worth, Texas, Sanara MedTech Inc. (&ldquo;Sanara,&rdquo;
the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo;) (NASDAQ: SMTI), a medical technology company focused
on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the
surgical, chronic wound and skincare markets, announced today the acquisition of certain assets related to its collagen products business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
acquisition of proprietary assets (the &ldquo;Asset Acquisition&rdquo;) from Applied Nutritionals, LLC, The Hymed Group Corporation,
and Dr. George Petito (collectively, the &ldquo;Sellers&rdquo;) is a major milestone for Sanara&rsquo;s strategy to own the intellectual
property, including trade secrets, for its hydrolyzed collagen products. In addition, the Company believes controlling its manufacturing
will reduce costs as well as help it to expand research and development efforts related to hydrolyzed collagen products. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Zach
Fleming, Sanara&rsquo;s Chief Executive Officer, stated, &ldquo;We believe that this transaction furthers our goals by eliminating the
royalties we pay to the Sellers  on CellerateRX<SUP>&reg;</SUP> Surgical Powder and Gel (&ldquo;CellerateRX&rdquo;) and HYCOL<SUP>&reg;
</SUP>Hydrolyzed Collagen (&ldquo;Hycol&rdquo;), giving Sanara control of the manufacturing process for CellerateRX and Hycol, and giving
us full rights to develop new collagen products for human wound care uses based on the acquired technology. I would also add that Sanara
has an outstanding relationship with the Applied Nutritionals team and we look forward to continuing to work with them on new innovative
products under the terms of the agreement.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
assets that Sanara acquired include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
                                            rights and ownership (for human wound care uses) for four 510(k) cleared collagen-based wound
                                            care products including CellerateRX and Hycol.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
                                            rights and ownership (for human wound care uses) for three new collagen-based products currently
                                            under development. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
                                            patents, patents pending, trademarks and regulatory approvals related to collagen human wound
                                            care products owned by the Sellers. This includes nine patents and all of the Sellers&rsquo;
                                            patents pending for collagen products for human wound care uses, five trademarks, and four
                                            510(k)s. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
initial purchase price for the assets that were acquired by the Company is $15.25 million, consisting of $9.75 million in cash paid at
closing, shares of the Company&rsquo;s common stock with an agreed upon value of $3.0 million, and four equal annual installments of
$625,000 in cash. The Sellers are also entitled to earnout payments of up to $10.0 million based on future sales of a collagen-based
product currently under development, as well as certain royalties and incentive payments on future products that are developed. Cash
at closing is being funded through a loan provided by Cadence Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">With
a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes and develops
surgical, wound and skincare products for use by physicians and clinicians in hospitals, clinics and all post-acute care settings and
offers wound care and dermatology virtual consultation services via telemedicine. Sanara&rsquo;s products are primarily sold in the North
American advanced wound care and surgical tissue repair markets. Sanara markets and distributes CellerateRX<SUP>&reg;</SUP> Surgical
Activated Collagen<SUP>&reg;</SUP>, FORTIFY TRG<SUP>&reg;</SUP> Tissue Repair Graft and FORTIFY FLOWABLE<SUP>&reg;</SUP> Extracellular
Matrix as well as a portfolio of advanced biologic products focusing on AMPLIFY<SUP>&trade;</SUP> Verified Inductive Bone Matrix, ALLOCYTE<SUP>&reg;
</SUP>Advanced Cellular Bone Matrix, BiFORM<SUP>&reg;</SUP> Bioactive Moldable Matrix and TEXAGEN<SUP>&reg;</SUP> Amniotic Membrane Allograft
to the surgical market. In addition, the following products are sold in the wound care market: BIAK&#332;S<SUP>&reg;</SUP> Antimicrobial
Skin and Wound Cleanser, BIAK&#332;S<SUP>&trade;</SUP> Antimicrobial Wound Gel, BIAK&#332;S<SUP>&reg;</SUP> Antimicrobial Skin and
Wound Irrigation Solution and HYCOL<SUP>&reg;</SUP> Hydrolyzed Collagen. Sanara&rsquo;s pipeline also contains potentially transformative
product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement
and cell compatible substrates. The Company believes it has the ability to drive its pipeline from concept to preclinical and clinical
development while meeting quality and regulatory requirements. Sanara is constantly seeking long-term strategic partnerships with a focus
on products that improve outcomes at a lower overall cost. In addition, Sanara is actively seeking to expand within its six focus areas
of wound and skin care for the acute, post-acute, and surgical markets. The focus areas are debridement, biofilm removal, hydrolyzed
collagen, advanced biologics, negative pressure wound therapy products and the oxygen delivery system segment of the wound and skincare
markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Information
about Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
statements in this press release that do not constitute historical facts are &ldquo;forward-looking statements,&rdquo; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &ldquo;aims,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;contemplates,&rdquo; &ldquo;continue,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expect,&rdquo; &ldquo;forecast,&rdquo; &ldquo;guidance,&rdquo; &ldquo;intend,&rdquo;
&ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;possible,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo; &ldquo;preliminary,&rdquo;
&ldquo;projects,&rdquo; &ldquo;seeks,&rdquo; &ldquo;should,&rdquo; &ldquo;targets,&rdquo; &ldquo;will&rdquo; or &ldquo;would,&rdquo;
or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include, among
others, statements regarding the potential benefits created by the Asset Acquisition, the anticipated impact of the Asset Acquisition
on Sanara&rsquo;s business and future financial and operating results, Sanara&rsquo;s ability to develop and commercialize the new collagen-based
products currently under development, including the manufacturing, distribution, marketing and sale of such products; Sanara&rsquo;s
ability to maintain or replace the Sellers&rsquo; manufacturing and distribution process, including relationships with vendors, the development
of new products, the timing of commercialization of our products, the regulatory approval process and expansion of the Company&rsquo;s
business in telehealth and wound care. These items involve risks, contingencies and uncertainties such as the extent of product demand,
market and customer acceptance, the effect of economic conditions, competition, pricing, uncertainties associated with the development
and process for obtaining regulatory approval for new products, the ability to consummate and integrate acquisitions, and other risks,
contingencies and uncertainties detailed in the Company&rsquo;s SEC filings, which could cause the Company&rsquo;s actual operating results,
performance or business plans or prospects to differ materially from those expressed in, or implied by these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Callon
Nichols, Director of Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">713-826-0524</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>CNichols@sanaramedtech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>SOURCE:
Sanara MedTech Inc</B>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "P @\# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX [FN?\ &_[%/@3QQXZN/$MS<:C:-=S?:+NSMYE$,SDY)Y&5R>N#WXQ7R_\
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M5L;A8-=U$C3=-+<D2R Y<>ZH&;Z@5XU?$U,PG&%K,]>CAX9?"4[W/GO]M?\
MX*#W/@?5;_P%\,[B,:S;DQ:CK^ XM7'6*$'(+#D%CTZ#GI^=NWQ=\8/%$S;-
M7\8>(+LF1]HDNIY#ZGJ:TO@[\*];^.GQ,TGPEI 9[_4ILS74GS"&,<R3.?0#
M)]SQ7[:? S]G_P (?L_>$X-%\,:=''-L N]2D4&YNW'5W?Z]!T%>S4J4<K@H
M05Y,\>G3K9G-SD[11^26F_L#?'?5M,2^A^']PD#+N"7%Y;PR_P#?MY P^F*Y
M"&V^+?[+WB:'41;>(/ VI*VU)Y(WCBEQ_"<_)(OMR*_>;^=8_BSPCHOCK0[K
M1O$&EVNL:7<KMEM;N(2(P^AZ'W'2N&.;SD[58)H[I93%*]*;3/A3PS^VO9?M
M%_LN_$GP]X@6'2_'EGX?N7:.,[8KZ-8^98_1O[R=NHXZ?GI\-F;_ (3+3_G;
M&V3^(_\ /-J]Y_;8_93G_9C\:P:IX<>X/@O6O,2TD+$O:.0=]LS9Y!4\$]1D
M<X->"_#?_D<[#Z2?^BVKW,)3HQIRG1VEKZ'AXJI6E.-.K\4=/4_?[2->M-<T
MXWMJTGV<.Z%IHFC.48JW# 'J#S5'PGXZT'QS:W%QH6I0ZE!#(8I&A.=K#L:V
MYH4FA>)T!CD4JRD<$'@BN8\!?##PY\,[.[MO#MA]ACNI/-F^=G+-VY)/'M7Q
M*]ERRO>_3_@GUTOK*J4U&SCKS;WOTLCH1J=HUXUF+J$W0&XP>8-^/7'6N0^,
MWPIL/C-X#O/#=_<268E998;F,9,,B_=;'<<D$>A[=:\?TG]FWQ59_M!3>,)-
M8A71S>R7HD21O.96R?**],<[>N,"J'[>GCSQ7X-\+^'(?#]]=Z987T\RWMU9
MDHX*A3&F\<J#E_KBO5H85/%4J>&J^\];]GN>#5S&;P.(JX_#N,8MJV_,MKGJ
MGP/^"MG^S_X#O=+LKN;6;J61[R>X9-GFOM  5<G'"@=37QCIW[5GQ"\;>/UT
M;6;F.]T'6;G^S+K0DMU5?(E8QLBG&\-M8X.[/2OH_P#8;\;>+?&GP\U-O$L]
MSJ%K:W?E6-_=DF21=H++N/+!3W]R.U?'OQZ_;97P)^T-KLO@3P)X7231[V2U
MEU2^M6EGNI48J[@JP"9.1D#)')->KATZ>*KT\1!5)]_,\K$1>(P>%K8*HZ--
M?9UU7ZE[Q_\ \$U=&^&>I3Z_XH^*.GZ#\/DN 3-=0D7FPMD0J,X:3;D9'IG;
M7KGQ@^ _PY_;B\*Z!+\*/&NG)JWA&U73%217VFV ^1)%P'7!!(;!!R:\V_;&
M\4:_^UE^S+\-?B/X9T6[DL;"[NX];TVU#2FVF(1 ^ ,L@*/ANV\9ZUS_ /P2
M_P#ACXRC^--WXI^PWFF>&;73Y;>ZN+B-HTN7<KLC7/WB"-Q],>]<[=5T?;SJ
M6G"^FA["5-5O80A>,K:ZGU5^Q?\ L3K^S-<:KKNM:O#K?BB_B%L'M598;>'(
M+*N>6+,!DD#H.*^JZ**^<JU9UIN<W=L^BI4H48*$%H%%%%9&P5\L_MH_L6_\
M-/-HVLZ1K$.B^)=+A:V5[J,M#/ 6+!&QRI#$G(!ZU]345K2JSHR4X.S1E5I0
MK1<)[,^$?@[\ ?AS^P_X;UV]^+/C739-7\56KZ9Y<8<*MJ01(D:@;VR3R^ !
M@"O)? O_  35T3XI:G'KOA/XI:=K?P]EN3B6UA8WBQALF$CHKA>,GZXJ'_@J
M1\,?&<_QBT[Q4+2]U7PO<:?';6LEO$TB63J?GC; ^4L?F]\^U:7[&.N>)/V5
M?V?OB;\3O$FG7<6AW)MHM'TF[#0FZN@64R!2.%.Y1NQR$-?1IU?8_6(5/?E;
M30^=E&G[;ZO.G[D;]S9U/]JKXA>"_'QT;1KA;#0M&N%TZUT$VR,/)C(0(Q(W
M%R!UR.3QBOKK]I+]G?3OVI/A=9Z!J.H3Z'=QR1WUM>1)YGDR[>0R$C<""1C(
M/ YKX,^"_P"W)'XR^/NBWOQ \!^&9DU2]CM5U+3[1EN+61V"QOEF(?#$ DC.
M.0>*_5OO[5GFE2-.5+V5/DDEJ^[,<FPU6U;V];VD9/1.^B_KL>8_LZ_ ?2_V
M=?AC9>#]+OI]1$4CW$]Y< *TTKG+,%'W1Z#)^IKT1M2M([M;1KJ%;IAN6 R#
M>1ZXSG%6J^8_%'[-7BK6OCXGBR'6XX](:\CO/.,C>?$JD$Q!1V.,=>AKR:,(
M8B<G6J<NC?JSU,=B*^"ITUA:/M+M)J]K+N>_>+?'&A>!K&*\U[4X-,MYI!%&
M\S8#,>P_SQ6W#,DT22QL'C=0RLO0@C(-<O\ $#X8^'?BAI]M9^(]/^WP6\GF
MQ?.R%6Q@\@@X-=-:6\=G;16\*!(HD$:+V"@8 KFE[/DCRWYNO;RL=U-XCVT^
M=+DLK6O>_6_3T)J***R.L***\Z\8?M#_  T^'^O3:)XC\:Z1HVK0JKR6=U<!
M)%5AE20>Q%5&,INT5J1*2@KR=B3XL_ 7P'\;M*-CXQ\.VFJ\?N[K;Y=S%_N2
MKAE^F<5\>?$;_@DMH5]<-<>"/&5UI*8)^Q:M"+A,^@D7:0/J&/O7W5X/\::'
MX^T*#6O#FJ6VLZ5.6$=Y:.'C8J<$ ^H/%;5=5+%5\/I"5CGJ8:AB-91N?C?X
MX_X)L?&KPE(WV'2]/\4VP&?.TF[&?H4DVMGZ UX)XF^'OC;X3ZH@US0=9\+W
ML;;HY9X)(#QW5^,CW!K^@NJ6K:+8:]92V>I65OJ%I*NUX+J)9$8'J""",5ZE
M/.*BTJ13/+J913>M.31^-_P,_P""@GQ0^$-Q:VNHZD_C/PZKYEL=6<O,$[^7
M,?F4^F<CVK]7O@G\:O#?QZ\ V7BKPS<&2UF^2>WDXEM90/FB<>H]>]?GE_P4
M9_9'\,_"6QT[Q]X+M5TC3;Z[^R7^DQC]S'(P)62+GY0<$%>@ZC%5_P#@E'X\
MN=)^,'B+PH9)&L=7TTW8CW?*LL+#Y\>I5L5MBJ-'%8?ZS15FC'"U:V&Q'U:J
M[IGOO_!5KQ5)I/P%T71HQA=8UA%=@>T2E\?C7RW_ ,$O_!=KXF_:.DU.[@6<
M:%IDEU"'&0LKD(K^Q'./K7TI_P %:-!GO_@YX3U6-"T.G:T1*PZ+YD149^I%
M>!_\$I=<BT[X^:[ISN%DU'16$:^OER!C_.G0TRV;6^HJ^N91OMH?K'1117S!
M],%<5\9_!-E\1OA3XK\-Z@C26NH:=-$0IPP;:2I'N"!7:U@^.]=MO#/@G7M6
MO)X[>VLK&:=Y9#A5"H3R35P;4DUW(FDX-,_G\\/P26OBO28)1B6+48(W_P!X
M3*#^HK^ARU_X]8?]Q?Y5_/-H]X=2\::==D;3<:I%,5]-TZMC]:_H9M?^/6'_
M '%_E7T6<?\ +NY\]D__ "\L? W_  5US_P@_P /?^PG/_Z)KR;_ ()/>%[;
M5OC1XGUFX3=-I6D!;<Y^ZTL@5C_WS7K/_!73_D1?A[_V$Y__ $37!?\ !(O_
M )'[X@?]@R#_ -&U<&UE;M_6I$[/,U?^M#].QQ1117RY].%?@=^TM;1VOQZ^
M(L42[%&LW1 ^K$G]2:_?&OP3_:>_Y. ^(W_89N?YU]%DO\2?H?/9Q_#AZG[5
M?L\\_ ?P!_V!+7_T4M?E[_P4X\0SZU^T_=63R,;;3-+MH(HR<A2VYV(]"<C\
MA7Z@_L\'_BP_@'_L"VG_ **6ORP_X*4Z;)IW[5FM/(I476GVEPGHP*LN1^*F
MHRRWUR7S+S)OZG'Y'V'_ ,$K?!L6A_L_ZAKICVW6MZM(6;'6*)0J?J7K[/KY
M%_X)@^)HM:_9C@L%8>?I6J7%LZ#J%.UU/XY/Y5]=5YN-;>)G?N>E@[+#PMV"
MBBBN([#XB_X*M>!X]8^"6B^)DA0W6B:FJ--CYA%,-A7/H6V'\!7R5_P34_Y.
MRT#_ *\+W_T0U?9__!4CQ7%HO[-JZ03^^UK5;>%5[D1MYI/_ (X*^,/^":?_
M "=EH'_7A>_^B&KZC#.3RZ=_.Q\OBE%9A"WD?LE7Y'?\%3_^3E+7_L!VW_H<
ME?KC7Y'?\%3O^3EK3_L!VW_H<E<.4_[RO1G?FW^[?-'NG_!)7P EGX#\8^,Y
M$5I=0OETV%L?,J1*&<9]"9%_[YK[]KY!_P""6P _9@/;.N7?_H$5?7U<F.DY
M8F;?<ZL#%1P\$NP5^<'_  5WUI_.^'&CK+F-A>7;QY_B'EJI(_X$WZU^C]?F
MG_P5VTD1^(/AQJ:HWSVUY;NW;AHBH_5JTRVWUJ-S/,K_ %60_P#X))>!;.XU
M7QYXPGB+WUK'!IMLY^ZJ/N>3\?D3GTSZU^E-?G?_ ,$C/$5NVD_$/0FE47:3
MVMXD6?F9"KJS#V!"Y_WA7Z'CH*,R;>*E<,M26&C86BBBO,/3/ ?VZ_ MIXZ_
M9@\:17,2O/IMM_:=M(1EHY(CNR/JNY?HQK\;?AN=WC+3S_LR?^BVK]JOVR/$
M%OX:_9C^(EU<R+&DFE26JD]VEQ&H_$L*_%7X:\>,=/'M)_Z+:OK<HNZ$_4^3
MS9+V\&M[']!Y;:"35"SUW3]0TLZE:WL%Q8 ,QN8I T>%R&Y''&#5YEW+BJ-G
MH.GZ=I9TVULH+>P(93;11A4PQ.[@<<Y/YU\FK6U/J9<WV3*\#_$3P_\ $;3Y
M[WP[J*ZC;02F&1E5D*L.V& ->,M^V/\ "?QA\8+CX170GOM0DN6T]I+JS#V,
MMPN<Q9)Y.1C.,$]Z]E\$?#OP_P##G3YK+P[IRZ=;SRF:15=G+,>^6)/X5XR?
MV-OA/X/^,5Q\7;DSV.H1W+:@T=U>!+**X;.9<$<')S@G /:NV/U?GE:]OL]S
MSE]:]C#V_+S?:[?*YV/QQ^-VA?LX^%+"0Z7]IFN&,%AIMIB)#M )R<851D=C
MUZ5\/6O[(/A[]LKQ;KWCGPKXBE\&7%U>>=K&BWEJ+D0S.=S20R!ERK'<<$#!
MSVK[A^.7P1T/]HSPI81G5/LLUNQFL=2M,2H-P&>,X93@=QTZU\.VO[7WA[]C
M7Q=KW@;PKX=E\9W%K>>3K&MW=T+42S1G:T<,85L*IW#))R<U[6#]E]5?L+_6
M.OI?ST_6YX.*^M?7U[:WU6VGK;RU_2Q>\:?ME6?[&]U#\'?AGX=M=9L/#),&
MHZGJ[MNN;HG=*0JD8^8GG\ ,"OM/]F'X^:?^T9\*[3Q59V0TNY65K6]L0VX0
M3J 2 V!D$$,/8U\5^-/V-;/]LBZB^,7PR\16NCV'B8F?4=+U=&WVMT#ME 90
M<\CI^(.#7VI^S#\ =/\ V<?A7:>%;.^_M2Y:5KJ]OMNT33L "0N3@  */8"N
M'%_5_9*W\3K^MSV,)[?VKO\ !T_2QZY1117BGM!1110 4444 >=_'7XM6?P7
M^']UXANK0W\GF+!;6O022MG:">PP"<^U?*6F_M%6G[55O>?"KQ]HD.FZ9XB7
M[/:W^F$E[:<'<C8;/<=1].]?5OQV^$EG\:/A_=>'KJ[-A)O6XMKK&1'*N<$C
MN.2/QKY2TW]G6T_97M[KXJ^/M;AU'3/#B_:+6PTP$/<SD[47+8[GH/KT%?3Y
M?]0^JS]K_%^SO>_2W3<^)S3^UOK]/ZO_  =.;:UNM^NQYAJG[&GAG]D+Q1HG
MC3QAXBE\;"WO/-TK0K6U^S"XECPRO-(6;:JG:< ') K[I^ 'Q_TSX]>'[R]M
M+&72[^QD$5U9RN'"$C(*L ,J?7 Z=*^%M5_;*\,_M>^*-#\%^,/#LG@G[1>^
M5I.NVMU]I%O+)A52:,JNY7.T9!&"17W'\"_@;HG[.?A?4(_[5-W-<MYU[J-U
MMB3Y1@8&?E4>Y/UIXSV3PJ^L7]OT]/R_6YKA'BEF#>'M]6M\[V\]?T(=3_:J
M\#:7\4D\"37%T=4-PMH]RL68$F/1"V<YS@=,9-=_XV^(?A_X<Z?#?>(M1CTV
MVFD$4;,K,6;V"@GZGM7FB_LV_#GQA\1H/B/:2/>W$DZW86UNE>UFF'23C.3G
MG@XR*])\;?#OP]\1M/AL?$6G1ZE;0R>=&K,5*L.X*D'ZCOWKR:BPBE34>:UO
M>[W\CU*3S&5*JVXN5_<[6\SHK>=+J"*:)@\<BAT8="",@U)4=O"EK;Q0Q*$C
MC4(BCH !@"I*\Y^1[BO97W"BBBD,*_+W_@JW\'9]+\<Z%\2+:(O8ZI NFWKA
M<B.>,?NR3C@,O'/<&OU"KDOBE\,]"^+_ (%U7PGXCM?M6E:A'L?!P\;?PNA[
M,#R#7;A,1]6K*IT.3%4/K%)PZGYW_P#!,G]IS3_!=U>?#'Q/J L['4)_M.C7
M%PX6*.9O]9"2>F\X8>I)K]//0U^'7[2/[)/C7]F_7Y_M]G-J?A=I?]"\06T9
M,3@_=63'^KD'3!ZXXS70_"7_ (*#?%[X4Z;%IB:M;^)M,A 6*WUU#,T8]!("
M'Q[$G%>WBL L6_;X=WN>'AL<\*O88A;'[2T5^8MG_P %<O$T=N%NOA]I<L^.
M7BO9$7\ 0?YUP_CS_@J-\6/%%G/::)::1X5CD!47%K"TUP@/HSDKGWVUY\<J
MQ+=FCT)9IADKIW/;O^"KGQ9TA?"&@?#JWG6XUN>[74[J)#G[/"@(3=Z%B>!Z
M#->3_P#!*7P;<:M\;]>\1@,MKI&E-"6Q\K/,P 7/J N:^8O _@#QY^T9X^DM
M-&M;WQ-X@O9!+=7L[,X3<<&6:4_=7Z^G%?LM^RW^SKIO[-?PPMO#MM(M[JUP
MPN=4U!5P+B<CG;WV+T /:O0Q+A@L)]63O)GGX=3QF*^L-6BA/VNOA-)\:O@!
MXI\.6J[M2\C[99 C.9XOG4?C@C\:_%[X3_$34_@Q\3M"\66<;K?Z->!Y;9CM
M+J#MDB;ZC(QZU_0+7YI_M[?L+ZE'KFH?$GX=Z:]]:71,^L:-:KNDBDZM/$O=
M3U91TZURY7BH1O0J[2.G,L/.5J]+>)]\_"?XK>'OC-X&T[Q3X9O([S3[Q 65
M6^>"3'S1N.S*>.:[.OP'^$7QV\;_  )UQM1\':W/I<C,/M-FWSV\^.,21G@G
MWZCM7U;H/_!6GQU:6I35_!VAZC/MP);>66 9]2"6_I16RFK&7[K5#HYM2E']
M[HS]2Z^ /^"E'[5FFZ9X7N_A/X:O8[O5]0PNMRPMN6U@!SY)/]]CC(["OG/X
MH?\ !2?XN?$/2[C3;"XL?"%G,"K/I$;"X*^@D8DJ?=<&M_\ 9!_8EUOXGW%Q
M\0OB!97%MX4@AEN[>WOLB;5I=C$.<_,(P>23][MZU=#!+"?OL4]MD9UL;+%+
MV.&6^[/D?PS_ ,C+HO\ U_V__HU:_H?M?^/6'_<7^5?STZ9@>.+(  *-6C
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MS1]:?\$M_P#DU_\ [CEW_P"@Q5]>U\A?\$M_^37_ /N.7?\ Z#%7U[7%C/\
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MH!4@X! XKS7[+DC:_-U_2Q[4?K*JSYK<EER][];_ *&E10!M  HK$[0HHHH
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M(Y(5GC=)%#QL-K*PR"/0BOGOXE_L$?!KXG:A/J-UX;.BZC-_K+C193;9/KL
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M82Z?*$D@U"!1+&2#M88)&#ST/K7D'Q)_X*-?"_X9_$RZ\'7EKJU^UC<&VO\
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M'_AB_P! UJ#[3IM]'LE0':>N00>Q!P?PK=IN=S<&MJV)JUJOMY/WCBP>7X?
MX98.DO<5]'KON<!\'_@CX:^">EWEGX>CG)O)1)//=2;Y'P,*,X P/IWKY/\
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M,/##4?ACHKA1116!VA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>smti-20230801.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaGKSbP9z5Z8uekhvWBybXmavyYkfesH7y4NjdH2EakB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:SMTI="http://sanaramedtech.com/20230801" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20230801">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20230801_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20230801_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>smti-20230801_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>smti-20230801_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sanaramedtech.com/role/Cover" xlink:href="smti-20230801.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140692546719760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200 Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20230801.xsd" xlink:type="simple"/>
    <context id="AsOf2023-08-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-08-01">0000714256</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-08-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-08-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-08-01">2023-08-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-08-01">SANARA MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-08-01">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-08-01">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-08-01">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-08-01">1200 Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-08-01">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-08-01">Fort Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-08-01">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-08-01">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-08-01">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-08-01">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-08-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-08-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-08-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-08-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2023-08-01">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-08-01">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-08-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-08-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#N^>Y?#3F*NUF:7?0$%OC&^D+*G/*"YXLLKLH[=<\X_!/3-7S$C$5R#D7/5
M5^U?PO<#+=/BQ7<I-;Q&%YL;SN ),"? \964^FU@WJ7+OT+&_P)02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " ",2@)7F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M (Q* E<LL#4^7@0  !81   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " ",2@)7GZ ;\+$"  #B#   #0
M            @ &A#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( (Q* E>7
MBKL<P    !,"   +              "  7T/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( (Q* E>JQ"(6,P$  "("   /              "  680  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " ",2@)7)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " ",2@)799!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex2-1.htm</File>
    <File>ex99-1.htm</File>
    <File>smti-20230801.xsd</File>
    <File>smti-20230801_lab.xml</File>
    <File>smti-20230801_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20230801_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20230801_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "smti-20230801.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20230801",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "AsOf2023-08-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://sanaramedtech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "AsOf2023-08-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-23-026375-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-026375-xbrl.zip
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M&#;XG>;R7W3JM@8>/:B.X8]"Y]%X<9-K==+N#UN=;KW6Z;[M]3^TAIU>5YQ
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MY%2 0;W^^ ;H[&U[, #*:)W5:X-V_U/GI U[]Z[?;B-EOG[\\0WSKNV8LMW
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MDT%=")Z#5ZW9IL*4]11T*KS@98):EIHKVB?'HLUED*0Y/J%F\SA=*%HT*P/
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M+U4,FL9PFA::E9U0'!P\!FXG3I'C9EKL_7SXI'%P<- \.-A'29C]MR[$;75
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MROD$JG3'+)!ZN@QW4Z99TCU[='BP]V4?Z!+D%9)+X(Z,M$;7EJ6^*D75:S)
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M/+(P7Q1=(V-'2O6:"8H0:&;?E N^-IYG?0S-<A:4%Z\D5!):\:F268U@G:9
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MY17RV1U=;A5=!ON$G.5J1BY7C$09HOCKT%I<L=%';"I]+TX/]O"49FJ69O"
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M^*9Y'CN<@DB),8(XO8:X2/%?ND0YOTO1 A@[!Y9;(+F!;T+L^@^XIW08!3;
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M 1L\HV?[*Y:6=*G&GB_61"1PC(@QI&E,S%U&IEAP/'X*U*<IWX/ZH#^D'^U
MH-U42HO*:T54,L!A=%<2/:N(%A9SA2G7Q()0@JB646@[%(%,S,G@:@:ARR3F
MK 4"#2H(* "#1IW9T3X-LQI%B8$0'T6Y2=->'\ GLB)6#O("CEJ1F6SBTMWL
M1I:Y76#G>]EZO>;@"4HC<<MKPNR8*#?29F3;(]R: 17 W,5[!7U/08R]7"!$
M0<O+++8%.5OOSUK5#'%; P)NK+FMNXM%'TS4+-F(%R8H@#Y6XG5- D0EE-#L
MC[%H^ROI1R)C7@O.F/'*I$!(4XSWPQ&ZEY!S*80=A2?_2",JTF[6R 3[-<1J
M1=,R$I O>1M\1<2(B/=XA4NOG"KVB4DS+C*!8OR]%)(YHWYB7)2)@&B8X$!U
M82S>;" W(UD[:3^JP@\ -X4QG#G=+XEALL=-L0Q3<H.P!KR:&TL]FM*JZX9@
M K*Q1G(N?(O,CM<_V/F]<.DIP B2D!!W/!%D6!4@3,@@2\9(D7CXW*](622X
M.L $0UXV5/%R"3"11(AB1'C&C*,K[.GOILP*62!&7 @W//)0I6&)0+Q1T@&:
MM2P9Z-BXQ-B'5B2$_<#%SH$Q%0$?K?6^MQ&<(SN+>T?L#S#;_<4N6NBVHH5>
M[**%MB9::'?GW=*=]]R6<\5B8R;ERR_INIRJ]BUL)5*G04%A"=<DBG$Q4Z=R
M2X*YH3O/9J%9;9M1:TD.!*F*KC2CI5A]9\T3W#+>R%%24"*<#>P&^8[[DAJU
MG*6A(X 7Q4:HKRHH<@M7ZB?(V4Z$B6J'ATS.8)G#M'2U1\9 QA!J%(#AVC<)
M#<L36)=*PP8NK^Z;A=3$?6C0OYI,$G:$I7ZYM"4E<O":S;EW=_CN\%[_\+XP
MA_<=F@P850V4UM(F,=P@"D[H>1;HJAFL&W1T3+2R=$XX5/CA7"6)7L07,HED
MB661J0EHO:3X<49%,HZC@#@'M>*TVLY2R@IA@H/(R99?5WS,A:5OT!0WJ(68
MR9%A#L^W]$/-:GJIQ))"CJ#&$T8"9XPJ8C"ZK$G#"3;!7>%G[H[0+1VA7\T1
M:I,*5Z^YT[+Q%/E(DA[?M_7KKJ$+FEI*-L-MK=['Q9MT@?X49>#I@*SG(.KC
M!R!')3,+!8)7'R=G)2HM=-DY3-TBRA"N,J:P67 .W[ZS/"*0I)MHW'"8+D3W
M>'-0QCC[9))4!%$6%#.<6&"!;0AMA#)R5[+J2(UMB*2(8RJ9:)+&6.>LY'9R
MYKFM5XBM$1SB4G;^9NR6W9%\L/-[T?S-FF&XL%=%'G7^'C@*7(V+3P:P\(SR
M]B@1:R_:QQS+J8E@Q3QB=B]BB.XEIRO:NF$YU0HC)0AENE6C.7PUP;99>",G
M9;U&WWB0B:NU&W(*LJ6R:IRF;JP]E)U5.CC7MO *9@!3H&!=)SMR\:<8?5,8
MKHMO>.S*@K-:WL37-MS%<.*-%(X-.".0&X&/O-ZH9&';*LE^48UEX0 +>]+Y
M;&#&/7E RLQ+RN.U4L;"3]P>R>1+5LSS@/"/=!I##_AWAB$&($_\6S)6!2)H
M0\]1,2/[M,5Z(D&"I'N7W3;/0%2.YC$FRWE@CE2_@T UD>_"PD5^K5'C<BY+
MV1D'B5$:8&7,3U[SA'Q)Z*>$'8\[Q=1FZN)1S60TL-=K(T*AM+/W/3A$K1/^
MR!G!I@(<9NY;=&?E3WD=/@)OJ</$A&\B&"-*9P0N2XA*. 1*FF6!)=DX#I.:
MS%H+2EGFD6G$H!^YS= E$,T)GQ5"QHK'0'KT%8I''FGSE:7G")=B:VFO=^CO
M^/6#G=^+YN&!2P0A,WD6/F++\C'5=@@BF46^IW1HRB,ZI]]F1 GT.SG ,6 3
MF/2^IG*$+\IP[H:I?;G,>,M2RF6193H'VM3ZX\+S]BSGZ_1\VQ%ASR9CIF57
M4'GDYKQPEX5S"*ZO:+$C_@<[/R#^L@AL@:S1V&60CM[*@+@WJ,SD)T7']D:M
MPCJ'[6T?,1 W.7@R4DI=ZZ5:3D$G%0L72N#G2R=A*IT#Q[UD:THT18O$!J_U
M"LQ5GK%[V6G#I)58>YN5-1"'T-TK36_BVDW<X+VOMT=4 G#@NH>M1B1P]S);
MM.!9JXWL*GT_B!Q(=N#\TY$_XD--*(3@+661_:OTP6S-;.WV??^)7</[^.O.
M^WA;WL=?=]['A^Y]W"*FOR&G]JCY_*YR:BGMIU[[W!EVVX.!^/R^W6_WWN(1
M6 OBM>PWJP@.+"@H5RUC4P6-'T],*(^_?]R7V<%?7H0*-]C(-7ZBL^GQANMW
ML(:+_&1/>LDYKMO>+:XS\*1R6"<]7.;NWW]Z\I?7]"[2N2W_W.W*_1CB;C.^
MYQ$9M+JM?HM']J%].FR?O!>=[DES=V3NS2[=[R/S"H3N$+TG[O8GI<?=CD>D
M-=S)?IGV-XSG+]_K3V]TX,>+EU>.^EOZXW\P@6<O;G0&H/<]UH]YX$O@ ZRW
MW4\"O6/JVPW+#<L0"8]E+4S%#THJNXOEN\_TWFW&1@"0W;;<KR'N-N-[GI'3
M?I.']:[=Z[]KB].F.&\/.\/>[LS<FVWZ/F?FOQ3['Y:2\C UD]O21CP<'N0'
M5.DPW>DDNV&M#@M(Q=P?57I)UY.*\;'=AM?I 3K*;O3\+@WV"G_\;Z]$;T[!
MDR_%&:(![YSR-^J4_^U&G/)WE_CJ17$\/NZ=_H['\_'[X8>S-_\/4$L#!!0
M   ( (Q* E?2@\$*4<(  '#X!  *    97@Q,"TR+FAT;>Q]67/;2+;F.R/X
M'S =MSND"%@E>:ON<DU%T!)5YKVRI"O*75WS!I))$6408&.1S/[U<];,! A*
MLLN6:9DSM]HBB267DV<_W_GYS>7;DU^ZG9_?]'M'\&^ _^_GR\'E2?^7GW_@
M?^'7'^3GGU^?'?T>#"]_/^G_W[],L[3\*3C87Y3!93PW17!J;H*+;!ZE(7\1
M!D.3Q]._P(UPZ[G>5YH/Y9,HB:_2GX*Q24N3OPKN^ZQ7P3S*K^+T29DM?@K@
M<OO%*"O+;$[?_>67GX_/3B_]<3Z91O,X6?YTU]/IVB+^C^'!_.67OZ6C8O'J
MYQ_P@; BYXVY?.RX:7SNOU>!OQAY?#7[K(/_^?4O_0^S>!27W<[!_M[3GW]X
M_<O:J6RW9<VV\&)\YGWY^=TO)V>]TVZG]^M%O_^V?WKY\P_O?KEU@S[K9GSI
M*3[D!OU1%64\7<J7<3HQ^/#]O1=Q^IEW[?+-8-CMX,8%WKZ]_B78*6=Q$?PM
MF?R[RE[UKG)CYC"(O^7T>3> W\P',ZY*,PG,=&K&97QM@J@(LFG0JZY@_,%!
M&#S=?_HL#$;+ -XT[)WV+GK!V_[19?_P3= [/S\9](\"_'!Z=G+VZZ _#&$D
M)X?X^C"(@DOS 9Z7Q/,87Y+$T2A.XG(9C+/Y(DJ7P8X,[G66Y]F-R75L87 S
MRPH8S&22FZ* :>?!HLH7\%T1S$QN8(@P_(.G^_O!L)K#XX/>M4DK PM5P;N"
MYP?/823'65X&O\'_S$(9RH\O#_:?ACB7P]Y1__2P'[SNG?Z/#O=M7!3X?XM%
M'!1E!,\91>G[.+V" </+\ZB,L]0-&GZ[SX"['6_$SYX]"WXSL+0G6;8(AEF%
M8^,Q'_RXOQ\&;S)8^"RU _YQ_^F/,+9TTK(!@]/#O?I2MXWS/,J];8=E^0QK
M&ZQ9VKTMH]@43OY;MS,(+H/3H!\,X?_WX>\WR,Y_VO+S#>;GO[WI7_1[R$:5
M)P8S.%RY^7<%7 .8:#F+R@!9#S#OT@!;*+/ 7AJE<*ROHW2,/ L6>QXD&7P7
MIW";"19Y#+\LHB2(YEF5ELCH+V], ES_;9PDR#.0SYQF/QS V3_*DB3*@7OM
M_-?!TW ?>!/\M[>_3[PN'L_:WU3@>$8FN*JB/(+]AA&#[/B5/P&GR7@H>$<1
M%*9$]E/.B._$_'H9K-RR9-Z'$^YVX.DW.%!\9:;S+ZHU8_$7IO;:B.X:_0$2
M#R_"'\99.HF1:Q8RE&@*U[H!?CXBVQZ8SWM@3L]^@\-RB<?F^.RB'R+]P&X6
M\<2(' 0JQRV>5V4%I#_.0)@!83$91*H5H>A,RRA.@6 ]8LS@SCRXRK()?;R.
MDBH:):;^AI">GYNQB1=@U#!Y3:?Q.#;I>(GOEP.3&WHV'(AH_#[-;A(SN3*3
M4,D^-Z AI6,35 NAU]PL0$;#\"*F3;SP)LKQ8,2&%+6S$:QVEJ^0;;<S9>%,
M!S_*Z7I].4X:%;TI'/'LIOAI2]R;-A<0X;V+R\'A21^D^.,1V*R9'/6/!Z>#
MR\'9Z7!K7VXX>P4]O]NQY@&Q4I#"UIAD_L)\1*4OR/59E"2@MX!BP5RL6(AU
M.3=1"M<!)P,SZPJ9+0O@^><S'#9AU1XA(<"Y[8W_7<4%J4G E5*PD),$B2 X
MCY8D0W_"XQQ<PI:+Z=EVD1BB*'](=2.%#6AJ8J8D?4$0#JM1@00#4O!@[^E.
MM,N$!XKOV.0HI(->@:K9>96/03LVW8XER& 2H9;<]%]81P>(/U4*0QR"/@(^
MX;C?P!@GP:]Y5BV"0\^61L';6RR2&'X]K<J<%B%*8+U.3@[I04.3)"8O0I;_
M1_E>\*O)\BL3'.T%YZ:,RXPN.[M)Y<T1#'<"CYOFV3PH8?'I*,"_K ^@>V0A
M2X9K @HK['-9T7!0*S$@X!_7J0'IH ?G,TJ$C9@9'!ZR4,Q/&+B 3["[;+,8
M(DFTYY!"P$)"?PQRS9%)X42@D19:DGW8_=YRQ/MM*@@TL$"0C9V W:E,T.-6
M;=;I/)J #GX=Q0D9%+ZQ^GG-=;IH9/#M\RP78V!<P<7)$IAN,<[C$;-==# *
MVWVZ=T NY!6!OZ7 S:= D#[1S22[20/\"HQ"VM(C$(Q,F\=FE%=1OA3Q^'R[
MI]_ GKZ-RBK'V(G;QYJ2\_?'I0M\1SM[83<4-=#7H(S25X\YE *S^3]/G@3'
ML4DF/X%E<&5>P0/^71G4D(*#X,D32?OX^6CP3QU&8^PO<>RC+)^8W'[W.HG&
M[\%F> %+4V1)/(&97/9>G_2#P_[)R7GOZ&AP^NO__<O^7^CS\+QWJ)_E'?*\
M,0K310%CT;]>!3?QI)SAK/;_VK:YEQ?ZC&N# C9*=$UA]>N+G)@IW7&D=\BC
MGSW[JUNORZ.V*Y[#%>M^:][]P^4%_@].'_Z%A6Q9TU%NHO=/1FA+P%06M!$^
MT;RDN9W7MT 2)_1=Y_6G>QO[ ^XL;^:GT6];^L<C3NIX*$;TJ":SRE5/,\=0
M/2W\' SMN"@R4'SP"O$4@(9KKDU*G^",ES/2O5T^!'W/8?%V-P+IUV"IJQH/
MMW<[Q$;PV639W:+0X_=V_($5"B$\Z<I0\('&A/ZT>3:)I\!8*!00!CG8AS?D
M@J! 6,'?DE>!G08PKFXG-Y3(P-^4$MZ7 )CU)Q36H1!NJK6P>3+LVS\VTVF<
MQ*A\L$_B-R0T\=4B(:,'ZMSD!::21&!&Z@=TQ(7!),[A.B"*# U6_U,YR[/J
M:A9DJ<&/1$8Q;LG<3.(HCW%8AS">/$/B!7*1#XD!>ATMR0D"WU8I'J%Q-I_#
M.^42.@PA^PUY-*^"G=&N/U0;;?,NPB=Z'_^6%^B!+()BD56%@>?%(PPJATCM
ML-QX?(/Q+$XF.(X(GPGG#MUV/$T\)L4,+IUER02_GIOYB/Z-4A!X^"NP"?01
M8LQ-KL&#1*X_O%L8PAAU/3R/09G#MF,:#WM]QK!.2QH&_6! *N.YW!G7IDH>
MT2\_0AC'NB$&;H0X#V^-MS;E9AWVU[21:%=0#A#F;Q$I32+,L ARE'(+$F9I
M-0] %0<I);D1))2&9\<7Y)J,\%P_@3.)DM*D=/I%7&*6!9$ /#18)!6*%8PT
MPW.1)P<[S_;V_[K[JMM9Y-EU/-%D%K@_S4@(EQ(Y*GT[B+))0$W%P#9<SW3Y
M-OH0SV&@9"@%Z$T=PT]71NG6W3VI2"I'W@5V0MT.OV_D"WSRQW-$?IQ4$_+:
MK6H$2NWUU]HG;\E_4\G?(^<C4];\8TL^&KU:+ JWE3[&FDPBL2W[' EH;?TO
M&SXE) ,574FW0Y&X8A8O@D,TV%6S%M<:60WV2U"+KJ*<>(&5?DF0V2=@>AX(
M7K(+B/VXB]QK+LP5Z-&<,,0J2NT='C,"L@-6.W=Z.L6)"KBLF$8HW9<4+P#3
M@O5UOE$2F)"9QBG>+^E/E.B&X4J-,\!]6_[T+1"FHQBFRF<'P>'>\=[%7O W
MC(^_@ONQ@N;9_G8[-VP[Q3?0[0Q9SUXZF[C8*7 S=W\*!F V@1X$JA8;3NAK
M9!TC67** &8<C/'<AN0!*/1A+FT1U';*(N3<0/)6@E!#%P,EV- UW8[U6Z"9
M3PX%>!W^S?F"OC<C1FL)+2_@%&-2N_!:@_H:,J'(#8)L.BQE\-P<J%)&F)M1
M$'><D(% "<'1F%DDFGA^"@:F.GR\<P.O\!P;^!08*R9&7M5]'>$MSH[MJ=FP
M4U,5H'450*].%V,3Q9JZ:58""0XQ%D:6R[!*\6=,+"=G&7U(5;QF\SF8'BB%
ML8Z'TF@:Y368DAM5Y2S+82A$K5:4EQEZS^8H4<=)5IC)5L';\"D!"1U&Q:S;
M.4ZRF^ $+,H<XP\7R%1<@(TRNLCK FSGN*(<K",S O.4J8:,W.LLGI#2!==-
MLFI4BC6(?!9N\S+A@K8<-[ Z<_)'-[(C.7MCY^#I;L 6-)C&<3;911[9?SVX
M/.K)G>(O-F,SN>W&5P',V5K3-$7X(I@!;X7)X^>0C@YE@P=^&N<X2L:D6\B[
MQ*C!]0M:EB_4K#T9I555]3GP>B^A/-B)=VTBTS0NX*K@WU64ER@2@8?C6X=F
M49)7*GBVKVEZ\G2]\^D3?[*!W*B>+[+#YU52QIR7!W+EY2MX\]I7ZP..8%GQ
MQ=W.LX,U;W[QL6\^>/K#"WKYG6]_&^5 9?+FY_IFWB&\Z^\?_>H]>O/U72_^
M[RHUNM;/5V9\<,#O[78^9LX'!^*9O//M*]O]G$4SWF4B/'<-,BFM?K(RUG7'
MH6W,WZZ0?\2QD]OC_T]?!6<+4M5^PA=)E.E5\,\HJ?#G;7I ,P6@+4[NIPP\
M\9=;%_I5<+E<P A[>32*QZ^"4U"O>3-.,USBI[50OMZ%OSSYCE(06L_^]IA_
M)^HD>?>['; !3J(;IT-&DVS!SC402!$A!&@(9$KQR\B/2(3T,8EN5G\B<4:&
M-"A[I3@'H\D\3N.BU/K%7!T![":D #X]#X4P_OEK!DR%;'T0H#TV9[!R%K<Y
M%^N''0SS1923'Q!.!=8FPD#R*Y#F-O'A(\=BK6QYNA0P:DH[YR[ "*5^.0RN
M*E!5DYA#PQRLQ)@*Z-Z<[0#?HHTWBZY5,P6^P'HX3)@*0?!Y7/1K9]KMW#W5
M;#RN<M*MV>EQ2YJ':M2A:M*L1>/(<$;HCR4] T92SO /+KZ$Y;#5Q#"8?,G5
M44?99/+D.,>!_89:\[#,C2F#"V-]O(<@ZBHP53%%I92<BAX0DSI'9/70ZU$E
M2+)V%8O:,HIK@R+G%#V.BZ+B, 8,*94GE]8)]/'/AY4!'? JTAP8G!1J90,D
M&PZDP"8,35DFXI]B&PCC+PG,$^$D*%B<TKVD&%:@O%W'!4%6R/F [1T;3-6A
MR'T,YS?*W7;O!J('ODL)5V2(CB"LD2=O*7K']5+*-<#X)"B80",8% 0CJ*BB
MM&1/.(YJ,!B$8M#(I1R8'V'@Q\RY1@T]6-9(LJ<7F((:1APA2!!10])ZB*1,
M&HU+JO%%EH'N+[LMC\N?\*B+=PZM7U5R9902[/=>59L7/$1:7O4 LSP0*CF.
M4TG^&CI_IAP#]FG9!Z"G(:_HBF_7JGFDBH*5?=V."R?"%53LY07ZR*N#:4:K
M.83(<4'6,+]1ASKP;103N/W$LKF"6@#4@EZ@!=0D>;Y>H<[66_EI5$-9;<)3
M4+%<9$4!(H14K_8,NU 9QX((!_:=?R&E)ZH*+KD6D>VA7U#B%SDIT1,(QN]8
M$"0TKX^ H5@)TPP^O%$ANPAP!;WI\(;KC/R&"P[AC):B\/ @B&G=P&5[5EY*
M?A_<8]DDT'OC5S.1'[L=JARWI>)C."0&795<3@ZZ:;8E[@V?$A$WET\#1[3P
M/SO%+AM1'Q7Z9  S6Q7-4E%R(-EGKY&AE X*/]B+;W+XDQSRD046VM+0AD^I
M3D,"=/-I%%23L_:A#I9JJT]MV,9C0 Z3)\ P!./_,+LCE(?YZ2BLP(I6@>>B
M;A\54>/0E<9DYG%:%1Q2&D>+&-TKYL,"HPQEE>,4[ 5T10$B,_K@?W^]&Q"9
MPBV<I3!!7TH\JB3/ :0JYJ][8\?7DP^ARCD7'6A5!7F2:0GY! .6F&(;\NCN
M&9!LHK6L68109J09'IA  K,NS.>,3@8N/!G<$9WL=D17H#AM.U4T I2<P"L)
M*CKZG3J3\.*>O30%3D(Y *C*9ZF'5+++SH%NYU/"G6O#7\_X_:TO7A, M:'3
MSQ8!#5P ].[!O/B4 .$G!D7O'$VW\U!QTK5#<2%;C9U^5+CXLX1.@2168Z>!
M'SJ]>U^_3C1U\Z(5MP<EGVWCCP\<?WSVB../6US[;S"/8H-T8^3\%P:DR11C
M$ *\1J!2UNH)DAATPHG$\1"P%/0F#(]@:GE(@;*\6I1C4(3F: YE>5S-PWH:
M+09/@%%=8P -?\KRJRB-_R//Q$%H<":!46!9 SN0&#P=P:P,@J0F(*\XTB:Z
M(S65*#C=$JM"1>O+X4\<8'!E4KQ-+#E78.9CI74[^,?6<-LTXIQ&H.EX+DV.
MNQI)ID0'#I?ZD><F=)'GJYA"OG!-FH&  JN=)!MEGW]8Q!Z8;XP8>? UL+M9
MZ')_+8:SF"9(O]T. D83]5/^MT$?D>C\?1H&/%#&K!8$%QY[Y>T_KBMO#QM1
M/R5_C7C'.7M<25%KGR-^>]<\G=.K98I<J1TT)P,GEQ8[)/CPD3&IU _%#QUX
MW)Z9>YX9KD_4^C-7C$NNJEI%+M(;PTNHX\/5NU+=[11]Y;;L]@66W1(EJ:^A
M5CZ[I8:-H@9V8'@,5!Q#()<Y'L*JJO5NA.ISFB!8^#C6Q)TY^HU45!=E!I8'
M)L68M& .HTX1M"2O(I#S2" )Q9^HD#M*2"IW.UK/4Y4(>4[TDV$M)-;_C[,J
M9PR#D11OA)Q!P5ZXPM [Q>!D6!'/A8(1\O$8'D9)0R0)?NWUSK<4N6$4F5['
M>2;Y9=U.0^&4'*):#MJ%$WZ8EZ.>/.9>QCV.8I'5"#16_.LFR]]COPL3)5RA
M5D13@WELKA(_FH]BB@7%.<CVHLJG$5).1*Z.A$N]^#N"_!CI)TI@BT(I1S.(
M \0.V$E<< X<E90E)BHXYPF1"^"IF,?AOIYBX#2IRH@JT*C>%LO'.<UI/(/'
M G$7$J^MT-&+JF^9?>#YS:+_@+*0584KZJ6+;Z("\Y=VW#3).2#?A]Y]<N6:
M9^V21I["Z_#[-(M9J\@F-*#5U0]KX=J5?0+JJ+#<N,H-I<1A1A:AI/@^[# @
M!)425XN?":P&O;*P(G#=(BMP"8 O+<<,L0)4D5W3LH"54:!SFZ>33A)1C=:N
M<?!I2TPI5ZMKO# 8=C9H\]@_:6HQY?1@N6$Q OZ:<3J._/U$JJP)( G)CMY_
MG>'2);C<:""-F>M5Z/3G:/MR/$O P$HC2@$;Q8N929=)L;ME=1O&ZBX&0U_V
M]N>+)%L:T*U,J=K\((7=-5Y>%Z7]!@?_^/'Y[<#>V\W>L,V^9K G:S0YJ29H
M- O0I]!BHFV]TW"L@Z*MM1JW9+!99" 9F*C:N!1,)H4AIIF/HH3Q-V;&E)1/
M3.??E9^3=$2H=M0_4(.N_0:R+X/')ZR82WB38\FBKW <ES[8^X@L*:(\Q1!C
M+5&+]"V'<Z:EF#:Q$-5JE-XI>PP*D&GD<$']>I''*)$HP,,1:13U0)_H_\,8
MTACKHZ5)U@)SNF(6H35T+]NRR$<Q([W?)5=(PL96R?^F3@'F2#5/P25%)C5-
MV8-=F(+*XT$\\$?KT(L6<"R WA@N"_'I7,P1"'#J$A1;0"6HYL9+DW:9UKXY
M4'(G2Z^7#.7-<I(@6LFD04HJ1;)LA[]8P=I,.:$Q3JM(@'EJF=GLBO. -EN7
M84W-Q?<;0'V^#: ^< #U^3: N@V@;@.HJZ(NR3("QP!#K\?N=>QY;+/%U-6.
M +:@7$V=)QU&L__7K=&^:?N9Y:-X L^'[<3D/JK[P_W=(]6%(7XCS /VRRO&
MF)!U+?[QFJ_+]V\1@G&4OS>E>*=4.^"2A88GCU2#;H?+(4:@(_O*"CPF_J.*
MTLA5NTZY4E50BA"F=X*2A1QS"]*T@1(U,7)+=YM&=P0>U.U@0H;3E"5<\Q$P
M0??,RK6N]D&*Z;]FDFK[]A&GM\-0X'JS]+R<'%_/JC)(XGFL1=UJ?Y)?FPW/
M);P':'PLWV5HO$62I PTS@$?C-E0YK'G1AWZ/^)*[$H+O"K-33P?87P([LJC
M&PI><7 ],24P6R_I8[<1Z,9YE 0P;0=B,>@H@3+""#J<U5&&APP&!>L)A]?3
MS]7=0NY?35.);0GE]C!MUF%"GX X7G_5[!]T'&#NZX0\"%7*56?<10&CD^*
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M:!QSJ*H$44H7>A/@HN3"HO/*X_Q+<C,U><YZ)88&DZ@JC!R;$5C:]AFVR8=
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M>6,2T,'?QDE"J6(PYM/LAX/]_>"($(R*8.>_#IZ&^_O[^-_>_OZNHCK9]]M
M0*-Q4&L_NCT0M[B:!N,P?"MWJ'#CQ?V !]KGNQ:0;?WM4/3#&S]^'GO!>6-!
M@%;O,P69/V*^8+I+/*&$,(Y+PC=,/F;"?3%M?HU%T$4M(9]XR_;SX!?J2!1,
MHW$,&NS@%S<.]:!5*;VHN87Z<\LH0UNO["Z-QN.<<DVK4I^H^2#<GL4]GPX%
MHU-R02]&W^EVC6>VK8R+"55,_XMHR8$RA+1,DNRFV#ILZL/_FHX:T&W74X3N
M\PKI2>?66VAO/1U0CD6RI"+'4@@*RT5'!E:$:F;1+@-=GM3BX$48/-U_^BRT
MV!AQ6E&! WD&\H1U=GVH#;1/@?GOO"AGNZSW3[G;+N=WE"Z)%<$D$G96M?'A
MMVA'H%Z/O/<5ONF+>0=^?%SN@:_IL>IV7ONTU*NNX-5"2,_#ST_16*M+A5Y*
MA5A+#M=JSF1*J([,@FL589\RBJPJ;6ET.QM>JT%T.TC& 17KLW@SF/:\?#+-
MJCS8^?MSJ<#G+!#)+K SD>A^<_(M"TS:7Y#$[TW[_9R=X#W@$XYL'5?FORM8
M=7[_B\][3#?/WK@]\^!@?YMZ\,"I!P?[V]R#[R#WX&"-0-OD3(.O)X7'NX$5
MPI2K6!,2+QY:"L,'E#J;*86+^ .HF#LO]S^'_'UQM_P5;\B?DK_K9OQP&O/6
MV/O((SG9#;J=L_7$6MLZ\K_D9BXP1LTS@A#25PQ6Q/5_6+^SWI ,Y=C.\16B
M_[DVRCX];\.OWX#3&!NUJ,%L;G?..4RI=A"I&M)4&^+=;>ZM>$KP7V%;(O(L
MNC9<)8!XS)@)4%01<\$Z!%G @/=4J@;/3_S'><74K3YOIER%H@);SX?GLQ[9
M=:-CP"RJ'K7SG(C[DWCOQZPP9<+3"H?8O%M6N+[ Z#BN+:^')Y@DFFCE^]E#
MWQ_O_.V4VCZ/"]-T]:^XWO? &'=9ZZEFEVLS)W*;XPB74CDKU#&I#77]U-%?
MG$\H5YUJ^Y@EX6+X2)_X5E!"!.]S6QFVX5-ZNO?4Q:2P'$HR0U^!ID/=W>,Q
M;.\H!GOB/,_0]U]0L.I1+<(CW%?,"\2><IS%P%K .\[.TKW>4Z0,G^U.JYR.
M=2L@AC(PP2) /42XID 9$WTH>_5P&%.#J1M1OF2(9B]=C+D8J/B-UJHOI;7J
MR"39S<,K*EOJNC-5$:CK-$/,%>+]',%6].:0%-/U<BBD^*TD,V*4@6$J5 :S
M\1-9N<(1P%HY(J,Q*=H7L*EBRLT=*,R*X]@2S:81S9B(I@VLG5G1Z6UHI*M@
MI,R-E 8<TF@30IQ3$&I*GG0.L9HJX95&@0PMJ(_L$6W!8Z2J"5&5U58(!2HN
MF:(N,T%VK10)1R%GT!165?\6D&0'DM&"5QNT=HUTCQ)U/&;!B=# 53G+<AB\
M]!T"L4KN*1PP)B 2LH*%W"$T',4?J>'U>$U?R2/@$*G@9GX:LT5*A.EVR+TE
M#\+, ^PY)$-A6V7]:)B'LW."6B=4\)%PKNA]@IO+?BJ:+7)IK&F.$3A+FR\
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MAN_P+O]]ZUU^:._RWQ^Q=_E/'I-OP<FZU:@_4:.>>GYBJRRP)GV,H5^/>[?
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MU,;3R,VRXPDY.SYMN!*G C;KK=!*',=F3HP=(>]@SQ^8BU(@@UB2^6CC0I9
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MD!-\F\6W6?LE7NVW8'3-JWFW<X0=+8;<L"' K<O1%7.!)YN#&$.GV=4TP"*
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MF,:Q3A; VCT7O">)PP!=2,\ZU!;I04C'-;EL?!_GZC!2_(+)T,B&A >_TC;
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M !U<UT!VA@:V&],)X^L?,6G-6"#+D:*N12JS4(FG^,;66NV2# Y@PX."L&?
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M#.,ZB_?" /PC%)'[(0-(9K&JELEW+*/.:0XL=%K_L06&.=X3E$[4D!&2Z+J
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ML C!TWT-EL5GPER<P R[E4R1IQ*P[<(H7Y5G8?4<7=CHTV:W?%6VLAN6.RF
M=!.T=(<OZAH+Y^.M%5;Y:YL4 XV<XI8\@*N-;S51&)"GOQ3R]!B?O=QY'OS]
M(OC[9?#W#\'?/P9__Q3\_7/P]ZO@[UV)9)(ZXG^%C][]639*J?_4G_$,LF *
MD<V@!T<"^/+AA71EO0>KMGD\9Q;>CW09B-_K=UOC09RN!!.MJRX*?[BX2[WL
M+9,V?P-ZJ?LL=CKV;'MSHS[ZQF"DFBKL1I=6JJ#(V(;35KNN782WJP T%.&"
M=0JNF(C&=>1'%2F4V\+J:7U]^8@+<1FXZ>LUYI_JR7D>G)P+ZKXX%[1V7R5
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MJ;M:* $M1PN/J&;VEFE17B2YH<SZ H82\C>!4%JLOFXO%36PRSI!KV"1 8Q
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M[#.LK#C!B4EO&OXF"62:-5+P%3WZ0P:,0"6.UJ]<*_,Y\WQI.F>4Y(+Z)-;
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MMD<$_D1<<VR 6/]F^^U&1H*HT92K;ZR16'!*[J),\Q6H')_)4,Y3%7+#&D^
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MA_4>X\J_.1T-0PI2X*K#?D^FHC*TFH@F^16[UOC7O*YJL+[ 944/FJ('A5J
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M5+:C3P0@:N9?Y"']7BO [/Y"\M]^XK]S#.1)7J'Q4(+]AB8'1\%18Y%9PV:
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M8.<+@855:EV"B<K4+*FTF1^ P19<1UACI&F!Q(4C'\QV2=778S[$MCR0Z(M
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M7C+E9$/)!4NZWNY>RV(ZR;P/LJC''/=&=B*&IHX+Z?QPR!E#%M63W'*$&>-
MPJA+5JE.*2A\Y\1;7>YS(0,@.*9^9DC]XIGP1[&=8ZO7I%1T5A=94EXV\H[N
M,]T(*]Z^K?!41WM+M_R:NW81@10F3NVX"%UC4)_((TP6T3RI[.]S*:9C&JBH
M<;F7M9Y''^E *9U'M,2?I422_HT[;)Z4L#OQB-CRK?,]D24:!L@G6_12=V.
M//LP.GPW.+]GYL>'ELA?7QFA?/6P;_&U=;K3Q!:UR,0A=RQ==L?2:0MKH2X8
M"V'*QRY<N4FK^J25UM'@(-@L.XP64:QYV'PGZB;B1$.[&*YP+H::R=#C/NSW
M;N!:Q#_&ZE/DM9OZRLQC[H"^F'!"",,<\C%\BG6;[TH]QAX@PM2:O&/!E]..
M-9;S+I25!&)?X:PDS]Z#RQCN20](C(9][CR"[3;_=M=4.'.'\AB<2"UUV WT
MBRE^;EO$+3>1OC>=Y9%%.M2H'F'DW<EF;F3+NTDX_'9N7T"LYW6#NYE%ZB8)
M=7L@WAN!GKWEYU!,]7NW<TR9.]] D!=\,3_>*L=4O_>M2*:^,9CD10<F>6@P
MR8L.3/)5.TYLQ*[[WL_/AR5RLP?)ZD';H(:]T0RS]T%#'@S3/\_@%IBFYBT,
M;FBSWY7";34OMHZ^S6407KF[T,+^61XVIP+OEK)0P]?EN@']7AO?FK.,G\''
M9<BVMNS@_=Y5 %/BC+%+GW3]/#J3[%%%MFI%M^3.H"8!Y-N$;^L((SZY;ON,
M#04$NG*(=18%9H#!QAS9GM;#&38#*S6,1?&?E.O]J-0B<-N?B;;PQ^BT0VV0
MJ>SO[>_$N]3S#,,!6*B5L!;!LH^+S!CBMMS:WQ076*.$7(IB++,4!]07T"E1
M\TN8-!JC08E,O17 R<Z9[%@HES&@#_;"7O"&BU;AHD5=+'*JX&J9N7YO_=3Q
ME,]5Q+DU4)OP(Z&S*&IJ-5A2^IY8F,D:UWZ\:4M-,PVVTY6BV>;5D"DK<UAK
M9;*#E+?0-KFC<V0%&S]J-%>\OD35CD7Q])GK>AG/@+0*QXX*>E]'&>L$(NP'
MV!\%S N'")@QA(DX.-2!L!-8B33"SAA8S'<!+Y_,%S!&>IY4TLD,8URJEM:H
MHG )M4X!A&M$#I0P:N0FE+>LHH\<[Z"2:"=+WN_9IG=NBSZ>!=Q+=CKL$>&X
M1=0G(RH*$NQ:*(77^4V-W:?C&ZBY-6#?=$.&,[VVC5JG=9.,\%,RK^>X)DD^
ME2I"<:2(]]MN%F16QB /P7HP#4P1.7]S6O9%C%9AB#A3U]@LEL%&NWO!D8CK
ME:D<-PR87@U5N!I#=MK1NMTZ2Z4^DKXP3.,6T$$S@T Y-U=(;9B;!.(\X;10
MM)5UU&C #*O!2^XP[Z2H<6J6#)RPP][R4^Y[2CN97-K3+7HI--O!X\8LVN"X
MWQN\'0V'[X<GX_/O.FNVA1;64TFL#&(,^:&:.++8K19#:P'ZMV@T![8ZD!R%
M" \AYCEV0HLN?.)*K9X3_5ZCS6O$(Z("M,*:%^(ND==5%WC*93C<U)H-EXC:
M(7^*C3,9G&XKX24?Q!>8Y/E']G@([0K#+_5IFU*E?2Y,7S'88>UD)WN-24C+
M7*,V^"C236W).*%/HBF?Q B7T$#$T)(J2M4[NWP^4- G%5NE<8Q*_YD8?>0Z
M-SKA<_ZO0_F%[JDJJ[W&V>TOB6YN3>\&IUN$>5+T@&FEPC5+%09BA*#98BPS
MW>8D%.-(T7(P=#@B]Q/_6:I4,D07[.B;U:3L#MPU$SO"SJK/H+:.Z9(@/2W7
M\QM.$^+2N_3)W"+=S]B4AON8(.0IL*65^ 9@/?#+$)>AC5=H1F6T&:U59(_^
M;UI<>.\Z9BO5YH&PJCTZO\REA^"'9H_W!O8+.1]UUVJO?M58;R]:S$G'E)LF
MB$BC3H'H8\A?:#<6>7TAP'?>6*%<C(R$>H>%O(U"@N07U"J[6/J$A4SQ*>4>
M>"$H*$2EX47@=H)FQ8!K64_F2:EC2JA0\Q*4 E-ZPB:!X9.VP?$8"+[5623[
MHF=X+_"(8!MJ#ZJ=OAR;%9!*BQ.D#]%(.N3*K6DX)1$-9.#SXK"%:$50U70'
MK9$UPX-3)<"<CQYRV4<>KS*H@[Z;TA=QKCE9W'D*V;D0=Y59'K'J6',Z>#4*
MF!?6<\(#L3-BR!1NGIUX5^A1E"F, $=0\2A6(@(5ND3"UDJO"NZ<Q!/PB+\N
MT,'*W&"EDP(\8@UFF3F=0)O6U84K9Q2P$%@YCISE1 ?A4'P^1T3,A*QGNV?U
M#(*24(A![R'0#6X6TNAQ&-BB,M4@/#@+]=5LS$[S 7$5.TV]X:_T5&<10"_2
MQH;=<:@/9A=>;A0N*_,WFA: VAWP8ANU#IY]5*2)%2"QA(/7H@.TG-AV&A+W
M<+S[FH^+NVTY$40G:SYAW"S;1S;1;!64^H3&2<FM1E'Q,.D38VM#G^?),M/1
M<SKLV^94.R'C!X9I8S=4[5C9)N:7!V2,%D3^7"'^VL5<:5?'=7_6TW*UL(:%
MVR43-R,27G:(A(=&)+SL$ D=(F&C-3&264CV;PJC2KATICT"PU\D12 ! EM@
MBDVR%E$BB-[KO/C(K&^4$W<HX26L-<400YQ8\. UF!Z"L85_A?Y@T$9(LA+<
MCRS6!&VBS U1I537;)D^_ZXE*]:2!4M(&'&"!;)EQT$G+49F<8,%.>FJM.TE
MG*2DO0R#4.2TTT=K^XV%'??"1DG$E-D[X$$^+@DA1114N))JPC@IXGI><MK8
MU%H[H=TT^:@X 7@S4EUW2%X1#0KK7+<TB;!WCB,!$GB] 6W&5*(#[0TDFT'4
MP(VATCW%6Z/DM5<M*.@GKEXT/2M@MK(+4\TK>G2UEE?RJI77UV1]0,' H3B>
MXK5?(:Y9U,$4HW$;K] ;7(*BINXV._0Z\WF=8;&G).&G]&_=CH4*2< TTHAA
MUW?#IH#3/VKZ08[P J=S3@CO-;U053!7JN(/B+931^I*Z>VBZ8$CZ9MSX_N2
M3K+RQW@50XH@T9)^CX2QU)@Z+ F]+=O#@2*;[-'2"2^$ ;+(9*,(/"("6W)Q
MM?2D<H+_=*)A"&O+T]K?6^1%^IFIBTT*N[2'/0S$<>IQ_W(MH 90W3U"&HHJ
MUM]15(7YF"8(]W 4*=[X$GV'3G8WYO3%F N&SEU^9M+.? S2(<R')];/\/%)
M^6[=L\)-\$F6=FW%#$?R FEERX6JFAY>&O.B6+OA>B^@5W&=JSX+[SPN_!F.
MS1:DL<=BSEO)O.JTY:U5AIR%2#YO%#HY/)]K2OOU;\I5,VN::G?^S.;L'_24
M$<TH39>1HTESDN.GX@>O,S@-?#Q1F=NTV30QHX['B//#,MUNW3=GW=&/I;ZA
M@=?#Q\0U;B?8,45\C.7E'.PB*M$#1IT =F&WX)NSX.BF.C$K9%)JL#G=<<EU
M84N4><"(&\X:.%U2P254U*X]D[RQ;LC(H-LTU8E]FSZ^L4]Z)UT;(UUJU0P+
M-0<124?S.S:ZV4CCF,1ZL)9+!N(SX8.$:$#. 5=[H>E#Y$@4,I!>,IVSN5'.
M)G<YQ@I![.)3)1&?/&?$.A@,LBROLY@M6>EZ' E"TIC"9.N69-ZCIX:T$AKX
ML1HR<5!'V.C.0HY"$%HN_T9"D%H'L4S911.^N=[>%1HLT6MNH8FC+E=JSPVT
MLM_3&+ R=*&X+N+2Z4RU"M+5[!P.(4"2<:JBW7&Q;:UPZ.0N"(H51@F_S%(B
M%HG@AEP4\9$(1+!-K;@O)IC(A3I<-(E!(,:S$E:JY'+ ?*X!G!:RA=P@IG,Z
MSMLD86HV\AM,*639+.,(0'[<BD=9?FHU(564>%+!TA&9B0FY:^ICYK:$*ZV4
M.44F^LR!E9[",/Z (S#CILW2%YI^36]@6E>X4A'J&R O0GBW4 0=NGQWKA/5
MY"?$K:#[O(L(PM8DKCET<67^D =%0I"-7F6AI4RA>]GZ*7,AT;U-%:^/<T.*
MLEQH9E%G>+@V[HLX*&_$BBVP,*K.I!(4.YF"8C U4C!R@AXWGY87C64SX'6,
M/OH7XDI3KT4'%V/96GEF2'QM&!-G1P2D\1RN1JS<VF,C<!8.ZLXVI^78H<&T
M-W'O-<N!.--G'IKIIN+^*V( E?QN/0;C7COQ;<>FLL!UX<O20H1]5<AEDZDQ
MZ#COB66C5LH$L5VS33>8-8[^=!5M*>AZW"Z-$%V_YW3VIONOQI*; 6><IRAF
M]3&U>2]K?7H:6[,7X673&G4['%Z*4JC<4 [VHM2!@VK.,E-1V>"E==_9%(%5
MU.:=]&CLG$Z&6\J=NSM,F^A"-'B=5C_X,(/ )RQ_R%NW EW#.])AIYS"]P7V
M, \=X#Q]6+,Z%$9*-H9P4^(;>RPPVV7\W(P&^KE# STT&NCG#@VTK<UNOE%K
MFZ_@<CPGE^-5G7XT!<;8&LQ2C^CZ*SE9KR,T?6QC9UL.-<%[5/H>33M5!1^R
MA"+TMNH>_CDUS:K[/5U-CO7"*HMB[N1"AZS+=A<&+18?.--BZ?EEU+<[)Y/E
MEIT#W[M$<B?JD9)(AH[ &LIU;0.P<6*,Q47$=!9HC5["ZRB/X*+M=MP3&",H
ME\0CI^R]9W6!ABFB-3B19/-(1MY,NK4URP9VC\66K*22VCAL_$I%!UK"A#3E
M9;(06@CC23_2/HOIA=Q>*-@)^"8)^$L=Y='1%.QAS2@ 7\)WFO:Y#ND]VZ75
M=5B:UEWY?%=+;4Y$*3H]ZA*?M /Q2Y"Z<K;4[I<S5A>U "?"H+Z F0OVP^#@
M\<$3<0EFW%I DET53 GMMC+74!?V[>"C15Z6"3R[$]*-$E+N=S%*RH]X?A_#
M(K5IWT(9R&XAEZ*LJ#F#5T+7(0N)HH=[5T=S-"K1305YFB6%$XZ*(W#5TVII
MFIKV>U/A)&X$'RRD1J21:OJTO-YQ#(F4F1N?OZ42G<)(C-_"_<(Z'!U/B@BV
MUC>9LA7:,+IBMBN1_KY>Z:ENKG&(9:@@Z./HD]=5VD5+"10@SQ2(0"9%;;;*
M,W/BA?R],6"N,,#;B"8:MAL;/ /)J\3P72 ,WB:%*%B"ZECBI X_0XE9:.9C
MXHB2CW^5W]HF[7S/>=!"3<"Q6D0O1AQ'$HP#3LJ(@C0<$8MJ."SLAE:?(@-F
MN[$3O/8$ H*')AQ=CJ9$8T ]C1E<J=&B)@E!(6"3J*<D+@Q)A_XI8$RVFB@K
MC49R' 5*<K".<<C%)'"6>TNT.ME,OD2$&]+XQ,:T2*N8$'2JKISN)LUJYNX
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M]*$9-#[1EJQR4,_D6;KLS/;-,=LGMYKMIA[$VJMMBL0-*D63'%WKPN.>P_N
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MPD-Y0EC"*!%KA#/5]L"%^U+UFTV]VG76-3<T7S48:66EEU)&YR]A5X"S05H
MP2^_NS$'[3<7("#8R@"<RRA)]1H[);(M&<V5.'ID4G1>(M1J"X?O%N^1,#:>
M>7L#^HM+PF%;@W.*-C';J+"!N>,7%[-1,)+A"T$TA>.8NS+ &V W)A2ZT):,
M.2)O5 T,?@[[M,;XF2Z=FU&HBJQ<U!?PR0)\^Z1$#AX=&%_-0G-$Q$E-<E5@
M(/%2K[4JNS&2#S7NN</K1MRN&#*3,N>63AENAPRI XP"!)/D!49C'/"%0#/D
MCE@MK7#%==#&0#;H?;E:TOVYYX&9,7$REF*Q^ C2^' B<'11@SK:RFL#/;O:
MDP(W?.85] JVIC(,1F ;IDNC(ML%2F99A]'P2ZX'EM0RK#B). 4L\ZSC1-JL
M)"H7 PXLK=%(7424- G>UA'FZ4%L#O/Y'&3S'(/N78)UL\X33+!*[24H[*L\
MIMIYLDDX4Z"C'AZR:Z(R,(6<BHM;T7&2"\MF?!1%E<,7Y;).ZM'8\$,EL4X&
M55Q&A2JM&B'!HFR.I>P&G42B1BV7[- ;?:V/X8IZ@<DWR:VX':Q#HM<R%5Y3
M&Y[6O7SPT>!#MJ;FQCH,Y:?F\%:S(L(%:B5CV:<6[.WC[/?.Z,'N((W2-#M-
MDJBEE*0U*IPX_NSP$C;3CT]#_5P]YSHPNR,MC?H]8@>4:G?R"G;Q($9<3E3J
M*/_*U(;(:4.!=C?H'NS8,+5.S.&[4T"7[0]8O.2*'X;'SW6T""RQ)*5["0QT
M0<IG-R@C2LL8]B1*"5ZI940$[A?)K I-!BT,%F3X8&(RKN>3@B\RB10\QN#\
M# /BBK=9DFE2POPE.O&B9ZK?V\%+9C.F=)WFK5[)KK$X6N;H^E+1$QBM!()\
ME:<UF%M%@ND)\%'LGY0M7=KF'GC;8W"V.L6Z,8IU8A0K*U,3,Z9C4@/30-B8
M#[/*%U;3L8R+-B4W?'6+6[5XH7,C!9(SP.?X683W8'?=7*G;6ZZ*GD 0$TT5
MZ/G_-G"P4E#7".H&1YEV\75VRQ/_D#DU)GG^D5Z=,MK<8$'JHT2YK[ZNI^H;
MO,@W>LRZZP?S4*0*9FL*=KIN6&>;[5EE%,EE/GS0'G9VG-ZH"/W"CHK*9#$H
M6\!Q$?REG?-@$%?2@A[[?=D7T@@9&J#7>+1FIBV[%'BNZ+5U=&G*Z^M>NBL
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MP[2E;I]I7X,;GW'1VLJ -(,3(8AH+^[)DSH\SZ:]B]O=<?_Q]K5W?']TCD&
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M6A.7$4:.2J<SY=PC)-U39OSKBZMAN_4>O]\ SL]B4YPF9J0 W-UIJ_"]7TZ
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M=S!T_;$(GBOG.*:-]#0IXBGV/+L%S&H+=N37%HII>9%\M*V[][IGHYLU[HV
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M@-#I=@@0)(-0,\HG2',6<?',:X\[S/A6#H#[&8_A%4I/E%NH!C6AB59G2$"
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M3=?RD]RL-\F_5C@E<LM_ 5!+ P04    " ",2@)7QP04\ED'  #?5P  %0
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M*&"43"\D#FWLG8'&WMD+QUZ4C,\G"HEML3;<GE'W$\YFQ+^3+%@ O,\&DWA
M:M/[]_(M/VX_MTIS/P;V0S5VCRD4.,X6R9"\IE%G"3,T*5P:,$%$;%.J[;XV
M3W9>7PH: )P]E$#1*(_WOU'./PJY%"-*M!0T*6[U0T_XO46@44"<0ZR1BQ*"
MKY)GEI+*%X(JSSG@,84B1YP[],C#67M9+&K>7GN*%W>$B/M*0,$C3B*&Q2*M
M3S/4^<R>Z7MBR,;#$']?"2A_Q G%L%BT]?.J;R\\,QF>,S\PA-)&7 I;*0T%
M\B@EG-]DF@FJ@V/+@2$4,N*:UTII*)!O4ZIF=E#[H.32S#=[.T.P/06@T!%7
MM@:EXL!?_=A'7NQ_"Y*OL :_G0 1NU<DUFLWXM@MI"BNY"(ARD,]9 _ECKJQ
MTB^T8?+W9D[5[OU3[LS0YFVA10_UI:!10$E7H:)QKJT[._F#E]8].RAOQ,2T
M2AC.GJELPED\X)($[\OWS*!\$;/0"EDH>&^(>%+9PL3K!R5C2MWTB=Z>;8"$
M"%@!-"2(^>F+4. \+I!IZC83R?AI-+>B]7UF\O>86O^"#PV"Y:"AP=S$"1".
M=!>D?VSTHLG-^I%.J7++%,9T96YL0T_AFR) <6A\4-\H!,90$:;+SI&N.WO
MO:FV^,;]<F]CM4?^!U!+ 0(4 Q0    ( (Q* E>?;J#O]"@  $T= 0 *
M          "  0    !E>#$P+3$N:'1M4$L! A0#%     @ C$H"5]*#P0I1
MP@  </@$  H              ( !'"D  &5X,3 M,BYH=&U02P$"% ,4
M" ",2@)7E9VGK@]T  #X:P, "0              @ &5ZP  97@R+3$N:'1M
M4$L! A0#%     @ C$H"5\J)OE4_$   \TD   H              ( !RU\!
M &5X.3DM,2YH=&U02P$"% ,4    " ",2@)7G_O)M'$H  "$! $ "P
M        @ $R< $ 9F]R;3@M:RYH=&U02P$"% ,4    " ",2@)7X,ZI4BP#
M  #R"P  $0              @ ',F $ <VUT:2TR,#(S,#@P,2YX<V102P$"
M% ,4    " ",2@)7E86!@?X*  " A@  %0              @ $GG $ <VUT
M:2TR,#(S,#@P,5]L86(N>&UL4$L! A0#%     @ C$H"5\<$%/)9!P  WU<
M !4              ( !6*<! '-M=&DM,C R,S X,#%?<')E+GAM;%!+!08
1    "  ( -T!  #DK@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
